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ABSTRACT
Recently, there has been a resurgence of interest in rigorous and scalable algorithms for
efficient inference of cancer progression using genomic patient data. The motivations
are manifold: (i) rapidly growing NGS and single cell data from cancer patients, (ii)
long-felt need for novel Data Science and Machine Learning algorithms well-suited for
inferring models of cancer progression, and finally, (iii) a desire to understand the tem-
poral and heterogeneous structure of tumor so as to tame its natural progression through
most efficacious therapeutic intervention. This thesis presents a multi-disciplinary effort
to algorithmically and efficiently model tumor progression involving successive accumu-
lation of genetic alterations, each resulting populations manifesting themselves with a
novel cancer phenotype.
The framework presented in this work along with efficient algorithms derived from it,
represents a novel and versatile approach for inferring cancer progression, whose accu-
racy and convergence rates surpass other existing techniques. The approach derives its
power from many insights from, and contributes to, several fields including algorithms
in machine learning, theory of causality, and cancer biology. Furthermore, a versatile
and modular pipeline to extract ensemble-level progression models from cross-sectional
sequenced cancer genomes is also proposed. The pipeline combines state-of-the-art tech-
niques for sample stratification, driver selection, identification of fitness-equivalent ex-
clusive alterations and progression model inference.
Furthermore, the results are rigorously validated using synthetic data created with
realistic generative models, and empirically interpreted in the context of real cancer
datasets; in the later case, biologically significant conclusions revealed by the recon-
structed progressions are also highlighted. Specifically, it demonstrates also the pipeline’s
ability to reproduce much of the current knowledge on colorectal cancer progression, as
well as to suggest novel experimentally verifiable hypotheses. Lastly, it also proves that
the proposed framework can be applied, mutatis mutandis, in reconstructing the evo-
lutionary history of cancer clones in single patients, as illustrated by an example with
multiple biopsy data from clear cell renal carcinomas.
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CHAPTER 1
INTRODUCTION
In the near future, cancer research is likely to become much more data-centric, primarily
because of the rapid growth and ready availability of vast amount of cancer patient data,
as well as because of advances in single-molecule single-cell technologies. Nonetheless, it
remains impractical to track the tumor progression in any single patient over time, thus
limiting the methods to work with data collected from biopsies of untreated tumors,
although emerging technology for noninvasive analysis of circulating tumor cells and cell
free DNA (in blood and urine) is beginning to paint an incomplete, but useful, picture1.
Armed with the insights derived from such analysis, it would be possible to optimize
therapy design (see CHA [117]) based on techniques of supervisory control theory, as
well as to contribute insights for prevention, prognosis, treatment and drug design in
new and possibly, unforeseen manners.
Motivated by the increased availability of genetic patient data, in this thesis we
therefore focus on the problem of reconstructing progression models of cancer. In par-
ticular, we aim at inferring the plausible sequences of genomic alterations that, by a
process of accumulation, selectively make a tumor fitter to survive, expand and diffuse
(i.e., metastasize). Along the trajectories of progression, a tumor (monotonically) ac-
quires or “activates” mutations in the genome, which, in turn, produce progressively
more “viable” clonal subpopulations over the so-called cancer evolutionary landscape
(see [128, 86, 186]). Knowledge of such progression models is very important for drug
development and in therapeutic decisions. For example, it is known that for the same
cancer type, patients in different stages of different progressions respond differently to
different treatments.
Before moving on in the description of the framework proposed in this thesis, we now
describe the adopted model of cancer evolution.
1For the sake of simplicity, we will limit our algorithmic studies to the ones dealing with data coming
from untreated patients, derived from their initial biopsies and/or during “watchful waiting”. For other
datasets, the algorithm will require electronic medical records of treatments and tests. For the sake of a
clear exposition we ignore these issues here.
1
2 CHAPTER 1. INTRODUCTION
1.1 A model of cancer evolution
Since the late seventies, evolutionary dynamics, with its interplay between variation and
selection, has progressively provided the widely-accepted paradigm for the interpretation
of cancer emergence and development [143, 52, 40]. Random alterations of an organ-
ism’s (epi)genome can sometimes confer a functional selective advantage to certain cells,
in terms of adaptability and ability to survive and proliferate. Since the consequent
clonal expansions are naturally constrained by the availability of resources (metabolites,
oxygen, etc.), further mutations in the emerging heterogeneous tumor populations are
necessary to provide additional fitness of different kinds that allow survival and prolif-
eration in the unstable micro environment. Such further advantageous mutations will
eventually allow some of their sub-clones to outgrow the competing cells, thus enhancing
tumor’s heterogeneity as well as its ability to overcome future limitations imposed by
the rapidly exhausting resources. Competition, predation, parasitism and cooperation
are indeed often observed in co-existing cancer clones [128].
In the well-known vision of Hananah and Weinberg [77, 78], the phenotypic stages
that characterize this multistep evolutionary process are called hallmarks. These can be
acquired by cancer cells in many possible alternative ways, as result of a complex bio-
logical interplay at several spatio-temporal scales that is still only partially deciphered
[86]. In this framework, we distinguish alterations driving the hallmark acquisition pro-
cess (i.e., drivers) by activating oncogenes or inactivating tumor suppressor genes, from
those that are transferred to sub-clones without increasing their fitness (i.e., passengers)
[58]. Driver identification is a modern challenge of cancer biology, as distinct cancer
types exhibit very different combinations of drivers, some cancers display mutations
in hundreds of genes [186], and the majority of drivers is mutated at low frequencies
(“long tail” distribution), not allowing their detection by examining the recurrence at
the population-level [60]. One can also use the evolutionary models to characterize,
what may be called, anti-hallmarks – the phenotypes that are possible by the varia-
tional processes, but rarely found to be selected. For instance, certain collections of
driver mutations, whose individual members are often present in the patient genomes,
are never seen jointly. These anti-hallmarks point to tumors’ vulnerabilities, and thus,
novel targets for therapeutic interventions.
Cancer clones harbour distinct types of “alterations”. The somatic ones involve
either few nucleotides or larger chromosomal regions, and are usually catalogued as
mutations - i.e., Single Nucleotide Variants (SNVs) and Structural Variants (SVs) at
multiple scales (insertions, deletions, inversions, translocations) – of which only some
are detectable as Copy Number Alterations (CNAs), which appear to be most prevalent
in many tumor types [195]. Also epigenetic alterations, such as DNA methylation and
chromatin reorganization, play a key role in the process [9]. The overall picture is
confounded by factors such as genetic instability [190], aneuploidy, tumor heterogeneity
and tumor-microenvironment interplay [3], the latter involving stromal and immune-
system cells with strong influence on the final effect of mutations [68]. Furthermore,
spatial organization and tissue specificity play an essential role on tumor progression as
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well [142]2.
In this scenario, genomic alterations are related to the phenotypic properties of tumor
cells via the structure and dynamics of functional pathways, in a process which has
been only partially characterized [185, 191, 92, 147]. In general, in fact, as there exist
many equivalent ways to disrupt signaling and regulatory pathways, many mutations
can provide equivalent fitness to cancer cells, leading to alternative routes to selective
advantage across a population of tumors [141]. Practically, if multiple genes are equally
functional for the same biological process, when any of those is altered the selection
pressure on the others is diminished or even nullified [8]. Such genes, e.g., apc/ctnnb1
in colorectal cancer [64], therefore show a trend of exclusivity across a cohort – with few
cases of co-occurrent alterations. The same applies when disruptive alterations hit on
the same gene, e.g., pten’s mutations and deletions in prostate cancer [67].
An immediate consequence of this state of affairs is the dramatic heterogeneity and
temporality of cancer, both at the inter-tumor and at the intra-tumor levels [55]. The
former manifests as different patients with the same cancer type can display few common
alterations. This led to the development of techniques to stratify tumors into subtypes
with different genomic signatures, prognoses and response to therapy [30]. The latter
refers to the noteworthy genotypic and phenotypic variability among the cancer cells
within a single neoplastic lesion, characterized by the coexistence of more than one
cancer clones with distinct evolutionary histories [63].
Cancer heterogeneity poses a serious problem from the diagnostic and therapeuti-
cal perspective as, for instance, it is now acknowledged that a single biopsy might not
be representative of other parts of the tumor, hindering the problem of devising effec-
tive treatment strategies [128]. Therefore, the quest for an extensive etiology of cancer
heterogeneity and for the identification of cancer evolutionary trajectories is nowadays
central to cancer research, and attempt to exploit the huge amount of sequencing data
available through public projects such as The Cancer Genome Atlas (TCGA) [136].
Such projects involve an increasing number of cross-sectional (epi)genomic profiles
collected via single biopsies of patients affected by various cancer types, which might
be used to extract trends of cancer evolution across a population of samples. Higher
resolution data such as multiple samples collected from the same tumor [63], as well
as single-cell sequencing data [134], might be complementarily used to face the same
problem within a specific patient. However, either the lack of public data or problems
of accuracy and reliability, due to technical and technological issues, currently prevent
a straightforward application [42].
Nonetheless, there is a serious conceptual gap in the understanding of how such tem-
poral heterogeneous cancer data could be analyzed, since available Machine Learning
algorithms are not well-suited for the purposes, primarily because of their stationarity
assumptions regarding the underlying statistical distributions. To solve this problem
2We mention that much attention has been recently casted on newly discovered cancer genes affecting
global processes that are apparently not directly related to cancer development, such as cell signaling,
chromatin and epigenomic regulation, RNA splicing, protein homeostasis, metabolism and lineage mat-
uration [60].
3
4 CHAPTER 1. INTRODUCTION
rigorously, we build our foundations on the sound theory of probabilistic causality, orig-
inally proposed by Suppes [172] (see Chapter §2), and devise a framework, which for the
first time algorithmizes Suppes’ formulation, while taming it’s efficiency satisfactorily,
even for many complex situations that are specifically important in cancer studies (e.g.,
synthetic lethality or oncogene addiction). While the contributions of this thesis are
primarily methodological – strongly supported by empirical studies using synthetic as
well as some experimental genomic data – it is hoped to attract other algorithmicists to
this problem and catalyze new directions of explorations.
1.2 Two facets of inferring cancer progression models
The aforementioned different perspectives regarding cancer progression lead to the dif-
ferent mathematical formulations of the problem of inferring a cancer progression model
from genomic data, which we examine at length in this thesis [13]. Indeed, such models
can either be focused to describe trends characteristics of a population, i.e. ensemble-
level, or clonal progression in a single-patient. In general, both problems deal with
understanding the temporal ordering of somatic alterations accumulating during cancer
evolution, but use orthogonal perspectives and different input data – see Figure §1.1.
Ensemble-level cancer evolution. It may seem desirable to extract a probabilistic
graphical model (PGM) explaining the statistical trend of accumulation of somatic al-
terations in a population of n cross-sectional samples collected from patients affected by
a specific cancer. To make this problem independent of the experimental conditions in
which tumors are gathered, we only consider the list of alterations detected per sample
– thus, as 0/1 Bernoulli variables.
Much of the difficulty lies in estimating the true and unknown trends of selective
advantage among genomic alterations in the data, from such observations. This hurdle is
not unsurmountable, if we constrain the scope to only those alterations that are persistent
across tumor evolution in all sub-clonal populations, since it yields a consistent model
of a temporal ordering of mutations. Therefore, epigenetic and trascriptomic states,
such as hyper and hypo-methylations or over and under expression, could only be used,
provided that they are persistent thorough tumor development [159].
Historically, the linear colorectal progression by Vogelstein is an instance of a solution
to the cancer progression modeling problem [184]. That approach was later generalized to
accommodate tree-models of branched evolution [38, 39, 173, 12] and, later, generalized
to the inference of directed acyclic graph (DAG) models by Beerenwinkel and others
[10, 65, 131]. We contributed to this research program with two related algorithms:
CAncer PRogression Extraction with Single Edges (CAPRESE, see [117] and §3) and
CAncer PRogression Inference (CAPRI, see [158] and §4). Both techniques rely on
Suppes’ theory of probabilistic causation to define estimators of selective advantage [172],
are robust to the presence of noise in the data and perform well even with limited sample
sizes. The former algorithm exploits shrinkage-like statistics to extract a tree model of
progression, the latter combines bootstrap and maximum likelihood estimation with
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regularization to extract general directed acyclic graphs (DAGs) that capture branched,
independent and confluent evolution. Both algorithms represent the current state-of-the-
art to approach this problem, as they outperform others in speed, scale and predictive
accuracy.
Figure 1.1: (A) Problem statement. (left) Inference of ensemble-level cancer progres-
sion models from a cohort of n independent patients (cross-sectional data). Considering
a list of somatic mutations or CNAs per patient (0/1 variables), a probabilistic graphical
model for the temporal ordering of fixation and accumulation of such alterations is in-
ferred in the input cohort. Sample size and tumor heterogeneity hardens the problem of
extracting population-level trends, as this requires to account for patients’ specificities
such as multiple starting events. (right) For an individual tumor, its clonal phylogeny
and prevalence is usually inferred from multiple biopsies or single-cell sequencing data.
Phylogeny-tree reconstruction from an underlying statistical model of reads coverage
or depths estimates alterations’ prevalence in each clone, as well as ancestry relations.
This problem is mostly hardened by the high intra-tumor heterogeneity and sequencing
issues. (B) A pipeline for ensemble-level inference. The optimal pipeline includes
several sequential steps to reduce tumor heterogeneity, before applying the CAPRI [158]
algorithm. Available mutation, expression or methylation data are first used to stratify
patients into distinct tumor molecular subtypes, usually by exploiting clustering tools.
Then, subtype-specific alterations driving cancer initiation and progression should be
identified with statistical tools and on the basis of prior knowledge. Next is the identifi-
cation of the fitness-equivalent groups of mutually exclusive alterations across the input
population, again done with computational tools or biological priors. Finally, CAPRI
processes a set of relevant alterations and such groups. Via bootstrap and hypothesis-
testing, CAPRI extracts a set of “selective advantage relations” among them, which is
eventually narrowed down via maximizing likelihood fit with regularization (via BIC
and AIC scores). The ensemble-level progression model is obtained by combining such
relations in a graph, and its confidence is assessed via bootstrap.
5
6 CHAPTER 1. INTRODUCTION
Clonal architecture in individual patients. At the time of this writing, technical
and economical limitations of single-cell sequencing prevent a straightforward application
of phylogeny inference algorithms to the reconstruction of the clonal evolutionary history
of genomic alterations within a single tumor [135, 188]. Conversely, samples of cells
collected from a single bulk tumor do not define an isogenic lineage [20] and most likely
contain a large number of cells belonging to a collection of sub-clones resulting from the
complex evolutionary history of the tumor, where the prevalence of a particular clone in
time and its spatial distribution reflect its growth and proliferative fitness. To overcome
hurdles such as this, many recent efforts have aimed at inferring the clonal signatures
and prevalence in individual patients from sequencing data [63, 62].
The majority of attempts employ different strategies, usually based on Bayesian
inference, to relate allelic imbalance to cellular prevalence, and benefits from multiple
sample per patient, taken across time or space. In particular, most tools usually process
a set of read counts from a high-coverage sequencing experiment to estimate Variant
Allele Frequency (VAF). Some of them are based on the VAF analysis of specific SNVs
[130, 164]. Recent algorithms attempt to minimize the error between the observed
and inferred mutation frequencies with distinct optimization procedures [91, 122, 48].
Other approaches support explicitly short-read data and different types of data, such
as CNAs, SNVs and B-allele fractions (BAFs) [54]. Distinct techniques, instead, use
genome-wide segmented read-depth information to determine mixtures of subclonal CNA
profiles [144, 145], while others use a generative approach to deconvolve sequencing data
to clonal architectures [196]. Clearly, any of these approaches gains precision from high-
coverage sequencing data, since high read counts yield high confidence estimate of allele
frequency.
As already discussed, several datasets are currently available that aggregate diverse
cancer-patient data and report in-depth mutational profiles, including e.g., structural
changes (e.g., inversions, translocations, copy-number variations) or somatic mutations
(e.g., point mutations, insertions, deletions, etc.), see [136]. These data, by their very
nature, only give a snapshot of a given tumor sample, mostly from biopsies of untreated
tumor samples at the time of diagnoses. As it still remains impractical to track the
tumor progression in any single patient over time, thus limiting most analysis methods
to work with cross-sectional data3.
For this reason, in this thesis we focus on the problem of reconstructing cancer pro-
gression models from cross-sectional data. As already stated, this problem is not new
and, to the best of our knowledge, two threads of research starting in the late 90’s have
addressed it. The first category of works examined mostly gene-expression data to recon-
struct the temporal ordering of samples (see [121, 71]). The second category of works
aimed at inferring cancer progression models of increasing model-complexity, starting
from the simplest tree models (see [38]) to more complex graph models (see [65]); see
the next section for an overview of the state-of-the-art. Building on the works described
3Unlike longitudinal studies, these cross-sectional data are derived from samples that are collected at
unknown time points, and can be considered as “static”.
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in [117, 158], we present a novel and comprehensive framework of the second category
that addresses this problem.
Moreover, the framework proposed in this thesis along with the described algorithms
is part of the TRanslational ONCOlogy (TRONCO) package (see [4, 33, 5]). In summary
(also see Chapter §2), starting from cross-sectional genomic data, such algorithms aim
at reconstructing a probabilistic progression model by inferring “selectivity relations”,
where a mutation in a gene A “selects” for a later mutation in a gene B. These rela-
tions are depicted in a combinatorial graph and resemble the way a mutation exploits
its “selective advantage” to allow its host cells to expand clonally. Among other things,
a selectivity relation implies a putatively invariant temporal structure among the ge-
nomic alterations (i.e., events) in a specific cancer type4. In addition, these relations
are expected to also imply “probability raising” for a pair of events in the following
sense: namely, a selectivity relation between a pair of events here signifies that the pres-
ence of the earlier genomic alteration (i.e., the upstream event) that is advantageous
in a Darwinian competition scenario increases the probability with which a subsequent
advantageous genomic alteration (i.e., the downstream event) appears in the clonal evo-
lution of the tumor. Thus the selectivity relation captures the effects of the evolutionary
processes, and not just correlations among the events and imputed clocks associated
with them. As an example, we show in Figure §1.2 the selectivity relation connecting a
mutation of egfr to the mutation of cdk, see §2.
Consequently, an inferred selectivity relation suggests mutational profiles in which
certain samples (early-stage patients) display specific alterations only (e.g., the alteration
characterizing the beginning of the progression), while certain other samples (e.g., late-
stage patients) display a superset subsuming the early mutations (as well as alterations
that occur subsequently in the progression).
Various kinds of genomic aberrations are suitable as input data, and include somatic
point/indel mutations, copy-number alterations, etc., provided that they are persistent,
i.e., once an alteration is acquired no other genomic event can restore the cell to the
non-mutated (i.e., wild type) condition5.
In what follows and in the rest of the thesis, we use the notations described below.
Atomic events, in general, are denoted by small Roman letters, such as a, b, c, . . .; when
it is clear from the context that the event in the model is, in fact, a genomic mutational
event, we may refer to it directly using the standard biological nomenclature, e.g., brca1,
brca2, etc. – it would be especially true, in the sections describing applications to
real data. Patterns over events are mostly denoted by Greek letters, and their logical
connectives with the usual “and” (∧), “or” (∨) and “negation” (·) symbols. Standard
operations on sets are used as well.
We are not employing distinct notations to denote observed probabilities and prob-
4It has already been mentioned the known existence of various molecular subtypes within the same
cancer.
5For instance, epigenetic alterations such as methylation and alterations in gene expression are not
directly usable as input data for the algorithm. Notice that the selection of the relevant events is beyond
the scope of this work and requires a further upstream pipeline, such as that provided, for instance,
in [177, 186].
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Figure 1.2: Selectivity relation in tumor evolution. In our framework, cancer
patients’ genomic cross-sectional data are examined to determine relationships among
genomic alterations (e.g., somatic mutations, copy-number variations, etc.) that mod-
ulate the somatic evolution of a tumor. When it is concluded that aberration a (say,
an egfr mutation) “selects for” aberration b (say, a cdk mutation), such relations can
be rigorously expressed using Suppes’ conditions, which postulates that if a selects b,
then a occurs before b (temporal priority) and occurrences of a raises the probability of
emergence of b (probability raising).
abilities in the model which we aim at inferring (i.e., the “theoretical probabilities”).
Which quantity is being referred to, is made clear from the context. In the following,
P(x) denotes the probability of x; P(x ∧ y), the joint probability of x and y, which is nat-
urally extended to the notation P(x ∧ y1 ∧ . . . ∧ yn) for an arbitrary arity; and P(x | y),
the conditional probability of x given y. Here x and y are patterns over events.
As with the discussion of selective advantage structures, we write c  e, where c
and e are events being modeled, in order to denote the selective advantage relation “c
has a selective influence on e”. As we extend our presentation to general patterns, we
generalize the notation to ϕ e with the meaning generalized mutatis mutandis6.
Before moving on, we now provide in the next Section an overview of the state-of-the-
art on the problem of cancer progression models as for what pictured in this Chapter.
1.3 State of the art
For an extensive review on cancer progression model reconstruction we refer to the recent
survey by [13]. In brief, progression models for cancer have been studied starting with
6Note that the scope of this thesis is intentionally kept limited from further generalizing the “selective
advantage patterns”; for instance, we are not dealing with any example of the form ϕi  ϕj , where ϕ
could be any general pattern (including a complex causal pattern or a temporal pattern). This choice
is justified in view of complexity, practicality, applicability and expressiveness in the context of cancer
progression driven by somatic evolution.
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the seminal work of [184] where, for the first time, cancer progression was described in
terms of what could be interpreted as a directed path a directed path. [184] manually
created a (colorectal) cancer progression from a genetic and clinical point of view. More
rigorous and complex algorithmic and statistical automated approaches have appeared
subsequently. As stated already, the earliest thread of research simply sought more
generic progression models that could assume tree-like structures. The oncogenetic tree
model captured evolutionary branches of mutations (see [38, 173]) by optimizing a cor-
relation-based score. Another popular approach to reconstruct tree structures appears
in [39]. Other general Markov chain models such as, e.g., [81] reconstruct more flexi-
ble probabilistic networks, despite a computationally expensive parameter estimation.
Other results that extend tree representations of cancer evolution exploit mixture tree
models, i.e., multiple oncogenetic trees, each of which can independently result in cancer
development (see [12]). In general, all these methods are capable of modeling diverging
temporal orderings of events in terms of branches, although the possibility of converging
evolutionary paths is precluded.
To overcome this limitation, the most recent approaches tends to adopt Bayesian
graphical models, i.e., Bayesian Networks (BN). In the literature, there have been two
initial families of methods aimed at inferring the structure of a BN from data (see [101]).
The first class of models seeks to explicitly capture all the conditional independence
relations encoded in the edges and will be referred to as structural approaches; the
methods in this family are inspired by the work on causal theories by Judea Pearl
(see [150, 151, 171, 179]). The second class – likelihood approaches – seeks a model that
maximizes the likelihood of the data (see [167, 79, 23]).
A more recent hybrid approach to learn a BN which combines the two families above
by (i) constraining the search space of the valid solutions and, then, (ii) fitting the
model with likelihood maximization (see [10, 65, 131]). A further technique to recon-
struct progression models from cross-sectional data was introduced in [6], in which the
transition probabilities between genotypes are inferred by defining a Moran process that
describes the evolutionary dynamics of mutation accumulation. In [25] this methodology
was extended to account for pathway-based phenotypic alterations.
This thesis is structured as follow. Chapter §2 together with Appendices §A and §B
describe the theoretical foundations on which the presented framework is based. In
Chapters §3 and §4 two efficient algorithms to respectively reconstruct tree-alike and
directed acyclic graph models of cancer progression are described. Chapter §5 presents
an R package which implements the described algorithms together with a series of func-
tionalities to support the researcher through all the steps of the analysis of cancer pro-
gression. This package is then adopted in Chapter §6 where a detailed analysis based on
a structured pipeline is performed for colorectal cancer. All the supplementary materials
concerning to the previous Chapters are reported in the remaining Appendices. Finally,
Chapter §7 concludes the thesis.
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CHAPTER 2
MODELING CANCER CLONAL EVOLUTION
Based on the discussion of §1, in this Chapter we will formalize the adopted framework
used to model cancer clonal evolution. In particular, we will define the proposed model
of selective advantage through different levels of complexity.
2.1 A probabilistic model of selective advantage
Central to the model proposed in this thesis is Suppes’ notion of probabilistic causa-
tion [172], which can be stated in the following terms: a selectivity relation1 among
two observables i and j is verified if (1) i occurs earlier than j – temporal priority (tp)
– and (2) if the probability of observing i raises the probability of observing j, i.e.,
P(j | i) > P(j | i)2 – probability raising (pr), see §A.2 for a deeper discussion of the
philosophical aspects of this theory.
Note that the definition of probability raising subsumes positive statistical depen-
dency and mutuality (see, e.g., [117, 158]). But, it should be emphasized that the
resulting relation (also termed prima facie causality) is purely observational and re-
mains agnostic of any possible mechanistic cause-effect relation involving i and j. When
through this thesis we term any relation to be causal, we will use this word with such
an interpretation, i.e., ignoring any mechanistic behaviour.
While Suppes’ definition of probabilistic causation has known limitations in the con-
text of general causality theory (see discussions in §A.2 and, e.g., [80, 98]), in the context
of cancer evolution, this relation appropriately describes various features of selective ad-
vantage in somatic alterations that accumulate as tumor progresses.
Therefore, in this framework, we implement the temporal priority among events
– condition (1) – as P(i) > P(j), because it is intuitively sound to assume that the
1Suppes describes such a relation in terms of causality; however, here we avoid this terminology as
we build on just two of his many axioms, which give rise to the notion of prima-facie causality.
2Please remind that we are considering cross-sectional data, hence without any explicit measurement
of time which needs to be imputed.
10
2.1. A PROBABILISTIC MODEL OF SELECTIVE ADVANTAGE 11
(cumulative) genomic events occurring earlier are the ones present in higher frequency
in a dataset. In addition, condition (2) is implemented as is, that is by requiring that for
each pair of observables i and j it holds that P(j | i) > P(j | i). Taken together, these
conditions give rise to a natural ordering relation among events, written “i  j” and
read as “i has a selective influence on j”. This relation is a necessary but not sufficient
condition to capture the notion of selective advantage, hence additional constraints need
to be imposed to filter any spurious correlation (see the discussions in §A.2). Spurious
correlations are both intrinsic to the definition (e.g., if i j  w then also i w, which
could be spurious) and to the model we aim at inferring, because of finite data as well
as presence of observational noise.
Building on this framework, we aim at devising inference algorithms that capture
the essential aspects of heterogeneous cancer progressions: branching, independence and
convergence – all combining in a progression model.
Furthermore, the complexity of cancer requires modeling multiple non-trivial patterns
of its progression: for a specific event, a pattern is defined as a specific combination of
the closest upstream events that confers a selective advantage.
As an example, imagine a clonal subpopulation becoming fit – thus enjoying ex-
pansion and selection – once it acquires a further mutation of gene c, provided that
it also has previously acquired a mutation in a gene in the upstream a/b pathway. In
terms of progression, we would like to capture these evolutionary trajectories: either
{a,¬b}, {¬a, b} or {a, b} precedes c (where ¬ denotes the absence of an event in the
gene).
To formally take this into account, we augment our model of selection in a tumor
with a language built from simple propositional logic formulas using the usual Boolean
connectives: namely, “and” (∧), “or” (∨) and “xor” (⊕). These patterns can be described
by formulæ in a propositional logical language, which can be rendered in Conjunctive
Normal Form (CNF). A CNF formula ϕ has the following syntax: ϕ = c1 ∧ . . . ∧ cn,
where each ci is a disjunctive clause ci = ci,1 ∨ . . .∨ ci,k over a set of literals, each literal
representing an event or its negation.
In this framework, we aim at reconstructing probabilistic graphical models of cancer
progression. Given the above premises, this problem reduces to the following: for each
input event e, assess a set of selectivity patterns {ϕ1  e, . . . , ϕk  e}, filter the spurious
ones, and combine the rest in a direct acyclic graph (DAG)3, G = (V,E), where the
nodes are the atomic events (augmented, eventually, with logical symbols) and the edges
represent selective advantage relations. Notice that, while we broke down the progression
extraction into a series of sub-tasks, the problem still remains complex: patterns are
unknown, potentially spurious, and exponential in formula size; moreover, data are noisy
and patterns must allow for “imperfect regularities”, rather than being strict4.
To summarize, in this setting we can model complex progression trajectories with
3A DAG is formed by a set of nodes and oriented edges connecting one node to another, such that
there are no directed loops among them.
4This statement implies that there could be samples – i.e., patients or tumor cells – contradicting a
pattern which still remains valid at a population level. For this reason a pattern x ∧ y  z is sometimes
called a “noisy and”.
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branches (i.e., events involved in various patterns), independent progressions (i.e., events
without common ancestors) and convergence (via CNF formulas).
For the sake of clarity, in the next sections we develop the presentation in steps of
successively increasing complexity of the selective advantage patterns: e.g., going from
singleton (i.e., “atomic”) patterns, to co-occurrance patterns consisting of atomic events,
up to patterns in Conjunctive Normal Forms (CNF) (e.g., [(‘burning cigarette’ ∧ ‘dried
wood’ ) ∨ (‘lightning’ ∧ ‘no rain’)  ‘forest fire’])5.
2.2 Singleton prima facie topologies
When at most a single incoming edge is assigned to each event (i.e., an event has at
most one unique parent: ∀e∈V ∃!c∈V c e), we term this causal structure singleton prima
facie topology, a special and important case of the most general prima facie topology
structures. Note once again that the general model can be represented as a direct acyclic
graph (DAG) where each edge represents a prima facie relation between a parent and
its child. In the special case of the singleton prima facie topology, such a graph is a
tree or, more generally, a forest when there are disconnected components. Thus, each
progression tree induces a distribution of observing a subset of the mutations in a cancer
sample (see [117] for a detailed discussion).
In [117] the following propositions (summarized in Figure §2.1 and discussed in details
in §3) were shown to hold for singleton prima facie topologies (see §3 and §C for a detailed
description and the related proofs), and used to derive an algorithm to infer tree (forest)
models of cancer progression.
Statistical dependence. Whenever probability raising holds between two events c
and e, then the events are statistically dependent in a positive sense, i.e.,
P(e | c) > P(e | c) ⇐⇒ P(e ∧ c) > P(e)P(c) . (2.1)
Mutuality. If c is a probability raiser for e, then so is the converse, i.e.,
P(e | c) > P(e | c) ⇐⇒ P(c | e) > P(c | e) . (2.2)
Natural ordering. For any two events c and e such that c is a probability raiser for
e, a “natural” ordering arises to disentangle a causality relation, i.e.,
P(c) > P(e) ⇐⇒ P(e | c)P(e | c) >
P(c | e)
P(c | e) . (2.3)
5The statement above, which is expressed for conveniency in Disjunctive Normal Form and could
be automatically translated in CNF, may also be shortened as ‘burning cigarette’  ‘forest fire.’ The
intended interpretation is that, ‘burning cigarette’ is an insufficient but non-redundant part of an unnec-
essary but sufficient causal condition (INUS) for ‘forest fire,’ as originally suggested by the philosopher
J. Mackie.
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Figure 2.1: Prima facie properties. Properties of Suppes’ definition of probabilistic
causation: c is a prima facie cause of e if it is a probability raiser of e, and it occurs
more frequently.
Putting together all these properties, it is straightforward to derive the following
characterization of singleton prima facie relations: c is said to be a singleton prima facie
cause of e if c is a probability raiser of e, and it occurs more frequently, i.e.,
c e ⇐⇒ P(e | c) > P(e | c) ∧ P(c) > P(e) . (2.4)
Consequently to this definition, we observe that (see also the discussions in §A.2) it
is necessary but not sufficient to identify the accumulative processes (path or branch)
and, thus, to solve the considered problem. In fact, as it can be easily observed in the
Figure §2.2, black arrows make this definition necessary, while red arrows (spurious,
resulting, e.g., from transitivities, because of the singleton hypothesis) make the condi-
tion insufficient. We remark that red arrows will always be present to indicate potential
genuine causes corresponding to actual selective advantage relations. Thus, a correct
inferential algorithm will have to select the real relations among the potential genuine
ones, within a subset of the prima facie causes.
A further discussion about spurious connections is now warranted. As deeply de-
scribed in §A.2, spurious causes may manifest through spurious correlation or chance.
In the infinite sample size limit the “law of large numbers” eliminates the effect of chance;
in other words, with large enough sample, chance by itself will not suffice to satisfy Sup-
pes’ conditions. Instead, the former situation for spuriousness depends on the topology
to be reconstructed, and might appear under observation like a prima-facie/genuine se-
lective advantage relation in disguise, even with an infinite sample size (purple edges, for
13
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branch P(a) > P(b) > P(d) and P(a) > P(c)
Figure 2.2: Singleton prima facie topology. Example of a linear path and branching
model (left) and corresponding singleton selectivity patterns with infinite sample size
(right). All the genuine connections are shown (red and black, directed by the temporal
priority), as well as edges (purple, undirected) which might be suggested by the topology
(or observations, if data were finite).
which the “temporal direction” has no causal interpretation, as it depends on the data
and topology). For these reasons, a singleton prima facie topology asymptotically will
not contain false negatives (i.e., all the actual selective advantage relations are modeled
in the topology) but it might contain false positives (red or purple edges, as Suppes’
prima facie conditions are not sufficient).
2.3 Co-occurence prima facie patterns
We now denote by a Boolean conjunctive clause, a propositional formula composed of
conjunctions of a set of literals: c = c1 ∧ · · · ∧ cn, which implies that n events c1, . . ., cn
have occurred (in some unspecified order) so as to collectively lead to effect e (graphically
pictured as in Figure §2.3), and we assume that each ci (1 ≤ i ≤ n) is an atomic event.
Suppes’ notion of probabilistic causation can be naturally extended to such co-
occurence patterns as in the following definition:
Definition 1 (Co-occurence probabilistic causation). For any conjunctive event c =
c1 ∧ . . . ∧ cn and e, occurring respectively at times {tci | i = 1, . . . , n} and te, under the
mild assumptions that 0 < P(ci),P(e) < 1, for any i, the conjunctive event c is a prima
facie conjunctive cause of e (c e) if all of its components ci occur before the effect and
their occurrences collectively raises the probability of the effect, i.e.,
max{tc1 , . . . , tcn} < te and P(e | c) > P(e | c) . (2.5)
where
{ P(e | c) = P(e | c1 ∧ · · · ∧ cn)
P(e | c) = P(e | c1 ∧ · · · ∧ cn) = P(e | c1 ∨ · · · ∨ cn) .
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co-occurrence P(a) > P(d) and P(b) > P(d) and P(c) > P(d)
Figure 2.3: Co-occurrence Selectivity Patterns. Example of conjunctive model (a
and b and c). The co-occurrence selectivity pattern is shown, with all true patterns and
infinite sample size. The topology is augmented by logical connectives; green arrows are
spurious patterns emerging from the structure of the true pattern a ∧ b ∧ c d.
This extension simply follows the semantics of co-occurence patterns, which states
that all causes must occur before their effect, thus justifying the choice of picking the
latest event, in time, prior to e as a generalization: namely, the max{·} operation applied
to the preceeding events. Clearly, this definition retains the semantics of singleton prima
facie relations unchanged, as it is a special case with c = c and max{tci} = tc. Unfortu-
nately, as before, it still has the same weakness and it is necessary but not sufficient to
identify co-occurence patterns.
The properties of singleton prima facie topologies also extend appropriately to co-
occurence topologies – see §C and §D for the related proofs, along with all the other
properties and theorems that appear in this thesis.
Proposition 1. The properties of statistical dependence, mutuality and natural order-
ing for singleton patterns are still valid for co-occurence patterns.
In this case some caution must be exercised in distinguishing between prima facie
singleton or co-occurance patterns. As shown in Figure §2.3, in fact, for any co-occurance
pattern in the real world (a and b and c) the following conjunctive clauses
a ∧ b d a ∧ c d b ∧ c d
as well as the singleton patterns a  d, b  d and c  d, are prima facie. The singleton
patterns can be spurious or transitive, as in Figure §2.2. But this time, we will also have
spurious sub-formulas, i.e., the conjunctive clauses that are syntactically strictly sub-
formulas of a∧b∧cd, that is the only genuine formula we would like to infer. Notice that
as in branch processes, topology-dependent spurious causes might also appear because
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of spurious correlations; in the Figure §2.2, we have not shown other potential spurious
relations, as what we depict to make it visualizable is just a one-level conjunctive network.
These selective advantage relations could include general spurious formulas constituting
of a sub-formula and any of its parents. Similarly, spurious relations due to chance
will vanish asymptotically as sample size grows to infinity. Summarizing, we note that
a co-occurence topology, just as in the singleton patterns framework, will not contain
false negatives (i.e., all real world selective advantage relations will be modeled in the
topology) but it might also contain, depending on the real world topology, false positives
(red, green or purple edges).
Before concluding, we note that the total number of potential formulas and transi-
tivities is exponential in the size of |G| = n, that is
n−1∑
i=1
(
n− 1
i
)
= 2n−1 − 1 .
Notice that this is a lower bound accounting only for the level of the connective, and
is expected to grow further when more complex real world accumulative processes are
considered. Finally, as shown in Figure §2.2, the number of spurious relations due to the
topology (purple edges), are quadratic in the formula size, being
2
(
n− 1
2
)
= (n− 1)(n− 2) .
This complexity hints at the fact that an exhaustive search of all the possible conjunctive
formula is not feasible, in general.
2.4 Generalization to conjunctive normal form
We consider next a formula in conjunctive normal form (CNF)
ϕ = c1 ∧ . . . ∧ cn,
where each ci is a disjunctive clause ci = ci,1 ∨ . . . ∨ ci,k over a set of literals and each
literal represents an event (a Boolean variable) or its negation. By following analogous
arguments as the ones used before, we can define ϕ e as follows.
Definition 2 (CNF probabilistic causation). For any CNF formula ϕ and e, occurring
respectively at times tϕ and te, under the mild assumptions that 0 < P(ϕ),P(e) < 1, ϕ
is a prima facie cause of e if
tϕ < te and P(e | ϕ) > P(e | ϕ) . (2.6)
As stated before, also this definition is necessary but not sufficient to identify selective
advantage relations, hence lacking the power to solve the considered problem.
Clearly, in this case, the number of prima facie (including both genuine and spurious)
relations grows combinatorially much more rapidly than the simplest case of a unique
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conjunctive clause (see §2.3); this situation is rather alarming, since even the simplest
case already produces an exponentially large set of prima facies causes in terms of the
number of events. In this case, in fact, further causal relations emerge as a result of
mixing events from all the clauses of ϕ. CNF formulas follow analogous properties as
singleton and co-occurrence topologies, as shown below.
Proposition 2. The properties of statistical dependence, mutuality and natural order-
ing for singleton and co-occurence prima facie topologies also extend to CNF formulas
mutatis mutandis.
We conclude this Section with two final comments about CNF formulas: their relation
with background contexts (see §A.2), and the notion of timing in Definition §2.
The first comment concerns Cartwright’s idea of background contexts as a con-
junction of independent factors §A.2. For illustrative purposes, consider the formula
(a ∧ b) ∨ c  d, which is in disjunctive normal form (DNF). If, for example, we were to
evaluate the claim a d, the (unique) background context would be the atomic event c,
being relevant to evaluate the claim a causes d. A symmetric situation holds, when we
were to evaluate b  d. In light of this discussion note that, if we convert the formula
to its CNF analogue (a ∨ c) ∧ (b ∨ c)  d, we need to correctly interpret the roles of
sub-formulas a ∨ c and b ∨ c in identifying a background context, c. It follows immedi-
ately that, for any CNF formula, the atomic events of all the disjunctive clauses in the
equivalent DNF formula provide all the possible background contexts a`-la-Cartwright.
The second comment concerns timing in the real world. Consider the CNF formula
above, denote it as ϕ and recall that Definition §2 requires tϕ < td. One might wonder
whether a trivial time-ordering relation exists, whose complexity is linear with respect to
all the operators in ϕ. Were it so, we would be able to parse ϕ into its constituents, and
recursively express the temporal relations as a direct function of those relations that hold
for its sub-formulas. Unfortunately, this appears not to be the case, except when the
underlying syntax is restricted to certain specific operators (e.g., conjunctions). Thus
appropriate care must be taken in implementing a model of time. Thus, an algorithm,
working on the illustrative example of the previous paragraph, cannot conclude any or-
dering about ta∨c, tb∨c and td, solely by looking at the marginal probabilities of their
atomic events – instead it must gather the correct information for certain sub-formulas
at the level of their connective (the ∨ in this case). A general rule that avoids these
difficulties and devises a correct and efficient timing-inference algorithms, may be stated
as follows: it is always safe to model probabilistic causation in terms of whole formu-
las, while permitting compositional reasoning over sub-formulas is operable only when
the syntax is restricted to certain Boolean connectives. Further related comments ap-
pear in §3 and §4, where we describe the algorithmic implementations of the described
framework.
Next we will describe efficient algorithmic implementations of the framework pre-
sented in this Chapter.
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SINGLETON MODELS OF CANCER PROGRESSION
In this Chapter we will present an algorithm for the efficient inference of singleton models
of cancer progression. As a reference, see [117].
3.1 Problem setting
Assuming that we have a set G of n mutations (events, in probabilistic terminology)
and s samples, we represent a cross-sectional dataset as an s×n binary matrix in which
an entry (k, l) = 1 if the mutation l was observed in sample k, and 0 otherwise. The
problem we solve here is the one of extracting a set of edges E yielding a progression
tree T = (G ∪ {}, E, ) from this matrix which, we remark, only implicitly provides
information of progression timing. The root of T is modeled using a (special) event
 6∈ G such that heterogenous progression paths or forests can be reconstructed. More
precisely, we aim at reconstructing a rooted tree that satisfies: (i) each node has at most
one incoming edge, (ii) the root has no incoming edges (iii) there are no cycles.
Each progression tree induces a distribution of observing a subset of the mutations
in a cancer sample that can be formalized as follows:
Definition 3 (Tree-induced distribution). Let T be a tree and α : E → [0, 1] a labeling
function denoting the independent probability of each edge, T generates a distribution
where the probability of observing a sample with the set of alterations G∗ ⊆ G is
P(G∗) =
∏
e∈E′
α(e) ·
∏
(u,v)∈E
u∈G∗,v 6∈G
[
1− α(u, v)
]
(3.1)
where all events in G∗ are assumed to be reachable from the root , and E′ ⊆ E is the
set of edges connecting the root to the events in G∗.
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We would like to emphasize two properties related to the tree-induced distribution.
First, the distribution subsumes that, given any oriented edge (a→ b), an observed sam-
ple contains alteration b with probability P(a)P(b), that is the probability of observing
b after a. For this reason, if a causes b, the probability of observing a will be greater
than the probability of observing b accordingly to the temporal priority principle which
states that all causes must precede, in time, their effects [160].
Second, the input dataset is a set of samples generated, ideally, from an unknown
distribution induced by an unknown tree or forest that we aim at reconstructing. How-
ever, in some cases, it could be that no tree exists whose induced distribution generates
exactly those input data. When this happens, the set of observed samples slightly di-
verges from any tree-induced distribution. To model these situations a notion of noise
can be introduced, which depends on the context in which data are gathered. Adding
noise to the model complicates the reconstruction problem.
The oncotree approach. In [38] Desper et al. developed a method to extract pro-
gression trees, named “oncotrees”, from static CNV data. In [173], Szabo et al. extended
the setting of Desper’s reconstruction problem to account for both false positives and
negatives in the input data. In the oncotrees, nodes represent alterations and edges
correspond to possible progressions from one event to the next.
The reconstruction problem is exactly as described above, and each tree is rooted
in the special event . The choice of which edge to include in a tree is based on the
estimator
wa→b = log
[ P(a)
P(a) + P(b) ·
P(a ∧ b)
P(a)P(b)
]
, (3.2)
which assigns to each edge a → b a weight accounting for both the relative and joint
frequencies of the events – thus measuring correlation. The estimator is evaluated after
including  to each sample of the dataset. In this definition the rightmost term is the
(symmetric) likelihood ratio for a and b occurring together, while the leftmost is the
asymmetric temporal priority measured by rate of occurrence. This implicit form of
timing assumes that, if a occurs more often than b, then it likely occurs earlier, thus
satisfying
P(a)
P(a) + P(b) >
P(b)
P(a) + P(b) .
An oncotree is the rooted tree whose total weight (i.e., sum of all the weights of the edges)
is maximized, and can be reconstructed in O(|G|2) steps using Edmond’s algorithm [43].
By construction, the resulting graph is a proper tree rooted in : each event occurs only
once, confluences are absent, i.e., any event is caused by at most one other event. This
method has been used to derive progressions for various cancer datasets e.g., [93, 85,
157]), and even though several methods that extend this framework exists (e.g., [39, 12,
65]), to the best of our knowledge, it is currently the only method that aims to solve
exactly the same problem as the one investigated here and thus provide a benchmark to
compare against.
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3.2 A probabilistic approach to selective advantage
We briefly recall the approach to probabilistic causation, on which this method is based.
For an extensive discussion on this topic we refer to our previous discussion in §2.
In his seminal work [172], Suppes proposed a set of conditions that are necessary for
any causal claim, that is, for any pair of two events c and e, occurring respectively at
times tc and te, under the mild assumptions that 0 < P(c),P(e) < 1, the event c is a
prima facie cause of the event e if it occurs before the effect and the cause raises the
probability of the effect, i.e.,
tc < te and P(e | c) > P(e | c) .
As already discussed in §2, the above conditions are not, in general, sufficient to
claim that event c is a cause of event e. In fact a prima facie cause is either genuine or
spurious. In the latter case, the fact that the conditions hold in the observations is due
either to coincidence or to the presence of a certain third confounding factor, related
both to c and to e [172]. Genuine causes, instead, satisfy Suppe’s criteria and are not
screened-off by any confounding factor (also see §C). However, they need not be direct
causes. See Figure §3.1.
Figure 3.1: Prima facie topology. Example of prima facie topology where all edges
(a, b) represent prima facie causes, i.e., a is a probability raiser of b and it occurs more
frequently. On the right, we filter out spurious selective advantage relations and select
only the real ones among the genuine, yielding a singleton prima facie topology.
Note that we consider cross-sectional data where no information about tc and te is
available, hence in this reconstruction setting we are restricted to consider solely the
probability raising (pr) property, i.e., P(e | c) > P(e | c), which makes it harder to
discriminate among genuine and spurious causes. Now we review some of its properties.
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Proposition 3 (Statistical dependence). Whenever the pr holds between two events a
and b, then the events are statistically dependent in a positive sense, i.e.,
P(b | a) > P(b | a) ⇐⇒ P(a ∧ b) > P(a)P(b) . (3.3)
This and the next proposition are well-known facts of the pr; their derivation as well
as the proofs of all the results we discuss here, are shown in §C.
Notice that the opposite implication holds as well: when the events a and b are still
dependent but in a negative sense, i.e., P(a ∧ b) < P(a)P(b), the pr does not hold, i.e.,
P(b | a) < P(b | a).
We would like to use the asymmetry of the pr to determine whether a pair of events
a and b satisfy a selective advantage relation so to place a before b in the progression
tree but, unfortunately, the pr satisfies the following property.
Proposition 4 (Mutuality). P(b | a) > P(b | a) ⇐⇒ P(a | b) > P(a | b) .
That is, if a raises the probability of observing b, then b raises the probability of
observing a too.
Nevertheless, in order to determine the order among pair of genetic events, we can
use the degree of confidence in the estimate of probability raising to decide the direction
of their relationship. In other words, if a raises the probability of b more than the other
way around, then a is a more likely singleton prima facie cause of b than b of a. Notice
that this is sound as long as each event has at most one cause; otherwise, frequent late
events with more than one predecessor, which are rather common in biological progressive
phenomena, should be treated differently. As mentioned, the pr is not symmetric, and
the direction of probability raising depends on the relative frequencies of the events. We
make this asymmetry precise in the following proposition.
Proposition 5 (Natural ordering). For any two events a and b such that the probability
raising P(a | b) > P(a | b) holds, we have
P(a) > P(b) ⇐⇒ P(b | a)P(b | a) >
P(a | b)
P(a | b) . (3.4)
That is, given that the pr holds between two events, a raises the probability of b
more than b raises the probability of a, if and only if a is observed more frequently
than b. Also notice that we use the ratio to assess the pr inequality. The proof of this
proposition is technical and can be found in §C.
From this result it follows that if we measure the timing of an event by the rate of
its occurrence (that is, P(a) > P(b) implies that a happens before b), this notion of pr
subsumes the same notion of temporal priority induced by a tree. We also remark that
this is also the temporal priority made explicit in the coefficients of Desper’s method [38].
Given these results, we define the following notion of singleton prima facie causaluty.
Definition 4. We state that a is a prima facie cause of b if a is a probability raiser of
b, and it occurs more frequently: P(b | a) > P(b | a) and P(a) > P(b).
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We term prima facie topology a directed acyclic graph (over some events) where
each edge represents a prima facie cause. When at most a single incoming edge is
assigned to each event (i.e., an event has at most a unique cause, in the real world),
we term this structure singleton prima facie topology. Intuitively, this last class of
topologies correspond to the trees or, more generally forests when they have disconnected
components, that we aim at reconstructing.
Before moving on to introducing the algorithm proposed here, let us once again
recall the definition of selective advantage, its role in the definition of the reconstruction
problem and some of its limitations. As already mentioned, it may be that for some prima
facie cause c of an event e, there is a third event a prior to both, such that a causes
c and ultimately c causes e. Alternatively, a may cause both c and e independently,
and the selective advantage relationship observed from c to e is merely spurious. In the
context of singleton topologies, namely when it is assumed that each event has at most
a unique predecessor, the aim is to filter out the spurious edges from a general prima
facie topology, so to extract a singleton prima facie structure (see Figure §3.1).
Proposition §5 summarizes Suppes basic notion of prima facie causality, while it is
ignoring deeper discussions of causationthat aim at distinguishing between actual genuine
and spurious causes (see §A), e.g. screening-off, background context, d-separation [22,
150, 80]. For our purposes however, the above definition is sufficient when (i) all the
significant events are considered, i.e., all the genuine causes are observed as in a closed-
world assumption, and (ii) we aim at extracting the order of progression among them
(or determine that there is no apparent relation), rather than extracting causalities per
se.
Finally, we recall a few algebraic requirements necessary for our framework to be well-
defined. First of all, the pr must be computable: every mutation a should be observed
with probability strictly 0 < P(a) < 1. Moreover, we need each pair of mutations
(a, b) to be distinguishable in terms of pr, that is, for each pair of mutations a and b,
P(a | b) < 1 or P(b | a) < 1 similarly to the above condition. Any non-distinguishable
pair of events can be merged as a single composite event. From now on, we will assume
these conditions to be verified.
3.3 Results and discussion
We will now present the method in details.
3.3.1 Extracting progression trees
The CAPRESE reconstruction method is described in Algorithm §1. The algorithm
is similar to Desper’s and Szabo’s algorithms, the main difference being an alternative
weight function based on a shrinkage-like estimator.
Definition 5 (Shrinkage-like estimator). We define the shrinkage-like estimator ma→b
of the confidence in the causationrelationship from a to b as
ma→b = (1− λ)αa→b + λβa→b , (3.5)
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where 0 ≤ λ ≤ 1 and
αa→b =
P(b | a)− P(b | a)
P(b | a) + P(b | a) βa→b =
P(a ∧ b)− P(a)P(b)
P(a ∧ b) + P(a)P(b) . (3.6)
This estimator is similar in spirit to a shrinkage estimator (see [45]) and, in fact, it
combines a normalized version of the pr, i.e., the raw estimate α, with a correction factor
β (which in this case is a correlation-based measure of temporal distance among events),
to estimate the confidence of each selective advantage relationship. The parameter λ
is the analogous of the shrinkage coefficient and can have a Bayesian interpretation in
terms of a measure of the belief that a and b are causally relevant to one another and of
the evidence that a raises the probability of b. In the absence of a closed form solution
for the optimal value of λ, one may rely on cross-validation of simulated data. The power
of shrinkage (and the shrinkage-like estimator) lies in the possibility of determining an
optimal value for λ to balance the effect of the correction factor on the raw model
estimate to ensure optimal performances on ill posed instances of the inference problem.
A crucial difference, however, between our estimator and classical shrinkage, is that this
estimator aims at improving the performance of the overall reconstruction process, not
limited to the performance of the estimator itself as is the case in shrinkage. That is, the
metric m induces an ordering to the events reflecting the confidence for their causation.
Furthermore, since we make no assumption about the underlying distribution, we learn
it empirically by cross-validation. In the next sections we show that the shrinkage-like
estimator is an effective way to get such an ordering especially when data are noisy. In
CAPRESE we use a pairwise matrix version of the estimator.
The raw estimator and the correction factor. By considering only the raw es-
timator α, we would include an edge (a → b) in the tree consistently in terms of (i)
Definition §4 and (ii) if a is the best probability raiser for b. When P(a) = P(b) the
events a and b are indistinguishable in terms of temporal priority, thus α is not sufficient
to decide their causal relation, if any. This intrinsic ambiguity is unlikely in practice
even if, in principle, it is possible. Notice that this formulation of α is a monotonic
normalized version of the pr ratio.
Proposition 6 (Monotonic normalization). For any two events a and b we have
P(a) > P(b) ⇐⇒ P(b | a)P(b | a) >
P(a | b)
P(a | b) ⇐⇒ αa→b > αb→a . (3.7)
This raw model estimator satisfies −1 ≤ αa→b, αb→a ≤ 1: when it tends to −1 the
pair of events appear disjointly (i.e., they show an anti-causation pattern), when it tends
to 0 no causation or anti-causation can be inferred and the two events are statistically
independent and, when it tends to 1, the causation relationship between the two events
is genuine. Therefore, α provides a quantification of the degree of confidence for a pr
selective advantage relationship. In fact, for any given possible causation edge (a, b), the
term P(b | a) gives an estimate of the error rate of b, therefore the numerator of the raw
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Algorithm 1: CAPRESE: a tree-alike reconstruction with a shrinkage-like esti-
mator
1: consider a set of n genetic events G plus a special event , added to each
sample of the dataset;
2: define a m× n matrix M where each entry contains the shrinkage-like
estimator
mi→j = (1− λ) · P(j | i)− P(j | i)P(j | i) + P(j | i) + λ ·
P(i ∧ j)− P(i)P(j)
P(i ∧ j) + P(i)P(j)
according to the observed probability of the events i and j;
3: [pr causation] define a tree T = (G ∪ {}, E, ) where (i→ j) ∈ E for i, j ∈ G
if and only if:
mi→j > 0 and mi→j > mj→i and ∀i′ ∈ G, mi,j > mi′,j .
4: [Independent progressions filter] define Gj = {x ∈ G | P(x) > P(j)}, replace
edge (i→ j) ∈ E with edge ( → j) if, for all x ∈ Gj , it holds
1
1 + P(j) >
P(x)
P(x) + P(j)
P(x ∧ j)
P(x)P(j) .
model α provides an estimate of how often b is actually caused by a. The α estimator is
then normalized to range between −1 and +1.
However, α does not provide a general criterion to disambiguate among genuine
causes of a given event. We show a specific case in which α is not a sufficient estimator.
Let us consider, for instance, a causal linear path: a → b → c. In this case, when
evaluating the candidate parents a and b for c we have: αa→c = αb→c = 1, so a and b
are genuine causes of c, though we would like to select b, instead of a. Accordingly, we
can only infer that ta < tc and tb < tc, i.e., a partial ordering, which does not help to
disentangle the relation among a and b with respect to c.
In this case, the β coefficient can be used to determine which of the two genuine causes
occurs closer, in time, to c (b, in the example above). In general, such a correction factor
provides information on the temporal distance between events, in terms of statistical
dependency. In other words, the higher the β coefficient, the closer two events are.
Therefore, when dealing with noisy data and limited sample sizes, there are situations
where, by using the α estimator alone, we could infer a wrong transitive edge to be the
most likely cause even in the presence of the real cause. For this reason, we reduce the
α estimator to the correction factor β, which, for each given edge (a, b), is normalized
within −1 and (1−max[P(a),P(b)])/(1 + max[P(a),P(b)]) < +1.
The shrinkage-like estimator m then results in the combination of the raw pr esti-
mator α and of the β correction factor, which respects the temporal priority induced by
24
3.3. RESULTS AND DISCUSSION 25
α.
Proposition 7 (Coherence in dependency and temporal priority). The β correction
factor is symmetrical and subsumes the same notion of dependency of the raw estimator
α, that is
P(a ∧ b) > P(a)P(b) ⇔ αa→b > 0⇔ βa→b > 0 and βa→b = βb→a . (3.8)
The independent progressions filter. As in Desper’s approach, we also add a root 
with P() = 1 in order to separate different progression paths, i.e., the different sub-trees
rooted in . CAPRESE initially builds a unique tree by using the estimator; typically,
the most likely event will be at the top of the progression even if there may be rare
cases where more than one event has no valid parent, in these cases we would already
be reconstructing a forest. In the reconstructed tree, all the edges represent the most
confident prima facie cause, although some of those could still be spurious causes. Then
the correlation-like weight between any node j and  is computed as
P()
P() + P(j)
P( ∧ j)
P()P(j) =
1
1 + P(j) .
If this quantity is greater than the weight of j with each upstream connected element
i, we consider the best prima facie cause of j to be a spurious cause and we substitute
the edge (i → j) with the edge ( → j). Note that in this work we are ignoring deeper
discussions of probabilistic causationthat aim at distinguishing between actual genuine
causes and spurious causes. Instead, we remove spurious causes by using a filter based on
correlation because the probability raising of the omnipresent event  is not well defined
(see Methods). In addition, we remark that the evaluation for an edge to be a genuine
or a spurious cause takes into account all the given events. Because of this, if events
are added or removed from the dataset, the same edge can be defined to be genuine or
spurious as the set of events included in the model is varied arbitrarily. However, since
we do not consider the problem of selecting the set of progression events, we assume that
all and only the relevant events for the problem at hand are already known a priori and
included in the model.
Finally, note that this filter is indeed implying a non-negative threshold for the
shrinkage-like estimator, when an edge is valid.
Theorem 1 (Independent progressions). Let G∗ = {a1, . . . , ak} ⊂ G a set of k prima
facie causes for some b 6∈ G∗, and let a∗ = maxai∈G∗{mai→b}. The reconstructed tree by
CAPRESE contains edge  → b instead of a∗ → b if, for all ai ∈ G∗
P(ai, b) < P(ai)P(b) 1
1 + P(b) +
P(b)2
1 + P(b) . (3.9)
The proof of this theorem can be found in §C. What this theorem suggests is that,
in principle, by examining the level of statistical dependency of each pair of events, it
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would be possible to determine how many trees compose the reconstructed forest. Fur-
thermore, the theorem suggests that CAPRESE could be defined by first processing the
independent progressions filter, and then using m to build the independent progression
trees in the forest.
To conclude, the algorithm reconstructs a well defined tree (or, more in general,
forest).
Theorem 2 (Algorithm correctness). CAPRESE reconstructs a well defined tree T
without disconnected components, transitive connections and cycles.
Additionally, asymptotically with the number of samples, the reconstructed tree is
the correct one.
Theorem 3 (Asymptotic convergence). Let T = (G ∪ {}, E, ) be the forest to recon-
struct from a set of s input samples, given as the input matrix D. If D is strictly sampled
from the distribution induced by T and infinite samples are available, i.e., s→∞, CAP-
RESE with λ→ 0 correctly reconstructs T .
The proof of these Theorems are also in §C. These theorems considered datasets
where the observed and theoretical probabilities match, because of s → ∞. However,
data often contains false positives and negatives (i.e., data are noisy) and resistance to
their effects is desirable in any inferential technique. With this in mind, we prove a
corollary of the theorem analoguos to a result appearing in [173].
Corollary 1 (Uniform noise). Let the input matrix D be strictly sampled from the
distribution induced by T with sample size s → ∞, but let it be corrupted by noise
levels of false positives + and false negatives −. Let pmin = minx∈G{P(x)}, CAPRESE
correctly reconstructs T for λ→ 0 whenever
+ <
√
pmin(1− + − −)
and + + − < 1.
Essentially, this corollary states that CAPRESE (and so the estimator m) is robust
against a noise affecting all samples equally. Also, the fact that it holds for λ → 0 is
sound with the theory of shrinkage estimators for which, asymptotically, the corrector
factor is not needed to regularize the ill posed problem.
3.3.2 Optimal shrinkage-like coefficient
Theorem §3 and Corollary §1 state that with infinite samples and mild constraints on
the false positive/negative rates we get optimal results with λ → 0. Precisely, for the
uniform noise model that we applied to synthetic data, we have + = − = ν/2, thus
the hypothesis required by Corollary §1 is
ν <
√
pmin
1/2 +
√
pmin
.
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For pmin = 0.05, which we set in data generation (see §C), this inequality implies correct
reconstruction for ν < 0.3 (a 15% error rate), with infinite samples. However, we are
interested in performance and the optimal value of λ in situations in which we have finite
sample sizes as well. Here, we empirically estimate the optimal λ value, both in the case
of trees and forests, as a function of noise and sample size. In the next section, we assess
performance of our algorithm empirically.
In Figure §3.2, we show the variation of the performance of CAPRESE as a function
of λ, for datasets with 150 samples generated from tree topologies. The optimal value,
i.e., lowest Tree Edit Distance (TED), for noise-free datasets (i.e., ν = 0) is obtained
for λ→ 0, whereas for the noisy datasets a series of U-shaped curves suggests a unique
optimum value for λ → 1/2, immediately observable for ν < 0.15. Identical results are
obtained when dealing with forests (not shown here). In addition, further experiments
with n varying around the typical sample size (n = 150) show that the optimal λ is largely
insensitive to the dataset size (see Figure §3.3). Thus we have limited our analysis to
datasets with the typical sample size that is characteristic of data currently available.
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Figure 3.2: Optimal shrinkage-like coefficient for reconstruction performance.
We show here the performance in the reconstruction of trees (TED surface) with n = 150
samples as a function of the shrinkage-like coefficient λ. Notice the global optimal
performance for λ→ 0 when ν → 0 and for λ ≈ 1/2 when ν > 0.
Summarizing, Figures §3.2 and §3.3 suggest that for sample size below 250 without
false positives and negatives the pr raw estimate α suffices to drive reconstruction to
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Figure 3.3: Optimal λ with datasets of different size. We show the analogous
of Figure §3.2 with 50 and 250 samples. The estimation of the optimal shrinkage-like
coefficient λ appears to be irrespective of the sample size.
good results (TED is 0 with 250 samples), i.e.,
ma→b
λ→0≈ αa→b (3.10)
which is obtained by setting λ to a very small value, e.g. 10−2, in order to consider at
least a small contribution of the correction factor too. Conversely, when ν > 0, the best
performance is obtained by averaging the shrinkage-like effect, i.e.,
ma→b
λ=1/2
=
αa→b
2
+
βa→b
2
. (3.11)
These results suggest that, in general, a unique optimal value for the shrinkage-like
coefficient can be determined, even in situations not captured by Theorem §3 and Corol-
lary §1.
3.3.3 Performance measure and synthetic datasets
To evaluate the performance of the algorithm, named CAPRESE, i.e., CAncer PRogres-
sion Extraction with Single Edge, proposed here to infer singleton prima facie topologies,
we made substantial use of synthetic data as a function of dataset size and the false pos-
itive and negative rates. Many distinct synthetic datasets were created for this purpose,
as explained below. The algorithm’s performance was measured in terms of Tree Edit
Distance (TED, [197]), i.e., the minimum-cost sequence of node edit operations (rela-
beling, deletion and insertion) that transforms the reconstructed trees into the ones
generating the data. The choice of this evaluation measure is motivated by the fact
that we are interested in the structure behind the progressive phenomenon of cancer
evolution and, in particular, we are interested in a measure of the genuine causes that
we miss and of the spurious causes that we fail to recognize (and eliminate). Also, since
topologies with similar distributions can be structurally different we choose to measure
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performance using structural distance rather than a distance in terms of distributions.
Within the realm of ‘structural metrics’ however, we have also evaluated the perfor-
mance with the Hamming Distance [76], another commonly used structural metric, and
we obtained analogous results (see §C).
Synthetic data generation and experimental setting. We generated synthetic
data by sampling from various random trees constrained to have depth log(|G|), since
wide branches are harder to reconstruct than straight paths, and by sampling event
probabilities in [0.05, 0.95] (see §C).
Unless explicitly specified, in all the experiments we used 100 distinct random trees
(or forests, accordingly to the test to perform) of 20 events each. This seems a fairly
reasonable number of events and is in line with the usual size of reconstructed trees,
e.g., [166, 69, 116, 148]. The scalability of the techniques was tested against the number
of samples by ranging |G| from 50 to 250, with a step of 50, and by replicating 10
independent datasets for each parameters setting (see the caption of the figures for
details).
We included a form of noise in generating the datasets, in order to account for
(i) the realistic presence of biological noise (such as the one provided by bystander
mutations, genetic heterogeneity, etc.) and (ii) experimental errors. A noise parameter
0 ≤ ν < 1 denotes the probability that any event assumes a random value (with uniform
probability), after sampling from the tree-induced distribution. Algorithmically this
process generates, on average, |G|ν/2 random entries in each sample (e.g., with ν = 0.1
we have, on average, one error per sample). We wish to assess whether these noisy
samples can mislead the reconstruction process, even for low values of ν. Notice that
assuming a uniformly distributed noise may appear simplistic since some events may be
more robust, or easy to measure, than others. However, introducing in the data both
false positives (at rate + = ν/2) and negatives (at rate − = ν/2) makes the inference
problem substantially harder, and was first investigated in [173].
In the next section, we refer to datasets generated with rate ν > 0 as noisy synthetic
dataset. In the numerical experiments, ν is usually discretized by 0.025, (i.e., 2.5%
noise).
Performance of CAPRESE compared to oncotrees
An analogue of Theorem §3 holds for Despers’s oncotrees (Theorem 3.3, [38]), and an
analogue of Corollary §1 holds for Szabo’s extension with uniform noise (Reconstruction
Theorem 1, [173]). Thus, with infinite samples both approaches reconstruct the correct
trees/forests. With finite samples and noise, however, their performance may show
different patterns, as speed of convergence may vary. We investigate this issue in the
current section.
In Figure §3.4 we compare the performance of CAPRESE with oncotrees, for the case
of noise-free synthetic data with the optimal shrinkage-like coefficient: λ→ 0, equation
(§3.10). Since Szabo’s algorithm is equivalent to Desper’s without false negatives and
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positives, we rely solely on Szabo’s implementation [173]. In Figure §3.5 we show an
example of reconstructed tree where CAPRESE infers the correct tree while oncotrees
mislead an edge.
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Figure 3.4: Comparison on noise-free synthetic data. Performance of CAPRESE
(dashed line) and oncotrees (full line) in average TED when data are generated by
random trees (left) and forests (right). In this case ν = 0 (no false positives/negatives)
and λ→ 0 in the estimator m.
In general, one can observe that the TED of CAPRESE is, on average, always
bounded above by the TED of oncotrees, both in the case of trees and forests. For
trees, with 50 samples the average TED of CAPRESE is around 6, whereas for Desper’s
technique it is around 13. The performance of both algorithms improves as long as the
number of samples is increased: CAPRESE has the best performance (i.e., TED ≈ 0)
with 250 samples, while oncotrees have TED around 6. When forests are considered, the
difference between the performance of the algorithms reduces slightly, but also in this
case CAPRESE clearly outperforms oncotrees.
Notice that the improvement due to the increase in the sample size seems to reach a
plateau, and the initial TED for our estimator seems rather close to the plateau value.
This empirical analysis suggests that CAPRESE has already good performances with
few samples, a favorable adjoint to Theorem §3. This result has some important practical
implications, particularly considering the scarcity of available biological data.
In Figure §3.6 we extend the comparison to noisy datasets. In this case, we used the
optimal shrinkage-like coefficient: λ→ 1/2, equation (§3.11). The results confirm what
observed without false positives and negatives, as CAPRESE outperforms oncotrees up
to ν = 0.15, for all the sizes of the sample sets. In §C, similar plots for the noise-free
case are shown.
We can thus draw the conclusion that our algorithm performs better with finite
samples and noise, since less samples are required to get good performances and a higher
resistance to false positives and negatives is shown.
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Oncotree Algorithm 1ncotrees CAPRESE
Noise-free data
w=0
w=.014
m=.313
m=.534
.9
.81
.08
.08
Target tree
Figure 3.5: Example of reconstructed trees. Example of reconstruction from a
dataset with 100 samples generated by the left tree (the theoretical probabilities are
shown, i.e., the doubly-circled event appears in a sample with probability .08), with ν =
0. In the sampled dataset oncotrees mislead the parent of the doubly-circled mutation
(w = 0 for the true edge and w = 0.014 for the wrong one). CAPRESE infers the
correct parent (the values of the estimator m with λ = 1/2 are shown, similar results
are obtained for λ→ 1).
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Figure 3.6: Reconstruction with noisy synthetic data and λ = 1/2. Performance
of CAPRESE and oncotrees as a function of the number of samples and noise ν. Accord-
ing to Figure §3.2 the shrinkage-like coefficient is set to λ = 1/2. The magnified image
shows the convergence to Desper’s performance for ν ≈ 0.1. The barplot represents the
percentage of times the best performance is achieved at ν = 0.
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Performance of CAPRESE compared to Conjunctive Bayesian Networks
Inspired by Desper’s seminal work, Beerenwinkel and others developed methods to es-
timate the constraints on the order in which mutations accumulate during cancer pro-
gression, using a probabilistic graphical model called Conjuntive Bayesian Networks
(CBN) [10, 65]. While the goal of this research was to reconstruct direct acyclic graphs
and not trees per se, evidence presented in [72] suggests that, in the absence of noise,
these models perform better than oncotrees even at reconstructing trees. For this reason,
we performed experiments similar to the ones suggested above, comparing CAPRESE
to the extension of CBN called hidden-CBN (h-CBN) that accounts for noisy genotype
observations [65]. This method combines CBNs with a simulated annealing algorithm
for structure search and a denoising of the genotypes via the maximum a posteriori
estimates to compute the most likely progression. One aspect that complicates a com-
parison between CAPRESE and (h-)CBN is that the methods assume different models.
For example, at the heart of CBN is a monotonicity assumption (i.e., an event can only
occur if all its predecessors have occurred) not assumed by CAPRESE. Despite the dif-
ferences between the model assumptions, we present a comparison between the methods
in §C, indicating that CAPRESE not only outperform oncotrees, but h-CBNs as well.
In particular, this suggests that CAPRESE converges much faster than h-CBNs with
respect to the sample size, also in the presence of noise.
We also analyze the rate of false positives/negatives reconstructed by CAPRESE
when (synthetic) data are sampled from DAGs ( §C). The rate of false positives goes to
0 as the sample size increases, implying that CAPRESE is capable of reconstructing a
tree subsumed by the underlying causal DAG topology. In addition, the number of false
negatives approaches a value proportional to the connectivity of the model from which
the data was generated. This is expected, since CAPRESE will assign at most one cause
to each considered event. However, it should be noted that further experiments with
samples selected from a wider array of topologies should be performed to confirm these
results and compare both methods in full. While not within the scope of this specific
work.
3.3.4 Case studies
In the next subsections we apply CAPRESE to real cancer data obtained by Comparative
Genomic Hybridization (CGH) and Next Generation Sequencing (NGS). This shows the
potential application of reconstruction techniques to various types of mutational profiles
and various cancers.
Performance on cancer CGH datasets
We test our reconstruction approach on a real ovarian cancer dataset made available
within the oncotree package [38]. The data were collected through the public platform
SKY/M-FISH [100], used to allow investigators to share molecular cytogenetic data. The
data was obtained by using the CGH technique on samples from papillary serous cystade-
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nocarcinoma of the ovary. This technique uses fluorescent staining to detect CNV data
at the resolution of chromosome arms. While the recent emergence of NGS approaches
make the dataset itself rather outdated, the underlying principles remain the same and
the dataset provides avalid test-case for our approach. The seven most commonly oc-
curring events are selected from the 87 samples, and the set of events are the following
gains and losses on chromosomes arms G = {8q+, 3q+, 1q+, 5q−, 4q−, 8p−, Xp−} (e.g.,
4q− denotes a deletion of the q arm of the 4th chromosome).
In Figure §3.7 we compare the trees reconstructed by the two approaches. Our
technique differs from Desper’s by predicting the causal sequence of alterations
8q+ → 8p− → Xp− ,
when used either λ→ 0 or λ = 1/2. Notice that among the samples in the dataset some
are not generated by the distribution induced by the recovered tree, thus comparing the
reconstruction for both λs is necessary.
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1q+ 8q+
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Figure 3.7: Reconstruction of ovarian cancer progression. Trees reconstructed by
oncotrees and CAPRESE (with λ → 0, with λ = 1/2 the same tree is reconstructed).
The set of CGH events considered are gains on 8q, 3q and 1q and losses on 5q, 4q,
8p and Xp. Events on chromosomes arms containing the key genes for ovarian cancer
are in bolded circles. In the left tree all edge weights are the observed probabilities of
events. In the right the full edges are the causationinferred with the pr and the weights
represent the scores used by CAPRESE. Weights on dashed lines are as in the left tree.
At this point, we do not have a biological interpretation for this result. However, we
do know that common cancer genes reside in these regions, e.g. the tumor suppressor
gene Pdgfr on 5q and the oncogene Myc on 8q), and loss of heterozygosity on the short
arm of chromosome 8 is quite common (see, e.g., http://www.genome.jp/kegg/). Re-
cently, evidence has been reported that 8p contains many cooperating cancer genes [193].
In order to assign a confidence level to these inferences we applied both paramet-
ric and non-parametric bootstrapping methods to these results. Essentially, these tests
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consist of using the reconstructed trees (in the parametric case), or the probability ob-
served in the dataset (in the non-parametric case) to generate new synthetic datasets,
and then reconstructs again the progressions (see, e.g., [46] for an overview of these
methods and [174] for the use of bootstrap for evalutating the confidence of oncogenetic
trees.). The confidence is given by the number of times the trees in Figure §3.7 are
reconstructed from the generated data. A similar approach can be used to estimate the
confidence of every edge separately. For oncotrees the exact tree is obtained 83 times out
of 1000 non-parametric resamples, so its estimated confidence is 8.3%. For CAPRESE
the confidence is 8.6%. In the parametric case with false positive and false negative
error rates of 0.21 and 0.027, following [173], the confidence of oncotrees is 17% while
the confidence of our method is much higher: 32%. When error rates are forced to 0 the
confidence of oncotrees raises to 86.6% and 90.9% respectively.
For the non-parametric case, edges confidence is shown in Table §3.1. Most notably,
our algorithm reconstructs the inference 8q+ → 8p− with high confidence (confidence
62%, and 26% for 5q− → 8p−), while the confidence of the edge 8q+ → 5q− is only
39%, almost the same as 8p− → 8q+ (confidence 40%). The confidences are similar
with either λ→ 0 or λ = 1/2.
Oncotrees (overall confidence 8.3%)
→ 8q+ 3q+ 5q− 4q− 8p− 1q+ Xp−
 .99 .06 .51 .22 .004 .8 .06
8q+ 0 .92 .08 0.16 0.4 .02 .007
3q+ .002 0 .04 0 0 .09 .04
5q− .001 .002 0 .52 .39 .009 .16
4q− 0 0 .27 0 .14 .05 .11
8p− 0 0 .07 .08 0 .004 .59
1q+ 0 0 0 .004 0 0 0
Xp− 0 0 .003 .003 .04 .01 0
CAPRESE (overall confidence 8.6%)
→ 8q+ 3q+ 5q− 4q− 8p− 1q+ Xp−
 .99 .06 .51 .22 .004 .8 .06
8q+ 0 .92 .06 .16 .62 .01 .008
3q+ .002 0 .03 .002 0 .09 .04
5q− .001 .002 0 .5 .26 .009 .17
4q− 0 0 .29 0 .09 .05 .12
8p− 0 0 .07 .08 0 .004 .59
1q+ 0 0 0 .004 0 0 0
Xp− 0 .001 .003 .004 .01 .01 0
Table 3.1: Estimated confidence for ovarian progression. Frequency of edge occur-
rences in the non-parametric bootstrap test, for the trees shown in Figure §3.7. Colors
represent confidence: light gray is < 0.4, mid gray is in the range [0.4, 0.8] and dark gray
is > 0.8. Bold entries are the edges recovered by the algorithms.
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Analysis of other CGH datasets. We report the differences between the recon-
structed trees also based on datasets of gastrointestinal and oral cancer ([69, 148] re-
spectively). In the case of gastrointestinal stromal cancer, among the 13 CGH events
considered in [69] (gains on 5p, 5q and 8q, losses on 14q, 1p, 15q, 13q, 21q, 22q, 9p, 9q,
10q and 6q), oncotrees identify the path progression
1p− → 15q− → 13q− → 21q−
while CAPRESE reconstructs the branch
1p− → 15q− 1p− → 13q− → 21q − .
In the case of oral cancer, among the 12 CGH events considered in [148] (gains on 8q,
9q, 11q, 20q, 17p, 7p, 5p, 20p and 18p, losses on 3p, 8p and 18q), the reconstructed trees
differ since oncotrees identifies the path
8q+→ 20q+→ 20p+
while our algorithm reconstructs the path
3p− → 7p+→ 20q+→ 20p+ .
These examples show that CAPRESE provides important differences in the recon-
struction compared to oncotrees.
Performance on cancer NGS datasets
In this section we show the application of reconstruction techniques to the validation
of a specific relation among recurrent mutations involved in atypical Chronic Myeloid
Leukemia (aCML).
In [154] Piazza et al. used high-throughput exome sequencing technology to identity
somatically acquired mutations in 64 aCML patients, and found a previously uniden-
tified recurring missense point mutation hitting setbp1. By re-sequencing setbp1 in
samples with aCML and other common human cancers, they found that around 25% of
the aCML patients tested positive for setbp1, while most of the other types of tumors
were negative. Assessing the possible relationship between setbp1 variants and the mu-
tations in many driver aCML oncogenes such as (e.g., asxl1, tet2, kras, etc.) no
significant association or mutual exclusion with setbp1 was found but for asxl1, which
was frequently mutated together with setbp1, hinting at a potential relation among the
events. In particular, asxl1 was presenting either a non-sense point or a indel type of
somatic mutation.
Hence, we reconstructed aCML progression models from the datasets provided
in [154], with the goal of assessing a potential selective advantage relation between mu-
tated setbp1 and asxl1. A more extensive analysis is postponed, as we only seek to
clearly illustrate the functionalities of the algorithm here.
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Figure 3.8: The setbp1-asxl1 relation in atypical Chronic Myeloid Leukemia.
Progression models where asxl1 indel and non-sense point are merged (left) and separate
(right) suggest that a missense point mutation hitting setbp1 can cause a non-sense
point mutation in asxl1, that the observed asxl1 mutations might be independent and
that indel asxl1 is an early event with high confidence.
As a first case (Figure §3.8, left), we treated the asxl1 missense point and indel
mutations as indistinguishable, and we merged the two events in the dataset. Afterwards,
we separated the two types of mutations for asxl1 (Figure §3.8, right).
In particular, it is interesting to notice that, when the asxl1 mutations are consid-
ered equivalent, the inference suggests that the mutations belong to two independent
progression paths (i.e., the independent progression filters “breaks” every potential se-
lective advantage relation among the events). Conversely, when the mutations are kept
separate, the progression model suggests that: (i) the missense point mutation hitting
setbp1 can cause a non-sense point mutation in asxl1 and (ii) the observed asxl1
mutations seems to be independent. Concerning edges confidence, as before assessed
via non-parametric bootstrap, it is worth noting that the confidence in the indel asxl1
mutation being an early event raises consistently in the latter case.
All in all, it seems that a progression model allows to test the significance of the
association firstly observed in [154] and also refines the knowledge by suggesting a specific
causal and temporal relations among events. With this this in mind, ad-hoc sequencing
experiments might be set up to assess these predictions, eventually providing a strong
evidence that could be used to, e.g., synthesize a progression-specific aCML-effective
drug.
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MORE COMPLEX MODELS OF CANCER PROGRESSION
In this Chapter we will present an algorithm that is capable of efficiently inferring com-
plex models of cancer progression such as directed acyclic graphs. As a reference, see
[158].
4.1 Problem setting
We define a progression DAG as a directed acyclic graph D = (N, pi), where N ⊆ U is
the set of nodes (e.g., selected from a universe U of mutations or propositional formulas)
and pi : N → ℘(N) is a function, which associates with each node j its parents pi(j) ⊆ N .
We wish to study the cases where such a DAG can be seen as a model for the following
classes of selectivity patterns, expressed in conjunctive normal form (CNF). The symbol stands for the selectivity relation.
Definition 6 (DAG patterns). A D = (N, pi) is a model for models the patterns⋃
j∈N
{
(c1 ∧ . . . ∧ cn) j | pi(j) = {c1, . . . , cn}} ,
where c1 ∧ . . . ∧ cn is a CNF formula (each clause cj is one of two kinds: either an
atomic event or a disjunction of events).
Each DAG represents an induced distribution of observing a subset of the considered
events in a set of samples (i.e., the probability of observing certain genetic alterations
in a group of patients or cells representing their mutational profile).
Definition 7 (DAG-induced distribution). Let D = (N, pi) be a DAG and α : N → [0, 1]
a labeling function, D generates a distribution where the probability of observing N∗ ⊆ N
events is
P(N∗) =
∏
x∈N∗
α(x) ·
∏
y∈N\N∗
[
1− α(y)
]
(4.1)
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Figure 4.1: Data processing pipeline for cancer progression inference. We
sketch a pipeline to best exploit CAPRI’s ability to extract cancer progression models
from cross-sectional data. Initially, one collects experimental data (which could be ac-
cessible through publicly available repositories such as TCGA) and performs genomic
analyses to derive profiles of, e.g., somatic mutations or Copy-Number Variations for
each patient. Then, statistical analysis and biological priors are used to select events
relevant to the progression and imputable by CAPRI - e.g., driver mutations. To ex-
ploit CAPRI’s supervised execution mode (see Methods) one can use further statistics
and priors to generate patterns of selective advantage - , e.g, hypotheses of mutual ex-
clusivity. CAPRI can extract a progression model from these data and assess various
confidence measures on its constituting relations - e.g., (non-)parametric bootstrap and
hypergeometric testing. Experimental validation concludes the pipeline.
whenever x ∈ N∗, pi(x) ⊂ N∗, and 0 otherwise.
Notice that this definition, as expected, is equivalent to the one used in [10] and
retains a tree-induced distribution such as those used in [117, 38, 173]. Further, notice
that a sample which contains an event but not all of its parents has a zero probability,
thus subsuming the conjunctive interpretation of DAGs, as the result of compositional
reasoning to infer co-occurrence patterns. These kinds of samples, which represent “ir-
regularities” with respect to D, might be generated when adding false positives/negatives
to the sampling strategy.
4.2 A novel efficient framework
Building on the framework described in the §2, we now describe the implementation
of my framework for CAncer PRogression Inference (named CAPRI)’s building blocks.
Notice that, in general, the inference of cancer progression models requires a complex
data processing pipeline, as summarized in Figure §4.1; its architecture optimally exploits
CAPRI’s efficiency.
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Assumptions. CAPRI relies on the following assumptions: i) Every pattern is ex-
pressible as a propositional CNF formula; ii) All events are persistent, i.e., an acquired
mutation cannot disappear; iii) All relevant events in tumor progression are observable,
with the observations describing the progressive phenomenon in an essential manner (i.e.,
closed world assumption, in which all events ‘driving’ the progression are detectable);
iv) All the events have non-degenerate observed probability in (0, 1); v) All events are
distinguishable, in the following sense: input alterations produce different profiles across
input samples.
Assumptions i-ii) relate to the framework derived in previous section, while iii)
imposes an onerous burden on the experimentalists, who must select the relevant genomic
events to model1. Assumption iv) relates instead to the statistical distinguishability of
the input events (see the next section on CAPRI’s Data Input).
Trading Complexity for Expressivity. To automatically extract the patterns that
underly a progression model, one may try to adopt a brute-force method of enumerating
and testing all possibilities. This strategy is computationally intractable, however, since
the number of (distinct) (sub)formulæ grows exponentially with the number of events
included in the model. Therefore, we need to exploit certain properties of the  relation
whenever possible, and trade expressivity for complexity in other cases, as explained
below.
Note that singleton and co-occurrence (∧) types of patterns are amenable to composi-
tional reasoning : if i1∧. . .∧ikj then, for any p = 1, . . . , k, ipj. This observation leads
to the following straightforward strategy of evaluating every conjunctive (and henceforth
singleton) relation using a pairwise-test for the selectivity relation (see Figure §2.2).
Unfortunately, it is easy to see that this reasoning fails to generalize for CNF patterns:
e.g., when the pattern contains disjunctive operators (∨). As an example, consider
pattern a ∨ b  c, in a cancer where {a,¬b} progression to c is more prevalent than
{¬a, b} and {a, b}. In this case, considering sub-formulas only we might find a  c but
miss bc because the probability of mutated b is smaller than that of c, thus invalidating
condition (1) of relation . Notice that in extreme situations, when the data is very
noisy, the algorithm may even “invert” the selectivity relation to c b.
This difficulty is not a peculiarity of my framework, but rather intrinsic to the prob-
lem of extracting complex “causal networks” (see, [151, 150, 98]). To handle this situ-
ation, CAPRI adapts a strategy that trades complexity for expressivity: the resulting
inference procedure, Algorithm §2, can be executed in two modes: unsupervised and
supervised. In the former, inferred patterns of confluent progressions are constrained to
co-occurrence types of relations, in the latter CAPRI can test more complex patterns,
i.e., disjunctive or “mutual exclusive” ones, provided they are given as prior hypotheses.
1Theoretically, this assumption - common to other Bayesian learning problems - is necessary to prove
CAPRI’s ability to extract the exact model in the optimal case of infinite samples. Practically, as all
relevant events are hardly selectable a priori and sample size is finite, further statistics can be used
to select the most relevant driver alterations – see also Section §4.3. Nonetheless, CAPRI can provide
significant results even if this assumption is not or cannot be verified.
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In both cases, CAPRI’s complexity – studied in next sections – is quadratic both in the
number of events and hypotheses.
Data Input (Step 1). CAPRI (sett, Algorithm §2) requires an input set G of n
events, i.e., genomic alterations, and m cross-sectional samples, represented as a dataset
in an m × n binary matrix D, in which an entry Di,j = 1 if the event j was observed
in sample i, and 0 otherwise. Assumption iv) is satisfied when all columns in D differ -
i.e., the alteration profiles yield different observations.
Optionally, a set of k input hypotheses Φ = {ϕ1  e1, . . . , ϕk  ek}, where each ϕi
is a well-formed2 CNF formula. Note that we advise that the algorithm be used in the
following regime 3: k + n m.
Data Preprocessing (Lifting, step 2). When input hypotheses are provided (e.g.,
by a domain expert), CAPRI first performs a lifting operation over D to permit direct
inference of complex selectivity relations over a joint representation, which involve input
events as well as the hypotheses. Lifting operation evaluates each input CNF formula –
for all input hypotheses in Φ – and outputs a augmented matrix D(Φ) to be processed
further as in step 1. As an example, consider hypothesis a ⊕ b  c augmented input
matrix D is:
D(Φ) =

a b c a⊕ b c
1 1 1 1⊕ 1 = 0
1 0 1 1⊕ 0 = 1
0 1 0 0⊕ 1 = 1
1 0 1 1⊕ 0 = 1
 .
Note that the first row (profile {a, b, c}) contradicts the hypothesis, while all other rows
support it.
Selectivity Topology (steps 3, 4, 5). We exploit a compositional approach to test
CNF hypotheses as follows: the disjunctive relations are grouped, and treated as if they
were individual objects in G. For example, when a formula ϕ d where ϕ = (a ∨ b) ∧ c
is considered, we assess ϕ  d as whether (a ∨ b)  d and c  d hold – with the proviso
that we treat (a ∨ b) as an individual event. Formally, with clauses (ϕ) we denote the
disjunctive clauses in a CNF formula.
Nodes in the reconstruction are all input events together with all the disjunctive
clauses of each input formula ϕ.
Edges in the reconstructed DAG are patterns that satisfy both conditions (1) and (2)
of the selectivity relation . Formally, CAPRI includes an edge between two nodes ϕ
2Formally, we require that ϕi 6v ei, where v represents the usual syntactical ordering relation among
atomic events and formulas, and disallows for example a ∨ b a.
3In the current biomedical setting, the number of samples (m) is usually in the hundreds, while
number of possible mutations (n) and hypotheses (k), absent any pre-processing, could be large, thus
violating the assumption; in these cases, we rely on various commonly used pre-preprocessing filters to
limit n to driver mutations, and k to simple hypotheses involving the driver mutations. However, in the
future as the number of samples increases, we envision a more agnostic application.
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and j only if both Γϕ,j = P(ϕ)−P(j) and Λϕ,j = P(j | ϕ)−P(j | ϕ) are strictly positive.
Note that ϕ can be both a disjunctive clause as well as a singleton event. A function
pi(·) assigns a parent to each node that is not an input formula. Note that this approach
works efficiently by nature of the augmented representation of D. The reconstructed
DAG contains all the true positive patterns, with respect to , plus spurious instances
of  which CAPRI subsequently removes in step 6 (see §D for a proof of this statement).
Note that D can be readily interpreted as a probabilistic graphical model, once it
is augmented with a labeling function α : N → [0, 1], where N is the set of nodes –
i.e., the genetic alterations – such that α(i) is the independent probability of observing
mutation i in a sample, whenever all of its parent mutations (i.e., pi(i)) are observed (if
any). Thus D induces a distribution of observing a subset of events in a set of samples
(i.e., a probability of observing a certain mutational profile in a patient).
Maximum Likelihood Fit (step 6). As the selectivity relation provides only a
necessary condition, we must filter out all of its spurious instances that might have been
included in D (i.e., the possible false positives).
For any selectivity relation, spurious claims contribute to a reduction in the likelihood-
fit4 relative to true patterns. Thus, a standard maximum-likelihood fit can be used to
select and prune the selectivity DAG (including a regularization term to avoid over-
fitting5). Here, we adopt the Bayesian Information Criterion (BIC), which implements
Occam’s razor by combining log-likelihood fit with a penalty criterion proportional to
the log of the DAG size via Schwarz Information Criterion (see [167]). The BIC score
is defined as follows.
bic (D, D(Φ)) = LL (D, D(Φ))− logm
2
dim(D). (4.2)
Here, D(Φ) is the augmented input matrix, m denotes the number of samples and dim(D)
is the number of parameters in the model D. Because, in general, dim(·) depends on the
number of parents each node has, it is a good metric for model complexity. Moreover,
since each edge added to D increases model complexity, the regularization term based
on dim(·) favors graphs with fewer edges and, more specifically, fewer parents for each
node.
At the end of this step, D and the labeling function are modified accordingly, based
on the result of BIC regularization. By collecting all the incoming edges in a node it
is possible to extract the patterns, which have been selected by CAPRI as the positive
ones.
4The maximum-likelihood estimation (MLE) is a method for estimating the parameters of a statistical
model given data. In general, given a dataset and its underlying statistical model, the maximum likeli-
hood estimation aim at selecting the set of values of the model parameters (in the setting of this thesis,
a set of arcs of a graphical model) that maximizes the likelihood function. Intuitively, this maximizes
the agreement of the selected model given the observed data. See also §B.
5In principle other regularisation strategies common to Bayesian learning could be used, e.g., Akaike
information criterion (see [23] and references therein). In this task, we prefer to work with BIC which,
in general, trades model complexity to reduce false positives rate.
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Algorithm 2: CAncer PRogression wenference (CAPRI)
1: Input: A set of events G = {g1, . . . , gn}, a matrix D ∈ {0, 1}m×n and k CNF causal claims
Φ = {ϕ1  e1, . . . , ϕk  ek} where, for any i, ei 6v ϕi and ei ∈ G;
2: [Lifting] Define the lifting of D to D(Φ) as the augmented matrix
D(Φ) =
 D1,1 . . . D1,n ϕ1(D1,·) . . . ϕk(D1,·)... . . . ... ... . . . ...
Dm,1 . . . Dm,n ϕ1(Dm,·) . . . ϕk(Dm,·)
 .
by adding a column for each ϕi  ci ∈ Φ, with ϕi evaluated row-by-row. Define then the coefficients
Γi,j = P(i)− P(j) and Λi,j = P(j | i)− P(j | i) pairwise over D(Φ);
3: [DAG nodes] Define the set of nodes N = G ∪
(⋃
ϕi
clauses (ϕi)
)
which contains both input events
and the disjunctive clauses in every input formula of Φ.
4: [DAG edges] Define a parent function pi where pi(j 6∈ G) = ∅ – avoid edges incoming in a formula 6–
and
pi(j ∈ G) = {i ∈ G | Γi,j ,Λi,j > 0}
∪ {clauses (ϕ) | Γϕ,j ,Λϕ,j > 0, ϕ j ∈ Φ} .
Set the DAG to D = (N, pi).
5: [DAG labeling] Define the labeling α as follows
α(j) =
{
P(j), if pi(j) = ∅ and j ∈ G;
P(j | i1 ∧ . . . ∧ in), if pi(j) = {i1, . . . , in}.
6: [Likelihood fit ] Filter out all spurious causes from D by likelihood fit with the regularization
BIC score and set α(j) = 0 for each removed edge.
7: Output: the DAG D and α;
Inference Confidence: Bootstrap and Statistical Testing. To infer confidence
intervals of the selectivity relations , CAPRI employs bootstrap with rejection resam-
pling by estimating a distribution of the marginal and joint probabilities as follows.
For each event, (i) CAPRI samples with repetitions rows from the input matrix D
(bootstrapped dataset), (ii) CAPRI next estimates the distributions from the observed
probabilities, and finally, (iii) CAPRI rejects values which do not satisfy 0 < P(i) < 1
and P(i | j) < 1 ∨ P(j | i) < 1, and iterates restarting from (i). We stop when we
have, for each distribution, at least K values (in this case K = 100). Any inequality
(i.e., checking temporal priority and probability raising) is estimated using the non-
6Although CAPRI is equipped with bootstrap testing it is still possible to encounter various degen-
erate situations. In particular, for some pair of events it could be that temporal priority cannot be
satisfactorily resolved, i.e. there is no significant p-value for any edge orientation. Thus, loops might
be present in the inferred prima facie topology. Nonetheless, some of these could be still disentangled
by probability raising, while some might remain, albeit rarely. To remove such edges we suggest to
proceed as follows: (i) sort these edges according to their p-value (considering both temporal priority
and probability raising), (ii) scan the sorted list in decreasing order of confidence, (iii) remove an edge
if it forms a loop.
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parametric Mann-Whitney U test7 with p-values set to 0.05. We compute confidence
p-values for both temporal priority and probability raising using this test, which need
not assume Gaussian distributions for the populations.
Once a DAG D is inferred both parametric and non-parametric bootstrapping methods
can be used to assign a confidence level to its respective pattern and to the overall model.
Essentially, these tests consist of using the reconstructed model (in the parametric case),
or the probabilities observed in the dataset (in the non-parametric case) to generate new
synthetic datasets, which are then reused to reconstruct the progressions (see, e.g., [45]
for an overview of these methods). The confidence is estimated by the number of times
the DAG or any instance of  is reconstructed from the generated data.
Complexity, Correctness and Expressivity. CAPRI has the following asymptotic
complexity (see §D): (i) Without input hypotheses the execution is self-contained and
polynomial in the size of D. (ii) In addition to the above cost, CAPRI tests input hy-
potheses of Φ at a polynomial cost in the size of |Φ|. In this case, however, its complexity
may range over many orders of magnitude depending on the structural complexity of
the input set Φ consisting of hypotheses. An empirical analysis of the execution time of
CAPRI and the competing techniques on synthetic datasets is provided in §D.
CAPRI is a sound and complete algorithm, and its expressivity in terms of the
inferred patterns is proportional to the hypothesis set Φ which, in turn, determines the
complexity of the algorithm. With a proper set of input hypothesis, CAPRI can infer all
(and only) the true patterns from the data, filtering out all the spurious ones (Theorem
2, §D). Without hypotheses, besides singleton and co-occurrence, no other patterns can
be inferred (see Figure §2.2). Also, some of these claims might be spurious in general
for more complex (and unverified) CNF formula (see §D).
4.3 Results and discussion
To determine CAPRI’s relative accuracy (true-positives and false-negatives) and perfor-
mance compared to the state-of-the-art techniques for network inference, we performed
extensive simulation experiments. From a list of potential competitors of CAPRI, we
selected: Incremental Association Markov Blanket (IAMB, [179]), the PC algorithm
(see [171]), Bayesian Information Criterion (BIC, [167]), Bayesian Dirichlet with likeli-
hood equivalence (BDE, [79]) Conjunctive Bayesian Networks (CBN, [65]) and Cancer
Progression Inference with Single Edges (CAPRESE, [117]). These algorithms consti-
tute a rich landscape of structural methods (IAMB and PC), likelihood scores (BIC and
BDE) and hybrid approaches (CBN and CAPRESE).
Also, we applied CAPRI to the analysis of an atypical Chronic Myeloid Leukemia
dataset of somatic mutations with data based onsee [154].
7The Mann-Whithney U test is a rank-based non-parametric statistical hypothesis test that can
be used as an alternative to the Student’s t-test and is particularly useful if data are not normally
distributed.
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Figure 4.2: Comparative Study. Performance and accuracy of CAPRI (unsupervised
execution) and other algorithms, IAMB, PC, BIC, BDE, CBN and CAPRESE, were
compared using synthetic datasets sampled by a large number of randomly parametrized
progression models – trees, forests, connected and disconnected DAGs, which capture dif-
ferent aspects of confluent, branched and heterogenous cancer progressions. For each of
those, 100 models with n = 10 events were created and 10 distinct datasets were sampled
by each model. Datasets vary by number of samples (m) and level of noise in the data
(ν) – see the Supplementary Information file for details. (Red box ) Average Hamming
distance (HD) – with 1000 runs – between the reconstructed and the generative model,
as a function of dataset size (m ∈ {50, 100, 150, 200, 500, 1000}), when data contain no
noise (ν = 0). The lower the HD, the smaller is the total rate of mis-inferred selectiv-
ity relations among events. (Blue box ) The same is shown for a fixed sample set size
m = 100 as a function of noise level in the data (ν ∈ {0, 0.025, 0.05, · · · , 0.2}) so as
to account for input false positives and negatives. Seesee §D for more extensive results
on precision and recall scores and also including additional combinations of noise and
samples as well as experimental settings.
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4.3.1 Synthetic data
We performed extensive tests on a large number of synthetic datasets generated by
randomly parametrized progression models with distinct key features, such as the pres-
ence/absence of: (1) branches, (2) confluences with patterns of co-occurrence, (3) in-
dependent progressions (i.e., composed of disjoint sub-models involving distinct sets of
events). Accordingly, we distinguish four classes of generative models with increasing
complexity and the following features:
trees forests connected DAGs disconnected DAGs
(1) 3 3 3 3
(2) 7 7 3 3
(3) 7 3 7 3
The choice of these different type of topologies is not a mere technical exercise, but
rather it is motivated, in this application of primary interest, by heterogeneity of cancer
cell types and possibility of multiple cells of origin.
To account for biological noise and experimental errors in the data we introduce a
parameter ν ∈ (0, 1) which represents the probability of each entry to be random in D,
thus representing a false positive (+) and a false negative rate (−): + = − = ν/2 .
The noise level complicates the inference problem, since samples generated from such
topologies will likely contain sets of mutations that are correlated but causally irrelevant.
To have reliable statistics in all the tests, 100 distinct progression models per topology
are generated and, for each model, for every chosen combination of sample set size m and
noise rate ν, 10 different datasets are sampled (see §D for my synthetic data generation
methods).
Algorithmic performance was evaluated using the metrics Hamming distance (HD),
precision and recall, as a function of dataset size, + and −. HD measures the structural
similarity among the reconstructed progression and the generative model in terms of the
minimum-cost sequence of node edit operations (inclusion and exclusion) that transforms
the reconstructed topology into the generative one8. Precision and recall are defined as
follows: precision = TP/(TP + FP) and recall = TP/(TP + FN), where TP are the
true positives (number of correctly inferred true patterns), FP are the false positives
(number of spurious patterns inferred) and FN are the false negatives (number of true
patterns that are not inferred). The closer both precision and recall are to 1, the better.
In Figure §4.2 we show the performance of CAPRI and of the competing techniques,
in terms of Hamming distance, on datasets generated from models with 10 events and
all the four different topologies. In particular, we show the performance: (i) in the case
of noise-free datasets, i.e., ν = 0 and different values of the sample set size m and (ii) in
the case of a fixed sample set size, m = 100 (size that is likely to be found in currently
available cancer databases, such as TCGA (see [136])) and different values of the noise
rate ν. As is evident from Figure §4.2 CAPRI outperforms all the competing techniques
with respect to all the topologies and all the possible combinations of noise rate and
8This measure corresponds to the sum of false positives and false negative and, for a set of n events, is
bounded above by n(n−1) when the reconstructed topology contains all the false negatives and positives.
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Figure 4.3: Atypical Chronic Myeloid Leukemia. (left) Mutational profiles of n =
64 aCML patients - exome sequencing in [154] - with alterations in |G| = 9 genes with
either mutation frequency > 5% or belonging to an hypothesis inputed to CAPRI (§D).
Mutation types are classified as nonsense point, missense point and insertion/deletions,
yielding m = 16 input events. Purple annotations report the frequency of mutations
per sample. (right) Progression model inferred by CAPRI in supervised mode. Node
size is proportional to the marginal probability of each event, edge thickness to the
confidence estimated with 1000 non-parametric bootstrap iterations (numbers shown
leftmost of every edge). The p-value of the hypergeometric test is displayed too. Hard
exclusivity patterns inputed to CAPRI are indicated as red squares. Events without
inward/outward edges are not shown.
sample set size, in terms of average Hamming distance (with the only exception of
CAPRESE in the case of tree and forests, which displays a behavior closer to CAPRI’s).
The analyses on precision and recall display consistent results (see §D). In other words,
we demonstrate on the basis of extensive synthetic tests that CAPRI requires a much
lower number of samples than the other techniques in order to converge to the real
generative model and also that it is much more robust even in the presence of significant
amount of noise in the data, irrespective of the underlying topology.
See §D for a more complete description of the performance evaluation for all the ana-
lyzed combinations of parameters. There, we have shown that CAPRI is highly effective
when the co-occurrence constraint on confluences is relaxed to disjunctive patterns, even
if no input hypotheses are provided, i.e., Φ = ∅. This result hints at CAPRI’s robust-
ness to infer patterns with imperfect regularities. Finally, we also show that CAPRI
is effective in inferring synthetic lethality relations in this case using the operator ⊕ as
introduced in §2; when a combination of mutations in two or more genes leads to cell
death, while separately, the mutations are viable. In this case, candidate relations are
directly input as Φ.
4.3.2 Atypical Chronic Myeloid Leukemia (aCML)
As a case study, we applied CAPRI to the mutational profiles of 64 aCML patients
described in [154]. Through exome sequencing, the authors identify a recurring missense
point mutation in the SET-binding protein 1 (setbp1) gene as a novel aCML marker.
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Among all the genes present in the dataset by Piazza et al., we selected those either
(i) mutated - considered any mutation type - in at least 5% of the input samples (3
patients), or (ii) hypothesised to be part of a functional aCML progression pattern in
the literature 9. The input dataset with selected events is shown in Figure §4.3; notice
that somatic mutations are categorised as indel, missense point and nonsense point as
in [154]. In Figure §4.3 we show the model reconstructed by CAPRI (supervised mode,
execution time ≈ 5 seconds) on this dataset, with confidence assessed via 1000 non-
parametric bootstrap iterations. The model highlights several non trivial selectivity
relations involving genomic events relevant to aCML development.
First, CAPRI predicts a progression involving mutations in setbp1, asxl1 and cbl,
consistently with the recent study by [126], in which these genes were shown to be
highly correlated and possibly functioning in a synergistic manner for aCML progres-
sion. Specifically, CAPRI predicts a selective advantage relation between missense point
mutations in setbp1 and nonsense point mutations in asxl1. This is in line with recent
evidence from [89] suggesting that setbp1 mutations are enriched among asxl1-mutated
myelodysplastic syndrome (MDS) patients, and in-vivo experiments point to a driver role
of setbp1 for that leukemic progression. Interestingly, my model seems also to suggest
a different role of asxl1 missense and nonsense mutation types in the progression, yet
more extensive studies (e.g., prospective or systems biology explanation) are needed to
corroborate this hypothesis.
Among the hypotheses given as input to CAPRI, the algorithm seems to suggest
that the exclusivity pattern among asxl1 and sf3b1 mutations selects for cbl missense
point mutations. The role of the asxl1/sf3b1 exclusivity pattern is consistent with
the study of [115] which shows that, on a cohort of 479 MDS patients, mutations in
sf3b1are inversely related to asxl1 mutations.
Also, in [2] it was recently shown that asxl1 mutations, in patients with MDS,
myeloproliferative neoplasms (MPN) and acute myeloid leukemia, most commonly occur
as nonsense and insertion/deletion in a clustered region adjacent to the highly conserved
PHD domain (see [61]) and that mutations of any type eventually result in a loss of
asxl1 expression. This observation is consistent with the exclusivity pattern among
asxl1 mutations in the reconstructed model, possibly suggesting alternative trajectories
of somatic evolution for aCML (involving either asxl1 nonsense or indel mutations).
Finally, CAPRI predicts selective advantage relations among tet2 and ezh2 mis-
sense point and indel mutations. Even though the limited sample size does not allow to
draw definitive conclusions on the ordering of such alterations, we can hypothesize that
they may play a synergistic role in aCML progression. Indeed, [133] suggests that the
concurrent loss of ezh2 and tet2 might cooperate in the pathogenesis of myelodysplas-
tic disorders, by accelerating the overall tumor development, with respect to both MDSs
and overlap disorders (MDS/MPN).
9Two hard exclusivity patterns - i.e., mutual exclusivity with “xor” - were tested, involving the
mutations of: (i) genes asxl1 and sf3b1 (see [115]), which is present in the inferred progression model
in Figure §4.3, and (ii) genes tet2 and idh2 (see [53]). The syntax in which the patterns are expressed
is in §D.
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AN R PACKAGE FOR TRANSLATIONAL ONCOLOGY
TRONCO is an R package for TRanslational ONCOlogy which provides a series of
software utilities to support the user in each step of the pipeline described in this thesis
(see Chapters §2, §3 and §4), i.e., from data import, through data visualization and, fi-
nally, to the inference of cancer progression models. Specifically, in the currenct version,
TRONCO implements CAPRESE and CAPRI algorithms for cancer progression in-
ference, which we extensively described in Chapter §3 and §4. As a reference, see [33, 5].
The core of the two algorithms is a simple quadratic loop1 that prunes arcs from an
initially totally connected graph. Each pruning decision is based on the application of
Suppes’ probabilistic causation criteria.
The pseudocode of the two implemented algorithms along with the procedure to
evaluate the confidence of the arcs by bootstrap is summarized in Algorithms §3, §4, §5
and §6, which depict the data preparation step, the CAPRESE and CAPRI algorithms
and finally the optional bootstrap step.
5.1 Package implementation
In this Section we will review the structure and implementation of the TRONCO pack-
age. For the sake of clarity, we will structure the description through the following
functionalities that are implemented in the package.
• Data import. Functions for the importation of data both from flat files (e.g.,
MAF, GISTIC) and from Web querying (e.g., cbioportal).
• Data exploration and correctness. Functions for the exploration and visual-
ization of the imported data.
1For CAPRI the size of the input actually depends on the structural complexity of the input “pat-
terns”, i.e., of the boolean formulæ employed in the “lifting operation’
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Algorithm 3: TRONCO Data Import and Preprocessing
Input: a data set containing MAF or GISTIC scores, e.g., as obtained from cBio
portal ([24, 15]).
Result: a data structure containing boolean flags for “events”, relative
frequencies and other metadata.
1 From the dataset (depending on the data format) derive a Boolean matrix M ,
where each entry 〈i, j〉 is true if event i is “present” in sample/patient j.
2 forall the events e do
3 Compute the frequency of the event e in the dataset and save it in a map F .
4 Compute the joint probability of co-occurrence of pair of events in the dataset
and save it in a map C.
5 end
6 return A data structure comprising the Boolean matrix M , the maps F and C
and other metadata.
• Data editing. Functions for the preprocessing of the data in order to tidy them.
• External utilities. Functions for the interaction with external tools for the anal-
ysis of cancer subtypes or groups of mutually exclusive genes.
• Inference algorithms. In the current version of TRONCO, the CAPRESE and
CAPRI algorithms are provided in a polinomial implementation.
• Confidence estimation. Functions for the statistical estimation of the confidence
of the reconstructed models.
• Visualization. Functions for the visualization of both the input data and the
results of the inference and of the confidence estimation.
Data import
The starting point of TRONCO analysis pipeline, is a dataset of genomics alterations
(i.e., somatic mutations and copy number variations) which need to be imported as a
TRONCO compliant data structure, i.e., a list R structure containing the required data
both for the inference and the visualization. The data import functions take as input
such genomic data and from them create a TRONCO compliant data structure.
The core of the data import functionalities from flat files is the function called
import.genotypes(geno, event.type = ‘‘variant’’, color = ‘‘Darkgreen’’).
This function imports a matrix of 0/1 alterations as a TRONCO compliant dataset.
The input “geno” can be either a dataframe or a file name. In any case the dataframe
or the table stored in the file must have a column for each altered gene and a rows for
each sample. Colnames will be used to determine gene names, if data are loaded from
file the first column will be assigned as rownames.
49
50 CHAPTER 5. AN R PACKAGE FOR TRANSLATIONAL ONCOLOGY
Algorithm 4: Pseudocode of the CAPRESE algorithm
Input: a dataset of n events, i.e., genomic alterations, and m samples packed in
a datastructure obtained from Algorithm 3.
Result: a tree model representing all the relations of selective advantage.
Pruning based on Suppes’ criteria.
1 Let G← a complete directed graph over the vertices n.
2 forall the arcs (a, b) in G do
3 Compute a score S(·) for the nodes a and b based on Suppes’ criteria.
4 if Suppes’ criteria are not met then
5 Remove the arc (a, b) from G
6 else if S(a) > S(b) and S(a) > 0 then
7 Keep (a, b) as edge. i.e., select a as “candidate parent”.
8 else if S(b) > S(a) and S(b) > 0 then
9 Keep (a, b) as edge. i.e., select b as “candidate parent”.
10 end
Fit of the Prima Facie directed acyclic graph to the best tree model.
11 Let T ← the best tree model obtained by Edmonds’ algorithm (see [43]).
12 return The resulting tree model T .
Besides this function, TRONCO implements data import from other file format such
as MAF and GISTIC files as wrappers of the function import.genotypes. Specifically,
the function import.MAF(file, sep = ‘‘\t’’, is.TCGA = TRUE) imports mutation
profiles from a Manual Annotation Format (MAF) file. All mutations are aggregated
as a unique event type labeled “Mutation” and are assigned a color accordingly to the
default of function import.genotypes. If the input is in the TCGA MAF file format,
the function also checks for multiple samples per patient and a warning is raised if any
are found. Furthermore, the function import.GISTIC(x) transforms GISTIC scores for
CNAs in a TRONCO compliant object. The input can be a matrix, with columns for
each altered gene and rows for each sample; in this case colnames or rownames mut be
provided. If the input is a character an attempt to load a table from file is performed.
In this case the input table format should be constitent with TCGA data for focal CNA;
there should hence be: one column for each sample, one row for each gene, a column
Hugo Symbol with every gene name and a column Entrez Gene Id with every genes
Entrez ID. A valid GISTIC score should be any value of: “Homozygous Loss” (-2),
“Heterozygous Loss” (-1), “Low-level Gain” (+1), “High-level Gain” (+2).
Finally, TRONCO also provides utilities for the query of genomic data from cbiopor-
tal. This is implemented in the function cbio.query(cbio.study = NA, cbio.dataset
= NA, cbio.profile = NA, genes) which is a wrapper for the CGDS package. This
can work either automatically, if one sets cbio.study, cbio.dataset and cbio.profile,
or interactively. A list of genes to query with less than 900 entries should be provided.
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Algorithm 5: Pseudocode of the CAPRI algorithm
Input: a dataset of n variables, i.e., genomic alterations or patterns, and m
samples.
Result: a graphical model representing all the relations of “selective advantage”.
Pruning based on the Suppes’ criteria
1 Let G← a directed graph over the vertices n
2 forall the arcs (a, b) ∈ G do
3 Compute a score S(·) for the nodes a and b in terms of Suppes’ criteria.
4 Remove the arc (a, b) if Suppes’ criteria are not met.
5 end
Likelihood fit on the Prima Facie directed acyclic graph
6 Let M← the subset of the remaining arcs ∈ G, that maximize the log-likelihood
of the model, computed as: LL(D | M)− ((logm)/2) dim(M), where D denotes
the input data, m denotes the number of samples, and dim(M) denotes the
number of parameters in M (see [101]).
7 return The resulting graphical model M.
This function returns a list with two dataframes: the required genetic profile along with
clinical data for the cbio.study. The output is also saved to disk as Rdata file. See
also the cbioportal page at http://www.cbioportal.org.
The function show(x, view = 10) prints to console a short report of a dataset “x”,
which should be a TRONCO compliant dataset.
All the functions described in the following sections will assume as input a TRONCO
compliant data structure.
Data exploration and correctness
TRONCO provides a series of function to explore the imported data and the inferred
models. All these functions are named with the “as.” prefix.
Concerning the imported data, the function as.genotypes(x) returns the 0/1 geno-
types matrix. This function can be used in combination with the function keysToNames(x,
matrix) to translate colnames to event names given the input matrix with colnames or
rownames which represent genotypes keys. Also, functions to get the list of genes, events
(i.e., each columns in the genotypes matrix, it differs from genes as the same genes of
different types are considered different events), alterations (i.e., genes of different types
are merged as 1 unique event), samples (i.e., patients or also single cells) and alteration
types. See the functions:
as.genes(x, types = NA)
as.events(x, genes = NA, types = NA)
as.alterations(x, new.type = "Alteration", new.color = "khaki")
51
52 CHAPTER 5. AN R PACKAGE FOR TRANSLATIONAL ONCOLOGY
Algorithm 6: Bootstrap Procedure
Input: a model T obtained from CAPRESE or a model M obtained from
CAPRI, and the initial dataset.
Result: the confidence in the inferred arcs.
1 Let counter ← 0
2 Let nboot← the number of bootstrap sampling to be performed.
3 while counter < nboot do
4 Create a new dataset for the inference by random sampling of the input data.
5 Perform the reconstruction on the sampled dataset and save the results.
6 counter = counter + 1
7 end
8 Evaluate the confidence in the reconstruction by counting the number of times
any arc is inferred in the sampled datasets.
9 return The inferred model T or M augmented with an estimated confidence for
each arc.
as.samples(x)
as.types(x, genes = NA))
Functions of this kind are also implemented to explore the results such as the models
that have been inferred (see as.models(x, models = names(x$model))), the recon-
structions (see the functions as.adj.matrix(x, events = as.events(x), models =
names(x$model),type = "fit")), the considered patters (see as.patterns(x)) and
the confidence (see as.confidence(x, conf)).
Similarly, a set of function to extract the cardinality of the compliant TRONCO data
structure are defined (see nevents(x, genes = NA, types = NA), ngenes(x, types
= NA), npatterns(x), nsamples(x) and ntypes(x)).
Furthermore, functions to asses the correctness of the inputes are also provided. With
function is.compliant(x, err.fun = "[ERR]", stage = !(all(is.null(x$stages))
|| all(is.na(x$stages)))) it is possible to verify the TRONCO data structure to be
compliant with the standards. The function consolidate.data(x, print = FALSE)
verifies if the input data are consolidated, i.e., if there are events with 0 or 1 probability
or indistinguishable in terms of observations. Any indistinguishable event is returned by
the function duplicates(x).
Finally, TCGA specific functions are provided. TCGA.multiple.samples(x) checks
if there are multiple sample in the input, while TCGA.remove.multiple.samples(x)
remove them accordingly to TCGA barcodes naming.
Data editing
TRONCO provides a wide range of editing functions. We will describe some of them in
the following, for a technical description we refer to the manual.
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Removing and merging. A set of functions to remove items from the data is pro-
vided; such functions are named with the “delete.” prefix. Specifically, using these func-
tions it is possible to remove genes (delete.gene(x, gene), events (delete.event(x,
gene, type)), samples (delete.samples(x, samples)), types (delete.type(x, type))
as well as patterns (delete.pattern(x, pattern)) and inferred progression models
(delete.model(x)). At the same time, functions to merge events (merge.events(x,
..., new.event, new.type, event.color)) and alterations types (merge.types(x,
..., new.type = "new.type", new.color = "khaki")) are also provided.
Binding. The purpose of the binding functions is to combine different datasets. The
function ebind(...) combines events from one or more datasets, whose events need be
defined over the same set of samples while the function sbind(...) combines samples
from one or more datasets, whose samples need to be defined over the same set of
events. Samples and events of two dataset can also be intersected through the function
intersect.datasets(x, y, intersect.genomes = TRUE).
Changing and renaming. The two functions rename.gene(x, old.name, new.name)
and rename.type(x, old.name, new.name) can be used respectively to rename genes
or alterations types. The function change.color(x, type, new.color) can be used
to change the color associated to the specified alteration type.
Selecting and splitting. Genomics data usually involves a vast number of genes,
the most of which is not relevant for cancer development (i.e., such as passenger mu-
tations). For this reason, TRONCO implements the function events.selection(x,
filter.freq = NA, filter.in.names = NA,filter.out.names = NA) which allows
the selection of a set of genes to be analyzed. The selection can be performed by fre-
quency and gene symbols. The 0 probability events can are removed by the function
trim(x). Moreover, the functions samples.selection(x, samples) and ssplit(x,
clusters, idx = NA) respectively filters a dataset based on selected samples id and
splits the dataset into groups (i.e., groups). This latter function can be used to analyze
specific subtypes within a tumor.
External utilities
TRONCO permits the interaction with external tools to (i) reduce inter-tumor hetero-
geneity by cohort subtyping and (ii) detect fitness equivalent exclusive alterations. The
first issue can be attacked by adopting clustering techniques to split the dataset in or-
der to analyze each cluster subtype separately. Currently, TRONCO can export and
inport data from [82] via the function export.nbs.input(x, map hugo entrez, file
= "tronco to nbs.mat") and the previously described splitting functions.
To handle alterations with equivalent fitness, TRONCO implements the interaction
with [7] through the functions export.mutex(x, filename = "tronco to mutex", filepath
= "./", label.mutation = "SNV", label.amplification = list("High-level Gain"),
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label.deletion = list("Homozygous Loss")) and import.mutex.groups(file, fdr
= 0.2, display = TRUE). Such exclusivity groups can then be further added as patters
(see the next Section).
Inference algorithms
In the current version of TRONCO are implemented the algorithms CAPRESE [117]
and CAPRI [158].
CAPRESE The CAPRESE algorithm [117] can be executed by the function
tronco.caprese(data, lambda = 0.5, do.estimation = FALSE, silent = FALSE)
with “data” being a compliant TRONCO data structure. The parameter “lambda” can
be used to tune the shrinkage-alike estimator adopted by CAPRESE, with the default
being 0.5 as suggested in [117].
CAPRI The CAPRI algorithm [158] can be executed by the function
tronco.capri(data, command = "hc", regularization = c("bic", "aic"),
do.boot = TRUE, nboot = 100, pvalue = 0.05,
min.boot = 3, min.stat = TRUE, boot.seed = NULL,
do.estimation = FALSE, silent = FALSE)
with “data” being a TRONCO compliant data structure. The parameters “command”
and “regularization” allows respectively to choose the heuristic search to be performed to
fit the network and the regularizer to be used in the likelihood fit (see [158]). CAPRI can
be also executed without the bootstrap preprocessing step by the parameter “do.boot”;
this is discouraged, but can speed up the execution with big input datasets.
As discussed in [158], CAPRI constrains the seach space using Suppes’ prima fa-
cie conditions which lead to a subset of possible valid selective advantage relations
which are then evaluated by the likelihood fit. Although uncommon, it may so hap-
pen (especially when pattern are given as input) that such a resulting prima facie
graphical structure may still contain cycles. When this happens, the cycles are re-
moved through the heuristic algorithm implemented in remove.cycles(adj.matrix,
weights.temporal.priority, weights.matrix, not.ordered, hypotheses = NA, silent).
The function takes as input a set of weights in term of confidence for any selective ad-
vantage valid edge, ranks all the valid edges in increasing confidence levels and, starting
from the less confident, goes through each edge and remove the ones that can break the
cycles.
Patterns CAPRI allows for the input of patterns, i.e., group of events which express
possible selective advantage relations. Such patters are given as input with the function
hypothesis.add(data, pattern.label, lifted.pattern, pattern.effect = "*",
pattern.cause = "*"). This function is wrapped by hypothesis.add.homologous(x,
54
5.1. PACKAGE IMPLEMENTATION 55
pattern.cause = "*", pattern.effect = "*", genes = as.genes(x), FUN = OR)
and hypothesis.add.group(x, FUN, group, pattern.cause = "*", pattern.effect
= "*", dim.min = 2, dim.max = length(group), min.prob = 0) which, respectively,
allow addition of analogous patterns (i.e., patterns involving the same gene of different
types) and patterns involving a specified group of genes. In the current version of
TRONCO, the implemented possible patters are the boolean operators AND, OR and
XOR (functions AND(...), OR(...) and XOR(...)).
Confidence estimation
To asses the confidence of any selectivity relations TRONCO implements non-parametric
and statistical bootstrap. For the non-parametric bootstrap, each event row is uniformly
sampled with repetitions from the input genotype and then, on such an input, the
inference algorithms are performed. The assesment concludes after K repetitions (e.g.,
K = 100). Similarly, for CAPRI, a statistical bootstrap is provided: in this case the
input dataset is kept fixed, but different seeds for the statistical procedures are sampled
(see, e.g., [46] for an overview of these methods). The bootstrap is implemented in the
function tronco.bootstrap(reconstruction, type = "non-parametric", nboot =
100, verbose = FALSE) where “reconstruction” is a compliant object obtained by the
inference by one of the implemented algorithms.
Visualization
During the development of the TRONCO package, a lot of attention was paid to the
visualization features which are crucial for the understanding of biological results. Shown
below is an overview of the main features; for a detailed description of each function,
please refer to the manual.
OncoPrint. OncoPrints are compact means of visualizing distinct genomic alterations,
including somatic mutations, copy number alterations, and mRNA expression changes
across a set of cases. They are extremely useful for visualizing gene set and pathway al-
terations across a set of cases, and for visually identifying trends, such as trends in mutual
exclusivity or co-occurence between gene pairs within a gene set. Individual genes are
represented as rows, and individual cases or patients are represented as columns. See
http://www.cbioportal.org/. The function oncoprint provides such visualizations
with a TRONCO compliant data structure as input. The function oncoprint.cbio
exports the input for the cbioportl visualization, see http://www.cbioportal.org/
public-portal/oncoprinter.jsp.
It is also possible to annotate a description (annotate.description(x, label))
and tumor stages (annotate.stages(x, stages, match.TCGA.patients = FALSE)) to
any oncoprint.
Reconstruction. The inferred models can be displayed by the function tronco.plot.
The features included in the plots are multiple, such as the choice of the regularizer(s)
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to show, editing font of nodes and edges, scaling nodes’ size in terms of estimated
marginal probabilities, annotating the pathway of each gene and displaying the estimated
confidence of each edge. We refer to the manual for a detailed description.
Reports. Finally, report utilities are provided. The function genes.table.report(x,
name, dir = getwd(), maxrow = 33, font = 10, height = 11, width = 8.5, fill
= "lightblue") can be used to generate LaTeX code to be used as report, while
genes.table.plot(x, name, dir = getwd()) generates reports histograms.
5.2 Use case of TRONCO
In this Section, we will present a case study for the usage of the TRONCO package
based on the work presented in [158]. A detailed discussion of the pipeline along with a
complete analysis based on it is provided in [33, 5].
Events selection
We will start by loading the TRONCO package in R along with an example ”dataset”
that comes within the package.
> library(TRONCO)
> data(aCML)
> hide.progress.bar <<- TRUE
We then use the function show to get a short summary of the aCML dataset that
has just been loaded.
> show(aCML)
Description: CAPRI - Bionformatics aCML data.
Dataset: n=64, m=31, |G|=23.
Events (types): Ins/Del, Missense point, Nonsense Ins/Del, Nonsense point.
Colors (plot): darkgoldenrod1, forestgreen, cornflowerblue, coral.
Events (10 shown):
gene 4 : Ins/Del TET2
gene 5 : Ins/Del EZH2
gene 6 : Ins/Del CBL
gene 7 : Ins/Del ASXL1
gene 29 : Missense point SETBP1
gene 30 : Missense point NRAS
gene 31 : Missense point KRAS
gene 32 : Missense point TET2
gene 33 : Missense point EZH2
gene 34 : Missense point CBL
56
5.2. USE CASE OF TRONCO 57
Genotypes (10 shown):
gene 4 gene 5 gene 6 gene 7 gene 29 gene 30 gene 31 gene 32 gene 33 gene 34
patient 1 0 0 0 0 1 0 0 0 0 0
patient 2 0 0 0 0 1 0 0 0 0 1
patient 3 0 0 0 0 1 1 0 0 0 0
patient 4 0 0 0 0 1 0 0 0 0 1
patient 5 0 0 0 0 1 0 0 0 0 0
patient 6 0 0 0 0 1 0 0 0 0 0
Using the function as.events, we can have a look at the events in the dataset.
> as.events(aCML)
type event
gene 4 "Ins/Del" "TET2"
gene 5 "Ins/Del" "EZH2"
gene 6 "Ins/Del" "CBL"
gene 7 "Ins/Del" "ASXL1"
gene 29 "Missense point" "SETBP1"
gene 30 "Missense point" "NRAS"
gene 31 "Missense point" "KRAS"
gene 32 "Missense point" "TET2"
gene 33 "Missense point" "EZH2"
gene 34 "Missense point" "CBL"
gene 36 "Missense point" "IDH2"
gene 39 "Missense point" "SUZ12"
gene 40 "Missense point" "SF3B1"
gene 44 "Missense point" "JARID2"
gene 47 "Missense point" "EED"
gene 48 "Missense point" "DNMT3A"
gene 49 "Missense point" "CEBPA"
gene 50 "Missense point" "EPHB3"
gene 51 "Missense point" "ETNK1"
gene 52 "Missense point" "GATA2"
gene 53 "Missense point" "IRAK4"
gene 54 "Missense point" "MTA2"
gene 55 "Missense point" "CSF3R"
gene 56 "Missense point" "KIT"
gene 66 "Nonsense Ins/Del" "WT1"
gene 69 "Nonsense Ins/Del" "RUNX1"
gene 77 "Nonsense Ins/Del" "CEBPA"
gene 88 "Nonsense point" "TET2"
gene 89 "Nonsense point" "EZH2"
gene 91 "Nonsense point" "ASXL1"
gene 111 "Nonsense point" "CSF3R"
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These events account for alterations in the following genes.
> as.genes(aCML)
[1] "TET2" "EZH2" "CBL" "ASXL1" "SETBP1" "NRAS" "KRAS" "IDH2"
"SUZ12" "SF3B1" "JARID2" "EED" "DNMT3A" "CEBPA" "EPHB3" "ETNK1"
"GATA2" "IRAK4" "MTA2" "CSF3R"
[21] "KIT" "WT1" "RUNX1"
Now we take a look at the alterations of only the gene SETBP1 across the samples.
> as.gene(aCML, genes=’SETBP1’)
Missense point SETBP1
patient 1 1
patient 2 1
patient 3 1
patient 4 1
patient 5 1
patient 6 1
patient 7 1
patient 8 1
patient 9 1
patient 10 1
patient 11 1
patient 12 1
patient 13 1
patient 14 1
patient 15 0
patient 16 0
patient 17 0
patient 18 0
patient 19 0
patient 20 0
patient 21 0
patient 22 0
patient 23 0
patient 24 0
patient 25 0
patient 26 0
patient 27 0
patient 28 0
patient 29 0
patient 30 0
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patient 31 0
patient 32 0
patient 33 0
patient 34 0
patient 35 0
patient 36 0
patient 37 0
patient 38 0
patient 39 0
patient 40 0
patient 41 0
patient 42 0
patient 43 0
patient 44 0
patient 45 0
patient 46 0
patient 47 0
patient 48 0
patient 49 0
patient 50 0
patient 51 0
patient 52 0
patient 53 0
patient 54 0
patient 55 0
patient 56 0
patient 57 0
patient 58 0
patient 59 0
patient 60 0
patient 61 0
patient 62 0
patient 63 0
patient 64 0
We consider a subset of all the genes in the dataset to be involved in patters based
on the support we found in the literature. See [158] as a reference.
> gene.hypotheses = c(’KRAS’, ’NRAS’, ’IDH1’, ’IDH2’, ’TET2’, ’SF3B1’, ’ASXL1’)
Regardless from which types of mutations we include, we select only the genes which
appear alterated in at least 5% of the patients. Thus, we first transform the dataset
into ”Alteration” (i.e., by collapsing all the event types for the same gene), and then we
consider only these events from the original dataset.
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Figure 5.1: Oncoprint function in TRONCO. Result of the oncoprint function in
TRONCO on the aCML dataset.
> alterations = events.selection(as.alterations(aCML), filter.freq = .05)
*** Aggregating events of type(s) Ins/Del, Missense point, Nonsense Ins/Del,
Nonsense point
in a unique event with label "Alteration".
Dropping event types Ins/Del, Missense point, Nonsense Ins/Del, Nonsense point for
23 genes.
*** Binding events for 2 datasets.
*** Events selection: #events=23, #types=1
Filters freq|in|out = {TRUE, FALSE, FALSE}
Minimum event frequency: 0.05 (3 alterations out of 64 samples).
Selected 7 events.
Selected 7 events, returning.
We now show a plot of the selected genes. Note that this plot has no title as by
default the function events.selection does not add any. The resulting figure is shonw
in 5.1.
> dummy = oncoprint(alterations,font.row=12,cellheight=20,cellwidth=4)
*** Oncoprint for ""
with attributes: stage=FALSE, hits=TRUE
Sorting samples ordering to enhance exclusivity patterns.
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Adding Hypotheses
We now create the dataset to be used for the inference of the progression model.
We consider the original dataset and from it we select all the genes whose mutations are
occurring at least 5% of the times together with any gene involved in any hypothesis.
To do so, we use the parameter filter.in.names as shown below.
> hypo = events.selection(aCML, filter.in.names=c(as.genes(alterations),
gene.hypotheses))
*** Events selection: #events=31, #types=4 Filters freq|in|out =
{FALSE, TRUE, FALSE}
[filter.in] Genes hold: TET2, EZH2, CBL, ASXL1, SETBP1 ... [10/14 found].
Selected 17 events, returning.
> hypo = annotate.description(hypo, ’CAPRI - Bionformatics aCML data
(selected events)’)
We show a new oncoprint of this latest dataset where we annotate the genes in
gene.hypotheses in order to identify them 5.2. The sample names are also shown.
> dummy = oncoprint(hypo, gene.annot = list(priors= gene.hypotheses),
sample.id = T, font.row=12, font.column=5, cellheight=20, cellwidth=4)
*** Oncoprint for "CAPRI - Bionformatics aCML data (selected events)"
with attributes: stage=FALSE, hits=TRUE
Sorting samples ordering to enhance exclusivity patterns.
Annotating genes with RColorBrewer color palette Set1 .
We now also add the hypotheses that are described in CAPRI’s manuscript. Hypoth-
esis of hard exclusivity (XOR) for NRAS/KRAS events (Mutation). This hypothesis is
tested against all the events in the dataset.
> hypo = hypothesis.add(hypo, ’NRAS xor KRAS’, XOR(’NRAS’, ’KRAS’))
We then try to include also a soft exclusivity (OR) pattern but, since its ”signature”
is the same of the hard one just included, it will not be included. The code below is
expected to result in an error.
> hypo = hypothesis.add(hypo, ’NRAS or KRAS’, OR(’NRAS’, ’KRAS’))
Error in hypothesis.add(hypo, "NRAS or KRAS", OR("NRAS", "KRAS")) :
[ERR] Pattern duplicates Pattern NRAS xor KRAS.
To better highlight the perfect (hard) exclusivity among NRAS/KRAS mutations,
one can examine further their alterations. See Figure 5.3.
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Figure 5.2: Annotated oncoprint. Result of the oncoprint function on the selected
dataset in TRONCO with annotations.
> dummy = oncoprint(events.selection(hypo, filter.in.names = c(’KRAS’, ’NRAS’)),
font.row=12, cellheight=20, cellwidth=4)
*** Events selection: #events=18, #types=4 Filters freq|in|out =
{FALSE, TRUE, FALSE}
[filter.in] Genes hold: KRAS, NRAS ... [2/2 found].
Selected 2 events, returning.
*** Oncoprint for ""
with attributes: stage=FALSE, hits=TRUE
Sorting samples ordering to enhance exclusivity patterns.
We repeated the same analysis as before for other hypotheses and for the same
reasons, we will include only the hard exclusivity pattern.
> hypo = hypothesis.add(hypo, ’SF3B1 xor ASXL1’, XOR(’SF3B1’, OR(’ASXL1’)), ’*’)
> hypo = hypothesis.add(hypo, ’SF3B1 or ASXL1’, OR(’SF3B1’, OR(’ASXL1’)), ’*’)
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Figure 5.3: RAS oncoprint. Result of the oncoprint function in TRONCO for only
the RAS genes to better show their hard exclusivity pattern.
Error in hypothesis.add(hypo, "SF3B1 or ASXL1", OR("SF3B1", OR("ASXL1")), :
[ERR] Pattern duplicates Pattern SF3B1 xor ASXL1.
Finally, we now repeat the same for genes TET2 and IDH2. In this case 3 events for
the gene TET2 are present, that is ”Ins/Del”, ”Missense point” and ”Nonsense point”.
For this reason, since we are not specifying any subset of such events to be considered,
all TET2 alterations are used. Since the events present a perfect hard exclusivity, their
patters will be included as an XOR. See Figure 5.4.
> as.events(hypo, genes = ’TET2’)
type event
gene 4 "Ins/Del" "TET2"
gene 32 "Missense point" "TET2"
gene 88 "Nonsense point" "TET2"
> hypo = hypothesis.add(hypo, ’TET2 xor IDH2’, XOR(’TET2’, ’IDH2’), ’*’)
> hypo = hypothesis.add(hypo, ’TET2 or IDH2’, OR(’TET2’, ’IDH2’), ’*’)
> dummy = oncoprint(events.selection(hypo, filter.in.names = c(’TET2’, ’IDH2’)),
font.row=12, cellheight=20,cellwidth=4)
*** Events selection: #events=21, #types=4 Filters freq|in|out =
{FALSE, TRUE, FALSE}
[filter.in] Genes hold: TET2, IDH2 ... [2/2 found].
Selected 4 events, returning.
*** Oncoprint for ""
with attributes: stage=FALSE, hits=TRUE
Sorting samples ordering to enhance exclusivity patterns.
We now finally add any possible group of homologous events. For any gene having
more than one event associated we also add a soft exclusivity pattern among them.
> hypo = hypothesis.add.homologous(hypo)
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Figure 5.4: TET/IDH2 oncoprint. Result of the oncoprint function in TRONCO
for only the TET/IDH2 genes.
*** Adding hypotheses for Homologous Patterns
Genes: TET2, EZH2, CBL, ASXL1, CSF3R
Function: OR
Cause: *
Effect: *
Hypothesis created for all possible gene patterns.
The final dataset that will be given as input to CAPRI is now finally shown. See
Figure 5.5.
> dummy = oncoprint(hypo, gene.annot = list(priors= gene.hypotheses),
sample.id = T, font.row=10, font.column=5, cellheight=15, cellwidth=4)
*** Oncoprint for "CAPRI - Bionformatics aCML data (selected events)"
with attributes: stage=FALSE, hits=TRUE
Sorting samples ordering to enhance exclusivity patterns.
Annotating genes with RColorBrewer color palette Set1 .
Model reconstruction
We next infer the model by running CAPRI algorithm with its default parameters:
we use both AIC and BIC as regularizators, Hill-climbing as heuristic search of the
solutions and exhaustive bootstrap (nboot replicates or more for Wilcoxon testing, i.e.,
more iterations can be performed if samples are rejected), p-value set at 0.05. We set
the seed for the sake of reproducibility.
> model = tronco.capri(hypo, boot.seed = 12345, nboot=10)
*** Checking input events.
*** Inferring a progression model with the following settings.
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Figure 5.5: Final dataset for CAPRI. Result of the oncoprint function in TRONCO
on the dataset used in [158].
Dataset size: n = 64, m = 26.
Algorithm: CAPRI with "bic, aic" regularization and "hc" likelihood-fit strategy.
Random seed: 12345.
Bootstrap iterations (Wilcoxon): 10.
exhaustive bootstrap: TRUE.
p-value: 0.05.
minimum bootstrapped scores: 3.
*** Bootstraping selective advantage scores (prima facie).
Evaluating "temporal priority" (Wilcoxon, p-value 0.05)
Evaluating "probability raising" (Wilcoxon, p-value 0.05)
*** Loop detection found loops to break.
Removed 26 edges out of 68 (38%)
*** Performing likelihood-fit with regularization bic.
*** Performing likelihood-fit with regularization aic.
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The reconstruction has been successfully completed in 00h:00m:02s
We then plot the model inferred by CAPRI with BIC as a regolarizator and we
set some parameters to get a good plot; the confidence of each edge is shown both
in terms of temporal priority and probability raising (selective advantage scores) and
hypergeometric testing (statistical relevance of the dataset of input). See Figure 5.6.
> tronco.plot(model, fontsize = 13, scale.nodes = .6, regularization="bic",
confidence = c(’tp’, ’pr’, ’hg’), height.logic = 0.25, legend.cex = .5,
pathways = list(priors= gene.hypotheses), label.edge.size=5)
*** Expanding hypotheses syntax as graph nodes:
*** Rendering graphics
Nodes with no incoming/outgoing edges will not be displayed.
Annotating nodes with pathway information.
Annotating pathways with RColorBrewer color palette Set1 .
Adding confidence information: tp, pr, hg
RGraphviz object prepared.
Plotting graph and adding legends.
Bootstrapping data
Finally, we perform non-parametric bootstrap as a further estimation of the confi-
dence in the inferred results. See Figure 5.7.
> model.boot = tronco.bootstrap(model, nboot=10)
Executing now the bootstrap procedure, this may take a long time...
Expected completion in approx. 00h:00m:03s
*** Using 7 cores via "parallel"
*** Reducing results
Performed non-parametric bootstrap with 10 resampling and 0.05 as pvalue
for the statistical tests.
> tronco.plot(model.boot, fontsize = 13, scale.nodes = .6, regularization="bic",
confidence=c(’npb’), height.logic = 0.25, legend.cex = .5,
pathways = list(priors= gene.hypotheses), label.edge.size=10)
*** Expanding hypotheses syntax as graph nodes:
*** Rendering graphics
Nodes with no incoming/outgoing edges will not be displayed.
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Figure 5.6: Reconstruction by CAPRI. Result of the reconstruction by CAPRI on
the input dataset.
Annotating nodes with pathway information.
Annotating pathways with RColorBrewer color palette Set1 .
Adding confidence information: npb
RGraphviz object prepared.
Plotting graph and adding legends.
We now conclude this analysis with an example of inference with the CAPRESE
algorithm. As CAPRESE does not consider any patter as input, we use the dataset
shown in Figure 5.2. These results are shown in Figure 5.8.
> model.boot.caprese = tronco.bootstrap(tronco.caprese(hypo))
*** Checking input events.
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Figure 5.7: Reconstruction by CAPRI and Bootstrap. Result of the reconstruction
by CAPRI on the input dataset with the assesment by non-parametric bootstrap.
*** Inferring a progression model with the following settings.
Dataset size: n = 64, m = 17.
Algorithm: CAPRESE with shrinkage coefficient: 0.5.
The reconstruction has been successfully completed in 00h:00m:00s
Executing now the bootstrap procedure, this may take a long time...
Expected completion in approx. 00h:00m:00s
Performed non-parametric bootstrap with 100 resampling and 0.5
as shrinkage parameter.
> tronco.plot(model.boot.caprese, fontsize = 13, scale.nodes = .6,
confidence=c(’npb’), height.logic = 0.25, legend.cex = .5,
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Figure 5.8: Reconstruction by CAPRESE and Bootstrap. Result of the recon-
struction by CAPRESE on the input dataset with the assesment by non-parametric
bootstrap.
pathways = list(priors= gene.hypotheses), label.edge.size=10,
legend.pos="top")
*** Expanding hypotheses syntax as graph nodes:
*** Rendering graphics
Nodes with no incoming/outgoing edges will not be displayed.
Annotating nodes with pathway information.
Annotating pathways with RColorBrewer color palette Set1 .
Adding confidence information: npb
RGraphviz object prepared.
Plotting graph and adding legends.
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5.3 TCGA MSI/MSS colorectal tumors
We conclude this Chapter with a more elaborate analysis performed with the TRONCO
package. As a reference, see Chapter §6 and [21].
We report the acronyms that will be adopted in this Section.
MSS Microsatellite Stable
MSI Microsatellite Highly-Instable
CNA Copy Number Alteration
TCGA The Cancer Genome Atlas
COADREAD Human Colon and Rectal Cancer (TCGA project)
MUTEX Mutual Exclusivity (tool)
CAPRI Cancer Progression Inference (algorithm)
TRONCO Translational Oncology (tool)
5.3.1 Summary
The summary and motivation of this study are detailed in the original paper [21]. Here,
we just mention that we will (i) use samples from the COADREAD project to implement
a case/control study, (ii) select somatic mutations and focal CNAs in 33 driver genes
manually annotated to 5 pathways by the Consortium, (iii) scan groups of exclusive
alterations with MUTEX ([7]) and, finally, (iv) retrieve progression models by running the
CAPRI algorithm ([158]) implemented in TRONCO.
Prerequisites. Install the TRONCO package either from Bioconductor or its official
webpage:
http://bimib.disco.unimib.it
In any case, check that the installed version is updated; this document references TRONCO
version 2.0, Mantis Shrimp. This study processes TCGA data originally archived at:
https://tcga-data.nci.nih.gov/docs/publications/coadread 2012/
For conveniency, we have converted such files to formats easily manipulable with R. We
host such files at TRONCO’s webpage, as of the download performed the 12 March 2015.
The files are:
• "crc clinical sheet.txt": clinical data file;
• "TCGA CRC Suppl Table2 Mutations 20120719.csv": MAF mutations file, origi-
nally Excel file, now converted to csv format with semi-comma separator;
• "crc gistic.txt": GISTIC file of focal CNAs;
• "TCGA-clusters.csv": clustering results, including MSI/MSS status.
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and the code that we provide you with takes care of downloading them autonomously.
For clarity and modularity, this tutorial makes use of different files, reported in
sections’ titles; the root file is named main.R, and starts by loading TRONCO, setting up
some variables and folder, then downloading data.
Listing 1: Root file main.R
# You might install TRONCO’s version from BIMIB Github as
library(devtools)
install_github("BIMIB-DISCo/TRONCO")
library(TRONCO)
# Working directory
workdir = "TCGA-data/"
dir.create(workdir)
# Data files
datafile = ’TCGA-COADREAD-TRONCO.zip’
download.file(
’https://github.com/BIMIB-DISCo/datasets/raw/master/TCGA-COADREAD-TRONCO.zip’,
destfile=datafile, method=’curl’)
unzip(datafile, exdir = workdir)
# Name input files
clinical.file = paste0(workdir, "/Clinical/crc_clinical_sheet.txt")
MAF.file = paste0(workdir,
"/Mutations/TCGA_CRC_Suppl_Table2_Mutations_20120719.csv")
GISTIC.file = paste0(workdir, "/CNV/crc_gistic.txt")
clusters.file = paste0(workdir, "/Clusters/TCGA-clusters.csv")
MUTEX.msi.file = paste0(workdir, "/MUTEX/msi_results.txt")
MUTEX.mss.file = paste0(workdir, "/MUTEX/mss_results.txt")
# Then this files sources the other scripts
source(’scripts/TCGA-import.R’, echo = TRUE)
source(’scripts/training-samples.R’, echo = TRUE)
source(’scripts/training-exclusivity.R’, echo = TRUE)
source(’scripts/training-reconstruction.R’, echo = TRUE)
source(’scripts/validation-samples.R’, echo = TRUE)
source(’scripts/validation-pvalues.R’, echo = TRUE)
5.3.2 Import of the TCGA data in TRONCO - TCGA-import.R
We begin by loading clinical attributes.
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clinical.data = TCGA.map.clinical.data(
file = clinical.file,
column.samples = ’patient’,
column.map = ’tumor_stage’)
head(clinical.data)
Now we process separately mutations and CNAs to prepare two TRONCO objects and save
them as Rdata. One will be the set of all CNAs, and shall be used afterwards to prepare
the control samples, the other will be the set of training samples with both CNAs and
mutations data.
Processing mutations. We can import the MAF file which annotates mutations for
the training samples, and augment each patient with its associated stage. We use flag
is.TCGA to check if any patient has multiple samples associated as we eventually want
to select only one sample per patient. These steps generates a TRONCO object, on which
we use show function to get a simple report of the dataset.
# Load MAF - use is.TCGA to match samples to patients
MAF = import.MAF(
file = MAF.file,
is.TCGA = TRUE,
sep = ’;’)
# Add stage annotation - use match.TCGA.patients to match long/short barcodes
MAF = annotate.stages(MAF, clinical.data, match.TCGA.patients = TRUE)
show(MAF)
As COADREAD has multiple samples, we use TRONCO functions which implement
TCGA aliquote disambiguation policies to select one sample per patient
# Check for duplicated samples - we find them
TCGA.multiple.samples(MAF)
# Remove duplicated samples according to TCGA criteria,
# shorten barcodes and add stages
MAF = TCGA.remove.multiple.samples(MAF)
MAF = TCGA.shorten.barcodes(MAF)
MAF = annotate.stages(MAF, clinical.data)
Processing Copy Numbers. As done for mutations, we import CNAs from focal
GISTIC profiles. Preprocessing is here minor, as GISTIC profiles are in a matrix which
can be imported directly in TRONCO after transposition. Editing of the GISTIC informa-
tion that we do not want to use, is done on the TRONCO object as we have functions for
its easy manipulation
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# Load as a plain table
GISTIC = read.table(
GISTIC.file,
check.names = FALSE,
stringsAsFactors = FALSE,
header = TRUE)
# Have a look at this table to remove useless information
head(GISTIC[, 1:5])
GISTIC $Entrez_Gene_Id = NULL
rownames(GISTIC) = GISTIC $Hugo_Symbol
GISTIC $Hugo_Symbol = NULL
# Import all GISTIC data
GISTIC = import.GISTIC( t(GISTIC) )
show(GISTIC)
# We want to use only high-confidence scores from the GISTIC,
# renamed as Amplification/Deletion
GISTIC = delete.type(GISTIC, ’Heterozygous Loss’) # low-level deletions
GISTIC = delete.type(GISTIC, ’Low-level Gain’) # low-level amplifications
GISTIC = rename.type(GISTIC, ’Homozygous Loss’, ’Deletion’)
GISTIC = rename.type(GISTIC, ’High-level Gain’, ’Amplification’)
GISTIC = annotate.stages(GISTIC, clinical.data)
show(GISTIC)
Subsetting samples for training. We now want to select only samples with both
somatic mutations and CNAs available - i.e., the intersection of the dataset GISTIC
and MAF. Notice that the GISTIC contains only genes with at least 1 CNV in the
dataset, so some well-known CRC genes such as pik3ca or fam123b are not annotated
in there.
c("PIK3CA", "FAM123B") \%in\% as.genes(GISTIC) # Shall be FALSE
Thus, we want to intersect patients as we assume that every patient has at least one
CNA, and make the union of all the genes annotated in MAF/GISTIC datasets. This shall
yield a new dataset called MAF.GISTIC; this and GISTIC will be exported as Rdata.
# We set intersect.genomes to FALSE to take the union of altered genes
MAF.GISTIC = intersect.datasets(GISTIC, MAF, intersect.genomes = FALSE)
# We remove events which have no observations in the dataset,
# and annotate stages
MAF.GISTIC = trim(MAF.GISTIC)
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MAF.GISTIC = annotate.stages(MAF.GISTIC, clinical.data)
show(MAF.GISTIC)
# Export these datasets as Rdata
save(MAF.GISTIC, file = paste0(workdir, ’MAF.GISTIC.Rdata’))
save(GISTIC, file = paste0(workdir, ’GISTIC.Rdata’))
5.3.3 Preparing the training datasets - training-samples.R
We first create some folders where we will separate TRONCO output, then we load the files
that we just created, and set some fancy colors.
# Prepare folders
dir.create(’./MSS’)
dir.create(’./MSI’)
sub.dir = c(’MUTEX’, ’Rdata-lifted’, ’Rdata-models’)
sapply(paste0(’./MSS/’, sub.dir), dir.create)
sapply(paste0(’./MSI/’, sub.dir), dir.create)
# Load MAF.GISTIC file, set some fancy colors to get cute visualization
load(paste0(workdir, ’/MAF.GISTIC.Rdata’))
MAF.GISTIC = change.color(MAF.GISTIC, ’Mutation’, ’darkolivegreen3’)
MAF.GISTIC = change.color(MAF.GISTIC, ’Amplification’, ’coral’)
MAF.GISTIC = change.color(MAF.GISTIC, ’Deletion’, ’cornflowerblue’)
Now we load clustering assignments from TCGA, we define the clustering maps for
patients to MSI/MSS status and use that to create the corresponding TRONCO objects
for each dataset.
# Load table data
file = read.delim(clusters.file, sep = ";")
head(file)
# Select just certain annotations, remove blank lines
tab = file[, c("patient", "MSI_status", "sequenced")]
tab = tab[1:276, ]
rownames(tab) = tab $patient
# Filter out non-sequenced samples, and order them (for console visualization)
tab = tab[tab $sequenced == 1, ]
tab = tab[order(tab $MSI_status), ]
print(tab)
# Define the maps to split samples
map.MSS = tab[tab $MSI_status == "MSS", , drop = FALSE]
74
5.3. TCGA MSI/MSS COLORECTAL TUMORS 75
map.MSI.H = tab[tab $MSI_status == "MSI-H", , drop = FALSE]
# These are the samples that we actually use
MSS.samples = rownames(map.MSS)
MSI.H.samples = rownames(map.MSI.H)
# Split is done by using samples.selection with appropriate vectors as input
MSS = trim(samples.selection(MAF.GISTIC, MSS.samples))
MSI.H = trim(samples.selection(MAF.GISTIC, MSI.H.samples))
show(MSS)
show(MSI.H)
To produce fancy figures, we shall also define some further groups and colors. Among
these, there are the 33 relevant driver genes identified by the Consortium which we
include now. Also, as we are not going to use any external clustering tool, we can
immediately subset MSI/MSS tumors to include only alterations in those driver genes.
# Plotting colors
alteration.color = ’dimgray’
pathways.color = c(’firebrick1’, ’darkblue’, ’darkgreen’, ’darkmagenta’,
’darkorange’)
# Driver events - 33 genes mapped to 5 pathways by TCGA
Wnt = c("APC", "CTNNB1", "DKK1", "DKK2", "DKK3", "DKK4", "LRP5", "FZD10",
"FAM123B", "AXIN2", "TCF7L2", "FBXW7", "ARID1A", "SOX9")
RAS = c("ERBB2", "ERBB3", "NRAS", "KRAS", "BRAF")
PI3K = c("IGF2", "IRS2", "PIK3CA", "PIK3R1", "PTEN")
TGFb = c("TGFBR1", "TGFBR2", "ACVR1B", "ACVR2A", "SMAD2", "SMAD3", "SMAD4")
P53 = c("TP53", "ATM")
# Some variable which will be processed by TRONCO plotting functions
pathway.genes = c(Wnt, RAS, PI3K, TGFb, P53)
pathway.names = c(’Wnt’, ’RAS’, ’PI3K’, ’TGFb’, ’P53’)
pathway.list = list(Wnt = Wnt, RAS = RAS, PI3K = PI3K, TGFb = TGFb, P53 = P53)
Finally, we can create the two datasets which we shall use - these contain as driver
events only alterations in the 33 TCGA genes. Also, we can use oncoprint function to
start making plots out of the data - see Figure 5.9.
# MSS tumors
MSS = trim(events.selection(MSS, filter.in.names = pathway.genes))
MSS = annotate.description(MSS, ’MSS subtype’)
# MSI-HIGH tumors
MSI.H = trim(events.selection(MSI.H, filter.in.names = pathway.genes))
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MSI.H = annotate.description(MSI.H, ’MSI-HIGH subtype’)
# We use TRONCO visualization function - oncoprint - to view these dataset
w = oncoprint(MSS,
title = ’MSS tumors - with all driver genes’,
legend.cex = .5, # Legend size for events type
gene.annot = pathway.list, # List of mapping to pathways/groups
gene.annot.color = pathways.color, # Mapping color
sample.id = T) # Sample names
w = oncoprint(MSI.H,
legend.cex = .5,
gene.annot = pathway.list,
gene.annot.color = pathways.color,
sample.id = T)
5.3.4 Exclusivity groups in the datasets - training-exclusivity.R
TRONCO relies on external tools such as MUTEX or others to detect exclusivity groups.
As the input/output formats of such tools is non-uniform, however, we do not support
direct conversion from TRONCO objects to every tool input/output.
In this case, we use the MUTEX tool to detect exclusivity groups in MSI/MSS datasets
and, inside TRONCO, there are input/output function to use with it, which we update
consistently.
# Export a file MSS.txt compliant to MUTEX input
export.MUTEX(MSS,
filename = ’MSS/MUTEX/MSS.txt’,
label.mutation = ’Mutation’,
label.amplification = ’Amplification’,
label.deletion = ’Deletion’
)
export.MUTEX(MSI.H,
filename = ’MSI/MUTEX/MSI.H.txt’,
label.mutation = ’Mutation’,
label.amplification = ’Amplification’,
label.deletion = ’Deletion’
)
Then we can run the Java MUTEX tool by following the routines explained at the
following webpage:
https://github.com/BIMIB-DISCo/mutex
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MSS tumors - with all driver genes
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Figure 5.9: MSS training tumors with selected 33 driver genes.
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In this case we provide you with the results of running MUTEX with its default pa-
rameters; we shall then collect results - groups with score below .2 threshold, as usually
done - in R’s runtime by using function import.MUTEX.groups.
MSI.H.MUTEX = import.MUTEX.groups(MUTEX.msi.file)
MSS.MUTEX = import.MUTEX.groups(MUTEX.mss.file)
The 3 groups detected for MSI tumors can be visualized by arranging GROBS returned
by oncoprint and obtain the plot that we show in Figure 5.10.
# Visualize groups via console
print(MSI.H.MUTEX)
# Then combine oncoprint via grid.arrange
grid.arrange(
oncoprint(
# Select only events for genes in group 1
events.selection(MSI.H, filter.in.names = MSI.H.MUTEX[[1]]),
title = paste("MSI-H - MUTEX group 1"),
legend.cex = .3,
font.row = 6,
ann.hits = FALSE, # Avoid annotating the hits for these groups
cellheight = 10,
silent = T, # Do not plot the oncoprint
gene.annot = pathway.list,
gene.annot.color = pathways.color,
) $gtable,
oncoprint(
events.selection(MSI.H, filter.in.names = MSI.H.MUTEX[[2]]),
title = paste("MSI-H - MUTEX group 2"),
legend.cex = .3,
silent = T,
font.row = 6,
ann.hits = FALSE,
cellheight = 10,
gene.annot = pathway.list,
gene.annot.color = pathways.color,
) $gtable,
oncoprint(
events.selection(MSI.H, filter.in.names = MSI.H.MUTEX[[3]]),
title = paste("MSI-H - MUTEX group 3"),
legend.cex = .3,
silent = T,
font.row = 6,
ann.hits = FALSE,
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cellheight = 10,
gene.annot = pathway.list,
gene.annot.color = pathways.color,
) $gtable,
ncol=1 # Display all plots in a single column
)
Other three groups will be used - in each subtype, in principle - according to both
literature on CRC, and analysis carried out by the Consortium with the MEMO tool
(Ciriello et al, Curr Protoc Bioinformatics. 2013 Mar;Chapter 8:Unit 8.17). We shall
define the following variables.
# Apriori CRC knowledge
KNOWLEDGE.PRIOR.WNT = c(’APC’, ’CTNNB1’)
KNOWLEDGE.PRIOR.RAF = c(’KRAS’, ’NRAS’, ’BRAF’)
# MEMO group estimated by TCGA for the non-hypermutated tumors:
TCGA.MEMO = c(’ERBB2’, ’IGF2’, ’PIK3CA’, ’PTEN’)
5.3.5 Reconstruction of the models - training-reconstruction.R
We first implement a selection strategy of driver events. For any dataset we select:
• all genes with an alteration frequency > 5%;
• all genes involved in an exclusivity prior (MUTEX / MEMO / knowledge-based).
We thus define this function
select = function(x, min.freq, forced.genes)
{
# Collapse multiple events per gene in one unique event
x.sel = as.alterations(x)
# Get a list of those with minimum frequency > min.freq
# but force inclusion of all events for genes in "forced.genes"
x.sel = events.selection(x.sel, filter.freq = min.freq,
filter.in.names = forced.genes)
# Subset input - select all events for any gene in "x.sel"
x = events.selection(x, filter.in.names = as.genes(x.sel))
return(x)
}
# We set this as a variable
MIN.FREQ = 0.05
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MSI-H - Mutex group 1
56% BRAF
26% KRAS
stage
group
stage
Stage I
Stage IIA
Stage IIB
Stage IIIB
none
group
RAS
none
Mutation
27 samples
2 events
2 genes
0 patterns
MSI-H - Mutex group 2
56% BRAF
15% TGFBR1
7% NRAS
4% NRAS
stage
group
stage
Stage I
Stage IIA
Stage IIB
Stage IIIB
none
group
RAS
TGFb
none
Deletion
Mutation
27 samples
4 events
3 genes
0 patterns
MSI-H - Mutex group 3
22% ACVR1B
19% ACVR2A
15% TP53
15% ERBB2
4% ACVR1B
stage
group
stage
Stage I
Stage IIA
Stage IIB
Stage IIIB
none
group
TGFb
P53
RAS
none
Deletion
Mutation
27 samples
5 events
4 genes
0 patterns
Figure 5.10: MSI exclusivity groups detected with MUTEX.
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Which can be used to subset the datasets to define the input objects for CAPRI.
# Selected MSS dataset
MSS.select = select(MSS,
MIN.FREQ,
unique( # All group genes
c(TCGA.MEMO,
KNOWLEDGE.PRIOR.WNT,
KNOWLEDGE.PRIOR.RAF,
unlist(MSS.MUTEX))
)
)
MSS.select = annotate.description(MSS.select,
’TCGA MSS colorectal tumors’)
# Selected MSI dataset
MSI.H.select = select(MSI.H,
MIN.FREQ,
unique(c(TCGA.MEMO,
KNOWLEDGE.PRIOR.WNT,
KNOWLEDGE.PRIOR.RAF,
unlist(MSI.H.MSS.MUTEX)
)
))
MSI.H.select = annotate.description(MSI.H.select,
’TCGA MSI-HIGH colorectal tumors’)
To visualize the selected data, one can use again oncoprint function.
oncoprint(MSS.select, gene.annot = pathway.list,
gene.annot.color = pathways.color)
As detailed in CAPRI’s definition, we are required to provide no pair of events (rows
in the oncoprint) which have the same signature. If that happens, those events are
statistically indistinguishable, and we prefer to eliminate one of them - being aware that
the inferred model would be equivalent whatever event we decide to delete. Further, we
also want that no event appears never (resp. always) the dataset - rows of all 0s or 1s.
To detect if MSS.select or MSS.select has any of these inconsistencies we use a TRONCO
function which outputs NULL if the dataset has no of these issues.
# Selected MSS is ok
cd = consolidate.data( MSS.select, T)
# In MSI we need to manipulate data instead
cd = consolidate.data( MSI.H.select, T)
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# FBXW7 amplification and PTEN mutations are discarded
MSI.H.select = delete.event(MSI.H.select, gene=’FBXW7’,
type =’Amplification’)
MSI.H.select = delete.event(MSI.H.select, gene=’PTEN’,
type =’Mutation’)
Now we really perform inference of selective advantage relations with CAPRI. We
first define a function which prepares all formulas that we want to test; these will include
exclusivity of genes with multiple alterations, MUTEX groups and other priors.
To create formulas from groups we use function hypothesis.add.group which cre-
ates all possible formulas from a group of genes, or generally alterations identified by
their name. The number of alterations determines the combinatorial number of formulas
to create, and if a gene in the group has multiple events associated to it, e.g., a mutation
and a CNA, a sub-formula is created to combine them. According to the overlap between
such events the formula will be written in either hard or soft exclusivity form. Notice
also that we use function hypothesis.add.homologous which creates, if a gene has mul-
tiple events associated, the same sub-formula created by hypothesis.add.group, but
regardless of the group.
After the creation of formulas we can apply the algorithm CAPRI to the dataset
using the function tronco.capri. In this case we set the seed to 12345 to get the same
results because of bootstrap random shuffling. The obtained progression model is plotted
using the function tronco.plot.
recon = function(x, folder, MUTEX, ...) {
lift = x
# 1. create formulas from every MUTEX group
if(!is.null(MUTEX))
# TRONCO function to create formulas from groups.
# Notice that only 1 formula per group is created
# by the dim.min constraint
for (w in MUTEX) {
lift = hypothesis.add.group(lift,
FUN = OR, # formula of "soft exclusivity" (OR)
group = w, # the group
dim.min = length(w) # only 1 group is maximal
)
}
# Now we subset Wnt groups to genes actually present in lift.
# Notice that formulas for groups with dimension smaller than 2
# will not be created
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KNOWLEDGE.PRIOR.WNT.subtype = KNOWLEDGE.PRIOR.WNT[
KNOWLEDGE.PRIOR.WNT %in% as.genes(lift)
]
lift = hypothesis.add.group(lift,
FUN = OR,
group = KNOWLEDGE.PRIOR.WNT.subtype,
dim.min = length(KNOWLEDGE.PRIOR.WNT.subtype))
# The same for the RAF group
KNOWLEDGE.PRIOR.RAF.subtype = KNOWLEDGE.PRIOR.RAF[
KNOWLEDGE.PRIOR.RAF %in% as.genes(lift)
]
lift = hypothesis.add.group(lift,
FUN = OR,
group = KNOWLEDGE.PRIOR.RAF.subtype,
dim.min = length(KNOWLEDGE.PRIOR.RAF.subtype))
# And the MEMO group
TCGA.MEMO.subtype = TCGA.MEMO[TCGA.MEMO %in% as.genes(lift)]
lift = hypothesis.add.group(lift,
FUN = OR,
group = TCGA.MEMO.subtype,
dim.min = length(TCGA.MEMO.subtype))
# Homologous in soft exclusivity
lift = hypothesis.add.homologous(lift, FUN = OR)
# Save to file the PDF of the lifted dataset, and its Rdata
lift = annotate.description(lift, as.description(x))
oncoprint(lift, file = paste0(folder, ’/Rdata-lifted/lifted.pdf’))
save(lift, file=paste0(folder, ’/Rdata-lifted/lifted.Rdata’))
# CAPRI execution with seed set, default parameters
model = tronco.capri(lift, boot.seed = 12345)
# As takes long to bootstrap, we make a simple visualization first
tronco.plot(model,
pathways = pathway.list,
confidence = c(’tp’, ’pr’, ’hg’), # Display p-values
... )
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# Example non-parametric and statistical bootstrap.
# Note that 5 iterations is purely explanatory,
# at least 100 should be performed for statistical significance
model = tronco.bootstrap(model)
model = tronco.bootstrap(model, type = "statistical", )
# Save the Rdata
save(model, file=paste0(folder, ’/Rdata-models/model.Rdata’))
# Plot the TRONCO model
tronco.plot(model,
pathways = pathway.list,
edge.cex = 1.5,
legend.cex = .5,
scale.nodes = .6,
confidence = c(’tp’, ’pr’, ’hg’), # Display p-values
pathways.color = pathways.color,
disconnected = F,
height.logic = .3,
file = paste0(folder, ’/Rdata-models/model.pdf’),
... )
return(model)
}
Now we can apply the function recon to MSS.select and MSI.H.select.
# Work..
MSS.models = recon(x = MSS.select, folder = ’MSS’, MUTEX = MSS.MUTEX)
MSI.models = recon(x = MSI.H.select, folder = ’MSI’, MUTEX = MSI.H.MUTEX)
5.3.6 Preparing the models for test - validation-samples.R
We create now another folder where we will put TRONCO’s output for test dataset, then
we load the file which contain the binary matrix with mutation data and we import it
into TRONCO format using import.genotypes function.
# Prepare folders
dir.create(’./VALIDATION’)
sub.dir = c(’MUTEX’, ’Rdata-lifted’, ’Rdata-models’)
sapply(paste0(’./VALIDATION/’, sub.dir), dir.create)
# Load mutations (binary matrix), process names
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new.data = load(paste0(workdir, "/Mutations/TCGA_fun.Rdata"))
head(tcga.f.ag)
rownames(tcga.f.ag) = tcga.f.ag $gene
tcga.f.ag $gene = NULL
tcga.f.ag = t(tcga.f.ag)
rownames(tcga.f.ag) = gsub(’_’, ’-’, rownames(tcga.f.ag))
# Import in TRONCO format
tcga.f.ag = import.genotypes(tcga.f.ag, ’Mutation’)
show(tcga.f.ag)
Now we separate the list of samples of the dataset just loaded into two sets, one for
MSI-HIGH and one for MSS. The discrimination is based on the mutation rate.
# Mutation rate to discriminate MSS and MSI-HIGH
plot(sort(rowSums(as.genotypes(tcga.f.ag))), col = ’darkgreen’, lty = 3,
xlab = ’Tumor sample’, ylab = ’Mutations (number)’)
title(’Validation dataset - Mutations per sample’)
abline(h = 500, col = ’red’, lty = ’dashed’)
abline(v = 204, col = ’black’, lty = ’dashed’)
text(x = 230, y = 10, ’MSI-H (Val.)’, cex = .8)
text(x = 170, y = 10, ’MSS (Val.)’, cex = .8)
text(x = 30, y = 600, ’500 mutations (cutoff)’, cex = .5)
# MSS tumors
tcga.f.ag.MSS = rownames(as.genotypes(tcga.f.ag))[
which(rowSums(as.genotypes(tcga.f.ag)) < 500)
]
# MSI-HIGH tumors
tcga.f.ag.MSI = rownames(as.genotypes(tcga.f.ag))[
which(rowSums(as.genotypes(tcga.f.ag)) > 500)
]
Then, based on the two list of samples using the function samples.selection we
produce two dataset: one for MSI-HIGH and one for MSS. After this we trim the new
datasets, shorten the barcodes of samples and keep only the genes mapped to selected
pathways. At the end of this operation we have two new dataset ready: tcga.f.ag.MSS
and tcga.f.ag.MSI.
# TRONCO objects for these tumors
tcga.f.ag.MSS = trim(samples.selection(tcga.f.ag, tcga.f.ag.MSS))
tcga.f.ag.MSI = trim(samples.selection(tcga.f.ag, tcga.f.ag.MSI))
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tcga.f.ag.MSS = TCGA.shorten.barcodes(tcga.f.ag.MSS)
tcga.f.ag.MSI = TCGA.shorten.barcodes(tcga.f.ag.MSI)
show(tcga.f.ag.MSS)
show(tcga.f.ag.MSI)
# Select just genes mapped to pathways
tcga.f.ag.MSS = trim(events.selection(tcga.f.ag.MSS,
filter.in.names = pathway.genes))
tcga.f.ag.MSI = trim(events.selection(tcga.f.ag.MSI,
filter.in.names = pathway.genes))
tcga.f.ag.MSS = change.color(tcga.f.ag.MSS, ’Mutation’, ’darkolivegreen3’)
tcga.f.ag.MSI = change.color(tcga.f.ag.MSI, ’Mutation’, ’darkolivegreen3’)
Now we can load the GISTIC of CNA data, change the events color and keep only
the events which are present in pathways. The file GISTIC.RData contains a dataset
already in TRONCO format.
# Load CNA data
load(paste0(workdir, ’GISTIC.Rdata’))
show(GISTIC)
GISTIC = change.color(GISTIC, ’Amplification’, ’coral’)
GISTIC = change.color(GISTIC, ’Deletion’, ’cornflowerblue’)
GISTIC = events.selection(GISTIC, filter.in.names = pathway.genes)
We have now the two dataset with mutations data and the dataset with CNA. The
next operation we have to do is to merge rispectively mutations and CNA data of MSS
and MSI-HIGH. We can do this using the function ebind which merge two datasets with
the same samples list and different events. We start with MSS.
# Join datasets with both mutations and CNAs: MSS
tcga.f.ag.MSS =
ebind(
samples.selection(tcga.f.ag.MSS,
intersect(
as.samples(tcga.f.ag.MSS),
as.samples(GISTIC))
),
samples.selection(GISTIC,
intersect(
as.samples(tcga.f.ag.MSS),
as.samples(GISTIC))
)
)
tcga.f.ag.MSS = trim(tcga.f.ag.MSS)
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tcga.f.ag.MSS = annotate.stages(tcga.f.ag.MSS, as.stages(GISTIC))
oncoprint(tcga.f.ag.MSS)
And we can do the same for MSI-HIGH.
# Join datasets with both mutations and CNAs: MSI-HIGH
tcga.f.ag.MSI =
ebind(
samples.selection(tcga.f.ag.MSI,
intersect(
as.samples(tcga.f.ag.MSI),
as.samples(GISTIC))
),
samples.selection(GISTIC,
intersect(
as.samples(tcga.f.ag.MSI),
as.samples(GISTIC))
)
)
tcga.f.ag.MSI = trim(tcga.f.ag.MSI)
tcga.f.ag.MSI = annotate.stages(tcga.f.ag.MSI, as.stages(GISTIC))
oncoprint(tcga.f.ag.MSI)
5.3.7 Validation of the models - validation-samples.R
At this point we can use the previously created select function on tcga.f.ag.MSS and
tcga.f.ag.MSI to subset data with the minimum frequency, as we did for training sets.
# Selected MSS tumors
tcga.f.ag.MSS.select = select(tcga.f.ag.MSS,
MIN.FREQ,
unique(c(TCGA.MEMO,
KNOWLEDGE.PRIOR.WNT,
KNOWLEDGE.PRIOR.RAF,
unlist(MSS.MUTEX)
)
))
# Mnemonic dataset title
tcga.f.ag.MSS.select =
annotate.description(tcga.f.ag.MSS.select,
’(Test) MSS colorectal tumors’)
# Selected MSI tumors
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tcga.f.ag.MSI.select = select(tcga.f.ag.MSI,
MIN.FREQ,
unique(c(TCGA.MEMO,
KNOWLEDGE.PRIOR.WNT,
KNOWLEDGE.PRIOR.RAF,
unlist(MSI.H.MUTEX)
)
))
# Mnemonic dataset title
tcga.f.ag.MSI.select =
annotate.description(tcga.f.ag.MSI.select,
’(Test) MSI-HIGH colorectal tumors’)
After this, we can check the consistency of the dataset with the consolidate.data
function already described before - you should find no output in this case.
Now we can reconstruct the two models with the function recon defined before.
# Reconstructions
tcga.f.ag.MSS.models = recon(x = tcga.f.ag.MSS.select,
folder = ’VALIDATION’, MUTEX = MSS.MUTEX)
tcga.f.ag.MSI.models = recon(x = tcga.f.ag.MSI.select,
folder = ’VALIDATION’, MUTEX = MSS.MUTEX)
Finally we list the p-values for MSS training model to be matched to those for test.
# P-values for MSS training for
# temporal priority, probability raising and hypergeometric test
as.selective.advantage.relations(MSS.models) # edges used for MLE
as.selective.advantage.relations(MSS.models, type = ’pf’) # all edges
as.selective.advantage.relations(tcga.f.ag.MSS.models) # edges used for MLE
as.selective.advantage.relations(tcga.f.ag.MSS.models, type = ’pf’) # all edges
# P-values for MSI-HIGH
as.selective.advantage.relations(MSI.models) # edges used for MLE
as.selective.advantage.relations(MSI.models, type = ’pf’) # all edges
as.selective.advantage.relations(tcga.f.ag.MSI.models) # edges used for MLE
as.selective.advantage.relations(tcga.f.ag.MSI.models, type = ’pf’) # all edges
The result of this operation is show for MSI-HIGH in Table §5.1 using BIC as a
regularizator and in Table §5.2 using AIC.
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CHAPTER 6
EVOLUTION OF COLORECTAL CANCER
In this Chapter, we present the design, development and evaluation of an optimal, versa-
tile and modular pipeline which exploits state-of-the-art tools to extract ensemble-level
cancer progression models from cross-sectional data. We also show its applications in
interpreting colorectal cancer data which, because of its high levels of heterogeneity, may
be thought of as one of the most challenging case studies. As a reference, see [21].
6.1 A pipeline to infer ensemble-level progression models
We have devised a customizable pipeline to infer ensemble-level cancer progression mod-
els from cross-sectional data with CAPRI [158]. To increase the statistical quality of its
predictions this pipeline pre-processes data to diminish the confounding effects of inter
and intra-tumor heterogeneity. At a high-level, one shall thus identify: (i) biologically
meaningful subtypes with similar molecular profiles via tumor stratification, (ii) the set
of driver alterations and (iii) the groups of fitness-equivalent (i.e., exclusive) alterations.
Specifically, let us consider n tumors (n patients) and assume the relevant (epi)genetic
data to be available. We do not put constraints on data gathering and selection, leav-
ing the user to decide the appropriate “resolution” of the input mutational data. For
instance, one might decide whether somatic mutations should be classified by type, or
aggregated. Or, one might decide to lift focal CNAs to the wider resolution of cyto-
bands or full arms. These choices depend on data and on the overall understanding of
such alterations and their functional effects for the cancer under study, and no single
all-encompassing rationale may be provided.
Given these premises, the pipelines consists in the following steps.
Step 1: Reducing inter-tumor heterogeneity by cohort subtyping. One might
wish to identify cancer subtypes in the heterogeneous mixture of input samples. In some
cases the classification can benefit from clinical biomarkers, such as evidences of certain
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cell types [14], but in most cases we will have to rely on multiple clustering approaches
at once, see, e.g., [137, 139].
Many common approaches cluster expression profiles [119] by relying on non-negative
matrix factorization techniques [59] or earlier approaches such as k-means, Gaussians
mixtures or hierarchical/spectral clustering - see the review in [34]. For glioblastoma
and breast cancer, for instance, mRNA expression subtypes provides good correlation
with clinical phenotypes [138, 102, 161]. However, this is not always the case as, e.g.,
in colorectal cancer such clusters mismatch with survival and chemotherapy response
[138]. Clustering of full exome mutation profiles or smaller panels of genes might be an
alternative as it was shown for ovarian, uterine and lung cancers [82, 199].
Step 2: selection of driver events. In subtypes detection, with more alterations
available it becomes easier to find similarities across n samples, as features selection
gains precision. In progression inference, instead, one wishes to focus on m  n driver
alterations, which ensure also an appropriate statistical ratio between sample size (n)
and problem dimension (m).
Multiple tools filter out driver from passenger mutations. MutSigCV identifies drivers
mutated more frequently than background mutation rate, [106]. OncodriveFM, avoids
such estimation but looks for functional mutations [66]. OncodriveCLUST scans muta-
tions clustering in small regions of the protein sequence [176]. MuSiC uses multiple types
of clinical data to establish correlations among mutation sites, genes and pathways [35].
Some other tools search for driver CNAs that affect protein expression [178]. All these
approaches use different statistics to estimate signs of positive selection, and we suggest
using them in an orchestrated way, as done in some platforms [70]. Notice that driver
genes will likely differ across subtypes, mimicking the different molecular properties of
each group of samples.
Step 3: fitness equivalence of exclusive alterations. When at the ensemble-level,
identification of “groups of equivalent but alternative” mutually exclusivity alterations
is crucial, prior to progression inference [158]. A plethora of tools can be used; greedy
approaches [194, 129] or their optimizations, such as MEMO, which constrain search-
space with network priors [28]. This strategy is further improved in MUTEX, which scans
mutations and focal CNAs for genes with a common downstream effect in a curated
signalling network, and selects only those genes that significantly contributes to the
exclusivity pattern [8]. Other tools, instead, employ advanced statistics or generative
approaches without priors [182, 198, 110, 112, 84, 175].
In the fitness equivalent groups, we distinguish between hard and soft exclusivity,
the former assuming strict exclusivity among events, with random errors accounting for
possible overlaps, the latter admitting co-occurrences. [8]. CAPRI is the only algorithm
where relations among group of genes can be input as “testable hypotheses” via logical
Boolean formulas. In this case, we can use logical connectives such as ⊕ (the logical
“xor”) as a proxy for hard-exclusivity, and ∨ (the logical “disjunction”) as a proxy
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for soft-exclusivity1. For example, these can be used to test wether colorectal tumors
“start” prevalently from β-catenin deregulation, i.e., apc ∨ ctnnb1 , and if they further
progress exclusively (⊕) through kras or nras alterations. In general, as this testing-
feature leaves the inference unbiased - see [158] - arbitrary hypotheses on significantly
mutated subnetworks could be considered as well [111, 181].
Step 4: progression inference and confidence estimation. Finally, CAPRI is
used to reconstruct cancer progression models of each identified molecular subtype,
provided that there exist a reasonable list of driver events and the groups of fitness-
equivalent exclusive alterations.
As already discussed in §4 CAPRI’s input is a binary n × (m + k) matrix M with
n samples, m driver alteration events (Bernoulli 0/1 variables) and k testable formu-
las. CAPRI first scans pairwise M to identify a set of S plausible selective advantage
relations, which then reduces to the most relevant ones, S∗ ⊂ S.
Construction of S depends on the number of non-parametric bootstrap iterations
and confidence p-values for estimating selective advantage among input events x and y.
CAPRI postulates that “x selects for y” if it estimates that “x is earlier than y” and
that “x’s presence increases the probability of observing y” [172]. These conditions are
implemented with the following inequalities:
p(x) > p(y) p(y | x) > p(y | ¬x) (6.1)
for which we get p-values by Mann-Withney U Testing. Here, p(·) is an empirical
marginal probability, p(· | ·) is a conditional, and ¬x is the negation of x.
Optimization of S is central to the tolerance to false positives and negatives in S∗.
CAPRI’s implementation in TRONCO [4] selects from S a subset of relations by opti-
mizing the score with regularization:
S∗ = arg min
Sˆ⊂S
{
−2 log[L(Sˆ |M)] + θ|Sˆ|
}
, (6.2)
where L(·) is the model likelihood; the estimated optimal solution is S∗.
Different values of θ lead to different tolerance to errors in S∗, the Akaike Information
Criterion (AIC) being for θ = 2, the Bayesian Information Criterion (BIC) for θ =
log(n). Both scores are approximately correct; AIC is more prone to overfitting but
likely to provide also good predictions from data and is better when false negatives are
more misleading than positive ones. BIC is more prone to underfitting errors, thus is
more parsimonious and better in opposite cases. As often done, we suggest to combine
both approaches and distinguish which relations are selected by BIC or AIC.
Model confidence can be estimated with non-parametric, parametric or statistical
bootstrap [47]. These procedures re-sample datasets to provide a confidence to every se-
lective advantage relation and to the overall model. Bootstrapped datasets are randomly
1Logical disjunction of a set of operands is true if and only if one or more of its operands is true.
For this reason, if we shall use that as a model of soft-exclusivity, we shall also check that the majority
of observations indeed shows an exclusivity trend, meaning that few cases of co-occurent observations
happen.
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generated by re-shuffling data and seed (non-parametric), just seed (statistical) or by
sampling from the model (parametric). CAPRI’s other statistics include hypergeometric
tests to assess how significant is the overlap between pairs of alterations.
Thus, this pipeline is similar in spirit to those implemented by consortia such as
TCGA to analyze huge populations of cancer samples collected [137, 139]. One of
the main novelties of this approach, which is only possible by the specific features of
hypothesis-testing provided by CAPRI [158], is the exploitation of groups of exclusive
alterations as a proxy to detect fitness-equivalent routes of cancer progression. Thus,
CAPRI is seen as an ideal tool for the efficient and theoretically-grounded investigations
in population-based studies on cancer genomics.
This approach allows one to produce a progression model for virtually every cancer
subtype identified in the input cohort, which shall be characteristic of the population
trends of cancer initiation and progression. In the following, we empirically charac-
terize the efficacy of the approach in processing colorectal cancer data from TCGA
project [137], demonstrating that we were able to re-discover most of the existing body
of knowledge about colorectal tumor progression or to propose further experimentally
verifiable hypotheses2.
6.2 Clonal evolution of MSI/MSS colorectal tumors
It is common knowledge that colorectal cancer (CRC) is a heterogeneous disease com-
prising different molecular entities. Since similar tumors are most likely to behave in a
similar way, grouping tumors with homogeneous characteristics may be useful to define
personalized therapies. Indeed, it is currently accepted that colon tumors can be classi-
fied according to their global genomic status into two main types: microsatellite instable
tumors (MSI) and microsatellite stable (MSS) tumors (also known as tumors with chro-
mosomal instability). This taxonomy plays a significant role in determining pathologic,
clinical and biological characteristics of CRC tumors [146]. Thus, MSS tumors are char-
acterized by changes in chromosomal copy number and show worse prognosis [125, 187].
On the contrary, the less common MSI tumors (about 15% of sporadic CRC) are char-
acterized by the accumulation of a high number of mutations and show predominance in
females, proximal colonic localization, poor differentiation, tumor-infiltrating lympho-
cytes and a better prognosis [183]. In addition, MSS and MSI tumors exhibit different
responses to chemotherapeutic agents [99, 189]. Regarding molecular progression, it is
also well established that each subtype arises from a distinctive molecular mechanism.
While MSS tumors generally follow the classical adenoma-to-carcinoma progression (se-
quential apc-kras-tp53 mutations) described in the seminal work by Vogelstein and
Fearon [51], MSI tumors results from the inactivation of DNA mismatch repair genes
like mlh-1 [183].
We adopted the discussed pipeline to process MSI and MSS colorectal tumors col-
lected from the The Cancer Genome Atlas project “Human Colon and Rectal Cancer”
2We remark that in-vitro and in-vivo experiments could provide an optimal validation for the newly
suggested selective advantage relations and hypotheses, yet this is out of the scope of the current work.
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Figure 6.1: .(A) Selected MSI-HIGH colorectal tumors used for the inference.
Data from the TCGA COADREAD project [137], restricted to 27 samples with both
somatic mutations and high-resolution CNA data available and a selection out of 33
driver genes annotated to wnt, ras, pi3k, tgf-β and p53 pathways. This dataset
is used to infer the model in Figure 6.3. (B) Altered pathways. Mutations and
CNAs in these tumors mapped to pathways confirm heterogeneity even at the pathway-
level. (C) Mutually exclusive alterations. Groups were obtained from [137] - which
run the MEMO[28] tool - and by MUTEX[8] tool. Plus, previous knowledge about
exclusivity among genes in the ras pathway was exploited. (D) Construction of a
formula. A Boolean formula inputed to CAPRI to test the hypothesis that alterations
the RAF genes kras, nras and braf confer equivalent selective advantage. The formula
accounts for hard exclusivity of alterations in nras mutations and deletions, jointly with
soft exclusivity with kras and nras alterations.
(COADREAD, [137]) – also see §E. Details on the implementation are available in §E
as well as source code to replicate this study. COADREAD has enough samples to
implement a training/test statistical validation of these findings - see §E. In brief, we
split subtypes by the microsatellite status of each tumor, and select somatic mutations
and focal CNAs in 33 driver genes manually annotated to 5 pathways in [137] - wnt,
raf, tgf-β, pi3k and p53. Groups of exclusive alterations were scanned by MUTEX
[8] (see §E), and fetched by [137] using the MEMO [28] tool; groups were used to create
CAPRI’s formulas, see §E. The data for MSI-HIGH tumors are shown in Figure 6.1, for
MSS tumors see §E. CAPRI was run, on each subtype, by selecting recurrent alterations
from the pool of 33 pathway genes and using both AIC/BIC regularizators. The model
inferred for MSS tumors is in Figure 6.2, the model for MSI-HIGH ones is in Figure
6.3. Each edge in the graph mirrors selective advantage among the upstream and down-
stream nodes, as estimated by CAPRI from training datasets (statistics: p < 0.05, 100
non-parametric bootstraps); only the minimum amount of edges is selected to maximize
the likelihood of data (see Online Methods). In Figure 6.3, for MSI-HIGH tumors, we
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Figure 6.2: Progression model of MSS colorectal tumors. Selective advantage
relations inferred by CAPRI constitute MSS progression; the input dataset are shown
in §E. Formulas written on groups of exclusive alterations are expanded with colors
representing the type of exclusivity (red for hard, orange for soft). We mark also those
relations that display significant p-values in the test dataset, and rank them if they
contribute (or otherwise) to max-likelihood. For all MSS tumors in COADREAD, we
find at high-confidence selection of sox9 alterations by fbxw7 mutations (with AIC),
as well as selection of alterations in pi3k genes by the kras mutations (direct, with BIC,
and via the MEMO group, with AIC).
show how the model predicts alternative routes to somatic evolution for COADREAD
samples. As statistical validation of these models, we mark those relations that display
significant p-values in the test datasets, and rank them if they contribute (or otherwise)
to max-likelihood. For some edges it is not possible to provide a validation, as some
upstream or downstream event may be missing in the test dataset, while other edges do
not show statistical evidence in the test datasets.
MSS (Microsatellite Stable). In agreement with the known literature, the progres-
sion model identifies kras, tp53 and apc as primary events in the carcinogenesis,
as well as nras and kras determining two independent evolution branches, the
former being “selected by” tp53 mutations, i.e. being a downstream event in the
model, the latter ”selecting for” pik3ca mutations. The leftmost portion of the
model links many wnt genes, in agreement with the observation that multiple
concurrent lesions affecting such pathway confer selective advantage. In this re-
spect, the model predicts multiple routes to eventually select alterations in sox9
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Figure 6.3: (A) Progression model of MSI-HIGH colorectal tumors. Selective
advantage relations inferred by CAPRI constitute MSI-HIGH progression; input dataset
in Figure 6.1. Formulas written on groups of exclusive alterations are expanded as in Fig-
ure 6.2. We note the high-confidence in apc mutations selecting for pik3ca ones, both in
training and test via BIC, as well as selection of the MEMO group (erbb2/pik3ca mu-
tations or igf2 deletions) predicted by AIC. Similarly, we find a strong selection trend
among mutations in erbb2 and kras. For each relation, we report its status in the
test dataset, so to understand whether that is specific of all the COADREAD samples
or not. (B) Predicting clonal expansion from the model. Evolutionary trajec-
tories from two example selective advantage relations. apc-mutated clones shall enjoy
expansion, up to acquisition of further selective advantage via mutations or homozygous
deletions in nras. These cases should be representative of different individuals in the
population, and the ensemble-level interpretation should be that “apc mutations select
for nras alterations, in hard exclusivity” as no sample harbour both alterations. A
similar argument can show that the clones of patients harbouring distinct alterations
in acvr1b - and different upstream events - will enjoy further selective advantage by
mutating tgfbr2 gene.
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gene, a transcription factor known to be active in colon mucosa [1]. Its mutations
are indeed selected by apc/ctnnb1 alterations - with apc mutations in 78% of
the tumors - or by fbxw7, an early mutated gene that both directly and in a
redundant way via ctnnb1 selects for its mutations or amplifications. sox family
of transcription factors have emerged as modulators of canonical wnt/β-catenin
signaling in many disease contexts, with evidences that multiple sox proteins phys-
ically interact with β-catenin and modulate the transcription of wnt-target genes,
as well as with evidences of regulating of sox’s expression by wnt resulting in feed-
back regulatory loops that fine-tune cellular responses to β-catenin/tcf activity
[103]. Also interestingly, fbxw7 has been previously reported to be involved in the
malignant transformation from adenoma to carcinoma [114], and it was recently
shown that SCFFbw7, a complex of ubiquitin ligase that contains such gene, tar-
gets several oncogenic proteins including sox9 for degradation [83]; this relation
has high-confidence also in the test dataset. The rightmost part of the model in-
volves genes from other pathways, and outlines the relation between kras and the
pi3k pathway. We indeed find, consistently in the training and test, selection of
pik3ca mutations by kras ones, as well as selection of the whole MEMO mod-
ule, which is responsible for the activation of the pi3k pathway [137]. Further,
Mutations in pten (in hard exclusivity with its deletions) were found to be a late
event acquired by a clone with kras mutations directly, or indirectly via erbb2
mutations. smad4 deletions or mutations (in hard exclusivity) are selected from
tumors harboring kras mutations. In a smaller group of tumors smad2 amplifica-
tion (1%) or mutation (5%) selects for braf mutations. To highlight, a sub-group
of tumors lacking apc, kras or tp53 but exhibiting mutations in fam123b (10%)
or mutations in tcf7l2 (9%) that later converge in dkk2 or dkk4 mutations.
Interestingly, these four genes are implicated in the wnt signalling pathway. It is
also worth pointing that the model predicts a selection trend among sox9/arid1a
and atm/fam123b; however, for the corresponding events, in the test, we find the
opposite model’s direction, suggesting a potential confounding effect which can be
inputed to these events having very similar frequencies in the training dataset.
MSI (Microstaellite Instable). In agreement with the current literature, braf is the
most commonly mutated gene in MSI tumors (55%) [95]. CAPRI also predicted
convergent evolution of tumors harbouring fbxw7 (51%) or apc (37%) mutations
towards deletions of nras gene, as well as selection of smad2 or smad4 mutations
by fam123b mutations, for these tumors. Relevant to all MSI tumors seems again
the role of the pi3k pathway. Indeed, a relation among apc and pik3ca mutations
was inferred with a high confidence in both training and test datasets, consistent
with recent experimental evidences pointing at a synergistic role of these muta-
tions, which co-occurr in the majority of human colorectal cancers [36]. Similarly,
we find consistently a selection trend among apc and the whole MEMO module.
Interestingly, both mutations in apc and erbb3 select for kras mutations, which
might point to interesting therapeutic implications. On the contrary, mutations
in braf mostly selects for mutations in acvr1b, a receptor that once activated
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phosphorylates smad proteins. It forms receptor complex with acvr2a, a gene
mutated in these tumors (18%) that selects for tcf7l2 mutations (also impli-
cated in the progression of MSS tumors). Tumors harbouring tp53 mutations are
those selected by exhibit mutations in axin2, a gene implicated in wnt signalling
pathway, and related to instable gastric cancer development [96].
6.3 Inference of patient-specific clonal evolution
We also discovered that the CAPRESE [117] algorithm can be used to successfully
reconstruct the clonal architecture in individual patients. This result is indicative of
the power of the selective advantage scores a`-la-Suppes [172], even outside the scope of
cross-sectional data. We performed the analysis on data from Gerlinger et al., which
have recently used multi-region targeted exome sequencing (> 70x coverage) to resolve
the genetic architecture and evolutionary histories of ten clear cell renal carcinomas [62].
Besides quantification of intra-tumor heterogeneity, their work found that loss of the
3p arm and alterations of the Von Hippel-Lindau tumor suppressor gene vhl are the
only events ubiquitous among their patients. In Figure 6.4 we show the clonal evolution
estimated for one of those patients, RMH004, computed with CAPRESE (shrinkage co-
efficient λ = 0.5, time < 1 sec) from the Bernoulli 0/1 profiles provided in Supplementary
Table 3 and Figure 4 of [62], with non-parametric bootstrap confidence (time < 6 sec).
This model shall be compared to the one inferred by processing the region-specific VAF
with a max-mini optimization of most parsimonious evolutionary trees [156], and per-
forming selection-by-consensus when multiple optimal solutions exist - Supplementary
Figure 9 in [62]. CAPRESE requires no arbitrarily defined curation criteria to select the
optimal tree, as it constructively searches for a solution which, in this case, is analogous
in suggesting parallel evolution of subclones via deregulation of the swi/snf chromatin-
remodeling complex – i.e., as may be noted from multiple clones with distinct pbmr1
mutations. Finally, the approach in [156], estimates also the number of non-synonymous
mutations acquired on a certain edge of the tree. While this model is silent about this,
it is very likely due to the limitations imposed by the lower-resolution and small sample
size of the data – 9 events from 8 regions, and not the VAFs for all alleles.
Single-cell synthetic data. We estimate the efficiency of our approach to single-cell
sequencing data, as if it was collected from patient RMH004 (synthetic data generated
from the clonal phylogeny architecture of Figure 6.4). To mimic a poor reliability of this
technology, to each sampled cell a noise model which accounts for false positives and
negatives in the calls of their genomic alterations is applied. Performance is measured as
the fraction of true-positive and negative ancestry relations inferred among cells (preci-
sion and recall), as a function of the number of sequenced cells and noise level. Results
evidence a very good performance even with very small number of cells and reasonable
noise levels, hinting at a promising application with this technology. Complete details
for synthetic data generation and further performance measures are provided in §E.
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Figure 6.4: (A) Application of ensemble-level algorithms to individual-patient
data. With data provided by Gerlinger et al in [62], we infer a patient-specific clonal
evolution from 6 biopsies of a clear cell renal carcinoma (5 primary tumor, 1 from the
thrombus in the renal vein, VT). Validated non-synonymous mutations are selected for
vhl, smarca4, pten, pbmr1 (p.Lys1282fs and p.Leu207fs), arid1a, atm and msh6
genes. CNAs are detected on 12 chromosomes. For this patient, both region-specific
allele frequencies and Bernoulli profiles are provided. Thus, we can extract a clonal
tree, signature and diffusion of each clone, by the unsupervised CAPRESE algorithm
[117]. (B) Clonal expansion in patient RMH004. The unsupervised model inferred
by CAPRESE predicts an analogous clonal expansion observed in [62], and extracted
with most parsimonious phylogeny tree reconstruction from allelic frequencies, and hand-
curated for selection of the optimal model. For simplicity, we show only expansion of the
sub-clones harbouring pten’s frame shift mutation. (C) Inference from single-cell
data. We estimate average precision and recall from single-cell sequencing data sampled
from the phylogeny history of patient RMH004 (details in §E). Sampled datasets vary
for number of sequenced cells, n ≤ 200, and noise in the data - as a model of potential
experimental errors in data collection, manipulation and analysis.
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CONCLUSIONS
The reconstruction of cancer progression models is a pressing problem, as it promises
to highlight important clues about the evolutionary dynamics of tumors and to help
in better targeting therapy to the disease (see e.g., [118]). In the absence of large
longitudinal datasets, progression extraction algorithms rely primarily on cross-sectional
input data, thus complicating the statistical inference problem.
In this thesis, we explore the nature of somatic evolution in cancer. The proposed
model of somatic evolution not only supports the heterogeneity and temporality seen in
tumor clonal populations, but it also suggests a selectivity/causality relation that can
be used in analyzing (epi)genomic data and exploited in therapy design.
Although strongly supported by empirical studies using synthetic as well as experi-
mental genomic data, the contributions of this thesis are primarily methodological, with
the aim of attaching the problem of understanding cancer evolution rigorously, by means
of strong foundations built upon the sound theory of probabilistic causality, originally
proposed by Patrick Suppes [172] (see §2).
With these premises, we devise efficient approaches, namely CAPRESE and CAPRI
algorithms, which for the first time algorithmize Suppes’ formulation to reconstruct
respectively tree and directed acyclic graph models of cancer progression (see §3 and
§4). These methods, while taming their efficiency satisfactorily, even for many com-
plex situations that are specifically important in cancer studies (e.g., synthetic lethality
or oncogene addiction), are kept computational efficient. Furthermore, the aforemen-
tioned algorithms along with a set of utilities to support the scientist in his effort of
understanding cancer progression are implemented in the TRONCO R package (see §5).
Additionally, the framework is shown to be effective in extracting evolutionary tra-
jectories for cancer progression both at the level of populations and individual patients.
In the former case a pipeline to minimize the confounding effects imputable to tumor
heterogeneity is proposed and applied to a highly-heterogeneous cancer such as colorec-
tal. In the latter we have also shown how the framework can be readily applied to
reconstruct clonal phylogeny from multi-sample data, with an application to clear renal
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cell carcinoma (see §6).
7.1 Future works
Despite in the last two decades many specific genes and genetic mechanisms that are
involved in different types of cancer have been identified, our understanding of cancer
progression is still largely elusive and faces fundamental challenges. Hence, several future
research directions are possible.
In particular, the various steps described in the pipeline need further improvements
with specific reference to the clustering in subtypes: while a series of state-of-the-art
techniques to tackle the problem exist, their results are not always satisfactory and, in
fact, in most studies, the identification of subtypes is not clear or it is done manually
(see e.g., [137]).
Moreover, with the objective of anticipating the forthcoming technologies, a further
development of the proposed framework could involve the introduction of timed data, in
order to extend the techniques to settings where a temporal information on the samples
is available, hence needs not be imputed.
In the current version, a progression model is reconstructed in terms of event (i.e.,
genetic alterations) at a lower grain than the actual progression in terms of functions
(i.e., hallmarks). One further improvement would be to link the inferred models to
hallmarks or pathways. This prior knowledge could also be exploited to improve the
reconstructions themselves.
Another interesting research direction would be to exploit the reconstructions by
CAPRESE or CAPRI for subsequent quantitative estimations of the progression of the
disease such as the waiting time between the occurrence of difference alterations and the
survival time of cancer patients.
Finally, as observed multiple times through the thesis, the proposed framework is
agnostic of the input data and, hence, it could be adopted also in different contexts.
As briefly done in §F with the task of discrimination discovery from data, it would be
interesting to explore how the framework proposed in this thesis can be used in different
fields of data mining.
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APPENDIX A
FOUNDATIONS OF CAUSATION
In this Chapter, we give an outline of the current state-of-the-art theories of causation,
which enjoys a long and colorful history, starting with the work of Aristotle and, more
recently, of Avicenna circa 1000 ad. However, we restrict our description only to the
main ideas and limitations of these theories, as a more detailed discussion of various
topics related to these theories is available elsewhere (see [88] or [80]).
The biological notion of causality proposed in this thesis is firmly grounded on the
notions of Darwinian evolution: in that, it is about an ensemble of entities (e.g., popula-
tion of cells, organisms, etc.). Within this ensemble, a causal event (say c) in a member
entity may result in variations (changes in genotypic frequencies); such variations are
exhibited in the phenotypic variations within the population, which is subject to Dar-
winian positive (and subsequently, Malthusian negative) selections, and sets the stage
for a new effect event (say e) to be selected, should it occur next; we then conclude that
“c e.”
While there could be other meaningful extensions of this framework (see [75])1, we
believe that it suffices in describing the causality relations implicit in the somatic evolu-
tion responsible for tumor progression. Note further that by its very statistical nature,
we capture just those relations that only reflect “Type-level Causality”, and relegate
“Token-level Causality”, – a more nuanced concept – to the future research. Thus, note
that, while our framework can estimate for a population of cancer patients of a particular
kind (say atypical Chronic Myeloid Leukemia, aCML, patients) whether and with what
probability a mutation (such as setbp1) would cause certain other mutations (such as
asxl1 single nucleotide variants or in-del) to occur, it will remain silent as to whether
a particular asxl1 mutation in a particular patient was caused by an earlier setbp1
mutation.
Based on the afore-mentioned biological framework, we will focus primarily on how to
1Also see the debate between Fisher and Wright in response to Fisher’s fundamental theorem of
genetics.
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devise efficient and accurate algorithms for extracting causal relations from the patient
genomic data; we leave it to the readers to intuit how an inferred causal relation may be
verified/refuted by in vitro or in silico experiments and how it could be used in therapy
design that would guide the clocks involved in cancer’s natural somatic evolution (more
details are forthcoming).
A.1 Hume’s regularity theory
The modern study of causation begins with the Scottish philosopher David Hume (1711-
1776). According to Hume, a theory of causation could be defined axiomatically, using
the following ingredients: temporal priority , implying that causes are invariably followed
by their effects [87], augmented by various constraints, such as contiguity, constant
conjunction2, etc. Theories of this kind, that try to analyze causation in terms of
invariable patterns of succession, have been referred to as regularity theories of causation.
Nonetheless, the notion of causation has spawned far too many variants and has
been a source of acerbic debates. All these theories present well-known limitations and
confusion, but have led to a small number of modern versions of commonly accepted
(at least among the philosophers) frameworks. See the theories discussed and studied
by Suppes et al. §A.2, Lewis et al. §A.3, and Pearl et al. §A.3.1. One of the most
prominent among these is Suppes’ probabilistic causation, whose axioms are expressible
in probabilistic propositional modal logics, and amenable to algorithmic analysis. It is
the framework upon which we build our analyses and algorithms.
We will momentarily discuss the main limitations of regularity theories [80], in order
to better prepare the reader for the subsequent discussions of these theories and the
algorithms to which they lead. Thus, the next three sections will focus on two issues: (i)
how the state-of-the-art theories of causation have attempted formulating a sound and
complete theory of causation, as well as (ii) what unsolved problems in this framework
still remain open.
Imperfect regularities. In general, one cannot state that causes are invariably (i.e.,
without fail) followed by their effects. For example, while we may state that “smoking
is a cause of lung cancer”, we do grant that there would be still some smokers who do
not develop lung cancer.
Situations such as these are referred to as imperfect regularities, and could arise for
many different reasons. One of these – which is a very common situation in the context
of cancer – involves the heterogeneity of the situations in which a cause resides. For
example, some smokers may have a genetic susceptibility to lung cancer, while others do
not; moreover, some non-smokers may be exposed to other carcinogens, while others are
not. Thus, the fact that not all smokers develop lung cancer can be explained in these
terms.
2Some of these notions have been modernized with the introduction of the machinery from statistical
inference, logic and model theory; but they have stayed more or less true to Hume’s programme.
122
A.2. PROBABILISTIC THEORIES OF CAUSATION 123
Irrelevance. An event that is invariably followed by another, can be irrelevant to it.
Consider the example in [104]: salt that has been hexed by a sorceror invariably dissolves
when placed in water, but hexing does not cause the salt to dissolve. In fact, hexing
is irrelevant for this outcome. Probabilistic theories of causation capture exactly this
situation by requiring that causes alter the probabilities of their effects, see §A.2.
Asymmetry. If we claim that an event c causes another event e, then, typically, we
would anticipate being able to claim that e does not cause c, which would naturally
follow from a strict temporal-priority-constraint: cause precedes effect temporally. In
the context of the preceding example, smoking causes lung cancer, but lung cancer does
not cause one to smoke.
Spurious regularities. Consider a situation – not very uncommon – where a unique
cause is regularly followed by two or more effects. As an example, suppose that one
observes the height of the column of mercury in a particular barometer dropping below
a certain level. Shortly afterwards, because of the drop in atmospheric pressure (the
unobserved cause for falling barometer), a storm occurs. In this settings, a regularity
theory could claim that the drop of the mercury column causes the storm when, indeed, it
is only correlated to it. Following common terminologies, we will say that such situations
are due to spurious correlations. There now exists an extensive literature discussing such
subtleties that are important in understanding the philosophical foundations of causality
theory; see [80].
A.2 Probabilistic theories of causation
In this Section we will introduce the notion of probabilistic causation. The basic idea
behind these theories is that “causes alter the probabilities of their effects;” see [80, 98]
for more details.
Suppes’ prima facie cause
Patrick Suppes proposed the notion of a prima facie cause that represents the core of
probabilistic causation and also provides the algorithmic foundations of our analysis.
Definition 8 (Probabilistic causation, [172]). For any two events c and e, occurring
respectively at times tc and te, under the mild assumptions that 0 < P(c),P(e) < 1, the
event c is called a prima facie cause of e if it occurs before and raises the probability of
e, i.e.
tc < te and P(e | c) > P(e | c) . (A.1)
From now on, the first condition will be referred to as temporal priority, whereas
the second as probability raising. This notion of causation has some advantages over
the simplest version of a regularity theory of causation, e.g., it deals with various issues
usually associated with imperfect regularities (§A.1).
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Figure A.1: Example of screening-off and of background context. (left) Example
of Reichenbach’s screening-off where c is a genuine cause of e and a is a genuine cause
of c, and the correlations between a and e are only just manifestations of these known
causal connections, and c is a common cause of both a and e, that is exactly the situation
of spurious correlation described in §A.1. (right) Example of Cartwright’s background
context.
Unfortunately, however, prima facie causality is still not sufficient in capturing a
causation relationship in its full generality. For instance, the problem of spurious reg-
ularities still remains, additionally requiring that prima facie causes be refined further
into two classes: genuine and spurious. In the latter case, as discussed, we may observe
a prima facie cause to be so labeled only because of spurious correlations. Also, as dis-
cussed extensively in the literature (see [80]), one may encounter certain situations, in
which Suppes’ characterization fails to provide a necessary condition. In the next two
paragraphs, we will briefly discuss an attempt to make Suppes’ conditions sufficient for
any causal claims, and another to determine when it is not necessary.
Reichenbach’s screening-off
In [160], Reichenbach discussed the notion of screening-off to describe a particular type
of probabilistic relationship. Consider, e.g., events a, c and e, and assume to observe
P(e | a ∧ c) = P(e | c), then we say that c is screening a off from e. When P(e ∧ c) > 0,
this is equivalent to stating that P(a ∧ e | c) = P(a | c) · P(e | c) – i.e., a and e happen
to be probabilistically independent, when conditioned upon c. The preceding situation
could occur in two cases, see Figure §A.1.
In the first case, c is a genuine cause of e while a is a genuine cause of c as well,
and the correlations between a and e are only just manifestations of these known causal
connections. For example, unprotected sex (a) appears to cause AIDS (e) only because
of sexually transmitted HIV infection (c). Then, we would expect that among those
who have already been infected with HIV, the probability of contacting AIDS would be
the same regardless of whether one is engaged in unprotected sex or not. Here c is a
proximate cause of e and an intermediate cause leading from a to e, i.e. an instance
of causal transitivity. In the second case, c is a common cause of both a and e, that is
exactly the situation of spurious correlation described in §A.1.
Building upon this idea, Reichenbach formulated the so-called Common Cause Prin-
ciple (CCP) to detect situations leading to “screening-off,” and so identify when a spu-
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rious correlation can be explained in terms of a common cause. Unfortunately, there are
situations where such a principle leads to computationally intractable criteria. Since,
these issues are not germane to the context of this work, we will not discuss them further,
other than pointing the interested readers to appropriate literature [80]. Nevertheless,
the idea of screening-off has significantly influenced some of the most widely-used recent
theories of causation, and has become central to the topic.
Simpson’s paradox and Cartwright’s background context
Up to now, we have discussed the sufficiency (or lack of it) of the characterization for
causality provided in the Reichenbach-Suppes framework. Conversely, we may also ex-
amine those situations where this framework also fails to give all the necessary conditions
for a causal claim. For example, consider smoking as a cause of lung cancer. But, exam-
ine in details a situation where it so happens that smoking is highly correlated with living
in the country: those who live in the country are much more likely to smoke than those
who do not. Suppose now that city pollution is a second cause of lung cancer, which
happens to be a much stronger cause than smoking. Consider now the problem of causal
claims on the combination of these two heterogenous populations: including those who
live in the country and those who do not. Then, an analysis of those two populations in
combination may falsely lead to the conclusion that smokers are, over all, less likely to
suffer from lung cancer than non-smokers. This example is an instance of the so-called
Simpson’s Paradox, which has been discussed extensively by various philosophers (see
Nancy Cartwright [22] and Brian Skyrms [170]).
Cartwright and Skyrms introduced the concept of background contexts to explain and
correct this problem. Let us call the set of all the factors that are causes of the event e
(a factor can be an atomic event but it can also be the composition of a set of events),
but are not caused by the event c, the set of independent causes of e. A background
context for a causal relationship from c to e is the maximal conjunction of factors, each
of which is either an independent cause of e, or the negation of an independent cause of
e (as shown in Figure §A.1). We will denote by variables b1, . . ., bn all the background
contexts of a causal relationship. According to Cartwright then, c causes e if and only
if P(e | c ∧ bi) > P(e | c ∧ bi), that is if c raises the probability of e in every background
context bi ∈ B. Skyrms proposed a slightly weaker condition: a cause must raise the
probability of its effect in at least one background context, without lowering it in any
other.
Eells’ taxonomy
Cartwright defined a cause in terms of raising the probability of its effect. But there
are other possible probabilistic relations between c and e, as described, for instance, by
Eells, who proposes the following taxonomy [44]: (i) c is a cause of e if and only if it
raises its probability in every background context B, (ii) c is an inhibition for e when
it lowers such a probability, (iii) c is causally irrelevant to e when it does not change it
and, finally, (iv) c is a mixed cause of e, otherwise.
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This thesis will adhere to the basic idea of a cause being a probability-raiser of its
effect and ignore for the time being all other variants. According to Suppes’ probabilistic
theories of causation, we can evaluate a causal claim in terms of Definition §8, further
augmented by the ideas of screening-off and background contexts; the same algorithmic,
inferential and logical tools that we propose here can be used mutatis mutandis, should
a user wish to explore a variant framework leading to a different axiomatic formulation
of causation – provided its expressivity is limited to a probabilistic propositional modal
logic – as seems the case to be.
Issues of probabilistic causation
Next we describe some thorny issues in the theory of probabilistic causation. We also
briefly point out some unresolved problems, proposed plans of attack, and ensuing crit-
icisms. For a deeper discussion see [80].
Pearl’s criticism. In [150], Pearl argues that the notion that causes “raise the prob-
abilities” of their effects cannot be expressed in the language of probability theory . In
particular, according to Pearl, the inequality P(e | c) > P(e | c) fails to capture the intu-
ition behind probability raising, which must be manipulative or counterfactual . Because
of this limit, Pearl argues that it is not possible to rigorously describe the intuitions be-
hind the probability raising theory and, for this reason, the only way to properly assess
a causal claim is exclusively by intervention. The methods described in this thesis are
not negated by these arguments as our model reasons about an ensemble (tumor with
heterogeneous cell-types) and type-level causality. Pearl’s theory is discussed further
in §A.3.1.
Determining the background context. As described, the background contexts of
a claim are all the factors causally relevant to the effect, but not to the cause. This
assumption appears to prevent Cartwright’s theory from being a reductive analysis of
causation. In fact, the theory appeals to causal relations to define a set of probabilistic
constraints on the possible causal claims compatible with the observations in terms of
probabilities. In any case, even if there is no reduction of causation to probability, in
practice, it can be difficult (or algorithmically complex) to determine the background
contexts without knowing the causal topology in advance. Unfortunately, this argument
introduces an unavoidable circularity.
A.3 Counterfactual theories of causation
Here we present a brief discussion of [127] theories of causation where the meaning of
causal claims is explained in terms of a possible-world semantics and counterfactual
conditionals of the form: had c not occurred, e would not have occurred either. For
detailed discussions see [127].
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Lewis’s counterfactuals
The most complete known counterfactual theory of causation is due to David Lewis [113]
and exploits a possible world semantics to state truth conditions for counterfactuals in
terms of similarity among possible worlds: one possible world is closer to actuality than
another, if it is more similar to the actual world.
Following this idea, Lewis defined two important constraints on the resulting simi-
larity relation: (i) similarity induces an ordering of worlds in terms of closeness to the
actual world and (ii) the actual world is the closest possible world to actuality. Then,
the evaluation of the counterfactual “if c were the case, e would be the case” is true just
in case it is closer to actuality to make the first term true along with the second – as
opposed to making it true without. Therefore, in terms of counterfactuals Lewis defines
the following notion of causality: given c and e, whether e occurs or not depends on
whether c occurs or not, and e causally depends on c if and only if, if c were not to occur
e would not occur. Thus, the idea of cause is conceptually linked to the idea of some-
thing that makes a difference, and this concept in turn is naturally described in terms
of counterfactuals. Lewis also characterized causation in terms of temporal direction by
stating that the direction of causation is the direction of causal dependence and that,
typically, events causally depend on earlier events but not on later ones.
Causal Chains. In [113], Lewis states that causal dependence between events is suffi-
cient but not necessary, i.e., it is possible to have causation without causal dependence.
Consider, e.g., when c causes d, which in turn causes e; Lewis argues that c must cause
e as well by means of a transitivity. However, since causal dependence is not transitive
as would be the case for causation according to Suppes, the causal relation between c
and e may not be evident. To overcome this problem, Lewis defines a causal chain as
the finite sequence of events c, d and e and defines that c is a cause of e if and only if
there exists a causal chain leading from c to e.
Issues of counterfactual causation
We briefly describe some issues inherent to these theories; for a deeper discussion,
see [127].
Context-sensitivity. Lewis’s theory assumes that causation is an absolute relation,
whose nature does not vary from one context to another. This approach has recently
been criticized since it often leads to absurd results [127], as demonstrated by various
easy-to-construct counter-examples.
Transitivity and Preemption. As discussed above, Lewis incorporates transitivities
in his notion of causation by defining them in terms of chains of causal dependence. The
transitivity of causation is sound in some contexts, but a number of counter-examples
has been shown to cast doubts on this interpretation of causation [127]; the debate
surrounding the transitivity of causation is unlikely to be easily settled. Nevertheless,
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in this work we aim at inferring minimal models of causation, in which each cause is
sufficient for its child to occur. For this reason, we have opted to remove transitivities.
A.3.1 Manipulability theories of causation
We now briefly discuss the notion of intervention as propounded by Judea Pearl [150]; in
general interventionist versions of manipulability theories can be seen as counterfactual
theories. For a detailed discussion on this and manipulability theories of causation refer
to [192].
Pearl characterizes his notion of intervention in terms of a primitive notion of causal
mechanism. According to him, the world is organized in the form of stable mechanisms
(i.e. physical laws) which are autonomous. Therefore, he states that we can change one
of them, without changing all the others. Thus an intervention may imply that: if we
manipulate c and nothing happens, then c cannot be cause of e, but if a manipulation of
c leads to a change in e, then we know that c is a cause of e, although there might be
other causes as well.
In other words, when among many events a causal relationship between some e
and its parents (i.e. directed causes, say c1, . . ., cn) is present, the interventions will
disrupt completely the relationships between e and c1, . . ., cn such that the value of e
is determined by the intervention only. Thus, intervention is a surgical operation in the
sense that no other causal relationship in the system are changed by it. Hence, Pearl’s
assumption is that the other variables that change in values under this intervention will
do so only because they are effects of e. Going back to the barometer example of §A.1:
observing the drop of the mercury column increases the probability of a storm coming,
but if we manipulate the drop of the mercury column by intervention such that its drop
is caused by the intervention only, then we will be able to qualify barometer as a cause
of storms instead of the drop itself. Pearl’s theory has been very influential among
the computational causality theorists, and has generated state-of-the-art algorithms for
causal network inference, which we shortly present in §B.
Issues of interventionist causation
Next, we point the reader to some problems that can arise in practice, when applying
intervention in the context of causal inference. For a deeper discussion we refer to [192].
Circularity. An intervention on an event e leaves intact all the other causal mecha-
nisms besides the ones involving c as a cause. Because of this, Pearl’s intervention could
lead to circularity problems, i.e., it seems that the causal mechanisms need to be known
in advance in order to asses them.
Possible and impossible interventions. Causal claims are described in terms of
counterfactuals of what would happen when applying intervention to a given causal
relationship. Moreover, the notion of intervention is connected with the possibility of a
human action to intervene in a system. In some contexts, however, it may be impossible
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to evaluate what would happen by performing a surgical intervention. Thus, it should be
clear that, regardless of the possible criticisms to Pearl’s framework, there are situations
where, at least relative to the current human capabilities, it is very complicated, if not
impossible, to perform intervention.
A.4 A simplified framework
In conclusion, each of the existing theories faces various difficulties, which are rooted
primarily in the attempt to construct a framework in its full generality: each theory aims
to be both necessary and sufficient for any causal claim, in any context. In contrast, this
thesis simplifies the problem by breaking the task into two: first, define a framework
for Suppes’ prima facie notion though it admits some spurious causes, but then deal
with spuriousness by using a combination of tools, e.g., Bayesian, empirical Bayesian,
regularization, which we recall in §B. The framework is based on a set of conditions that
are necessary even though not sufficient for a causal claim, and is used to refine a prima
facie cause to either a genuine or a spurious cause (or even ambiguous ones, to be treated
as plausible hypotheses which can be refuted/validated by other means), see §2.
Statement of assumptions. Along with the described interpretation of causality,
through out this document, we make following simplifying assumptions to guarantee the
convergence of the method:
(i) All causes involved in cancer can be expressed by monotonic Boolean formulas: i.e.,
all causes are positive and can be expressed in CNF where all literals occur only
positively. The size of the formula and each clause therein are bounded by small
constants.
(ii) All events are persistent: i.e., once a mutation has occurred, it cannot disappear.
Hence, we do not model situations where P(e | c) < P(e | c).
(iii) Closed world: all the events which are causally relevant for the progression are ob-
servable and the observation can significantly describe the progressive phenomenon.
(iv) Relevance to the progression: all the events have probability strictly in the real open
interval (0, 1), i.e. it is possible to asses if they are relevant to the progression.
(v) Distinguishability: no two events appear equivalent, i.e. they are neither both
observed nor both missing simultaneously.
We conclude by observing and stressing that the assumptions of above are to be
intended as theoretical and, given them, we can prove asymptotic convergence of the
framework. Nevertheless, as described along the thesis, there can be practical examples
were these assumptions may not strictly be true and, yet, the approach still provides
valid insights.
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APPENDIX B
LEARNING BAYESIAN NETWORKS
In this Chapter we briefly discuss the notion of Bayesian Network (BN) and how to learn
both its parameters and structure ab initio, with no prior knowledge. For a detailed
discussion on the topic, refer to [101, 151]. This Section is intended to be accessible to a
non-technical audience, although citations are provided for technical resources on each
algorithm discussed.
B.1 Preliminaries
A BN is a statistical model that succinctly represents a joint distribution over n variables
and encodes it in a direct acyclic graph over n nodes (one per variable)1. In BNs,
the full joint distribution can be written as a product of conditional distributions on
each variable. An edge between two nodes A and B denotes statistical dependence,
P(A ∧B) 6= P(A)P(B), no matter on which other variables we condition on (i.e., for
any other set of variables C it holds P(A ∧B | C) 6= P(A | C)P(B | C). In such a graph,
the set of variables connected to a node X determines its set of “parent” nodes pi(X).
Note that a node cannot be both ancestor and descendant of another node, as this would
cause a directed cycle.
Also, the joint distribution over all the variables can be written as
∏
X P(X | pi(X)).
Of course, if a node has no incoming edges (i.e., no parents), we simply use its marginal
probability P(X). Thus, to compute the probability of any combination of values over
the variables, we need only parameterize the conditional probabilities of each variable
given its parents. If the variables are binary, the number of parameters in each con-
ditional probability table is locally of exponential size: namely, 2|pi(X)| − 1. Thus, the
total number of parameters needed to compute the full joint distribution is only of size∑
X 2
|pi(X)| − 1, which is considerably less than 2n − 1 for sparse networks.
1In the setting of this thesis, each variable is a modeled event and, for consistency with the BN
notation, we will denote these as capital letters in this section.
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A useful property of the graph structure is that we can define, for each variable, a set
of nodes called the Markov blanket so that, conditioned on it, this variable is independent
of all other variables in the system. It can be proven that for any BN, the Markov blanket
consists of a node’s parents, children as well as the parents of the children.
The usage of the symmetrical notion of conditional dependence introduces important
limitations of structure learning in BNs. In fact, note that edges A → B and B → A
denote equivalent dependence between A and B, thus distinct graphs model the exact
same set of independence and conditional independence relations. This yields the notion
of Markov equivalence class as a partially directed acyclic graph, in which the edges
that can take either orientation are left undirected. A theorem proves that two BNs
are Markov equivalent when they have the same skeleton and the same v-structures,
the former being the set of edges, ignoring their direction (e.g., A → B and B → A
constitute a unique edge in the skeleton) and the latter being all the edge structures
in which a variable has at least two parents, but those do not share an edge (e.g.,
A→ B ← C)2 [18].
BNs have an interesting relation to canonical boolean logical operators ∧, ∨ and
⊕ and formulas over variables. In fact these formulas, which are “deterministic” in
principle, in BNs are naturally softened into probabilistic relations to allow some degree of
uncertainty or noise. This probabilistic approach to modeling logic allows representation
of qualitative relationships among variables in a way that is inherently robust to small
perturbations by noise. For instance, the phrase “in order to hear music when listening
to an mp3, it is necessary and sufficient that the power is on and the headphones are
plugged in” can be represented by a probabilistic conjunctive formulation that relates
power, headphones and music, in which the probability that music is audible depends
only on whether power and headphones are present. On the other hand, there is a small
probability that the music will still not play (perhaps we forgot to load any songs into
the device) even if both power and headphones are on, and there is small probability
that we will hear music even without power or headphone (perhaps we are next to a
concert and overhear that music).
Note that in this review, we only consider the subset of networks that have dis-
crete random variables that are visible. Networks with latent and continuous variables
present their own challenges, although they share most of the mathematical foundations
discussed here.
B.2 Approaches to learn the structure of a BN
In the the literature, there have been two initial families of methods aimed at learning the
structure of a BN from data. The methods belonging to the first family seek to explicitly
capture all the conditional independence relations encoded in the edges, and will be
referred to as constraint based approaches (§B.2.1). The second family, that of score based
approaches (§B.2.2), seeks to choose a model that maximizes the likelihood of the data
2In BN terminology, parent A and C are considered “unwed parents.” For this reason, the v-structure
is often called an immorality or an unshielded collider.
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given the model. Since both the approaches lead to intractability (NP-hardness) [26, 27],
computing and verifying an optimal solution is impractical and, therefore, heuristic
algorithms have to be used, which only sometimes guarantee optimality. Recently, a
third class of learning algorithms that takes advantage of specialized logical relations
(mentioned in the previous section) have been introduced (§B.2.3). In the rest of this
section we describe in detail some of these approaches.
B.2.1 Constraint based approaches
We present an intuitive explanation of several common algorithms used for structure
discovery by explicitly considering conditional independence relations between variables.
For more detailed explanations and analyses of complexity, correctness and stability, refer
to the related references.
The basic idea behind all algorithms is to build a graph structure reflecting the
independence relations in the observed data, thus matching as closely as possible the
empirical distribution. The difficulty in this approach lies in the number of conditional
pairwise independence tests that an algorithm would have to perform to test all possible
relations. This is indeed exponential requiring to condition on a power set, when testing
for the conditional independence between two variables. This inherent intractability
requires the introduction of approximations.
Here, we focus on two specific constraint based algorithms, the PC algorithm [171]
and the Incremental Association Markov Blanket (IAMB, [179]), because of their proven
efficiency and widespread usage. In particular, the PC algorithm solves the aforemen-
tioned approximation problem by conditioning on incrementally larger sets of variables,
such that most sets of variables will never have to be tested, whereas the IAMB first
computes the Markov blanket of all the variables and conditions only on members of the
blankets. A few more details about these algorithms follow.
The PC algorithm. The PC algorithm [171] begins with a fully connected graph
and, on the basis of pairwise independence tests, iteratively removes all the extraneous
edges. It is based on the idea that if a separating set exists that makes two variables
independent, we can remove the edge between them. To avoid an exhaustive search of
separating sets, these are ordered to find the correct ones early in the search. Once
a separating set is found, the search for that pair can end. The PC algorithm orders
separating sets of increasing size l starting from 0, the empty set, and incrementing until
l = n − 2. The algorithm stops when every variable has fewer than l − 1 neighbors,
since it can be proven that all valid sets must have already been chosen. During the
computation, the larger the value of l is, the larger number of separating sets must be
considered. However, by the time l gets too large, the number of nodes with degree l
or higher must have dwindled considerably. Thus, in practice, we need only consider a
small subset of all the possible separating sets.
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Incremental Association Markov Blanket algorithm. A different type of con-
straint based learning algorithms uses the Markov blankets to restrict the subset of
variables to test for independence. Thus, when this knowledge is available in advance,
we do not have to test a conditioning on all possible variables. A widely used and ef-
ficient algorithm for Markov blanket discovery is IAMB. In it, for each variable X, we
keep track of a hypothesis set H(X). The goal is for H(X) to equal the Markov blanket
of X, B(X), at the end of the algorithm. IAMB consists of a forward and a backward
phase. During the forward phase, it adds all possible variables into H(X) that could
be in B(X). In the backward phase, it eliminates all the false positive variables from
the hypotheses set, leaving the true B(X). The forward phase begins with an empty
H(X) for each X. Iteratively, variables with a strong association with X (conditioned
on all the variables in H(X)) are added to the hypotheses set. This association can
be measured by a variety of non-negative functions, such as mutual information. As
H(X) grows large enough to include B(X), the other variables in the network will have
very little association with X, conditioned on H(X). At this point, the forward phase is
complete. The backward phase starts with H(X) that contains B(X) and false positives,
which will have little conditional association, while true positives will associate strongly.
Using this test, the backward phase is able to remove the false positives iteratively until
all but the true positives are eliminated.
B.2.2 Score based approaches
This approach to structural learning seeks to maximize the likelihood of a set of observed
data. Since we assume that the data are independent and identically distributed, the
likelihood of the data L(·) is simply the product of the probability of each observation.
That is,
L(D) =
∏
d∈D
P(d)
for a set of observations D. Since we want to infer a model G that best explains the
observed data, we define the likelihood of observing the data given a specific model G as
LL(G, D) =
∏
d∈D
P(d | G) .
The actual likelihood is not used in practice, as this quantity becomes very small and
impossible to represent in a computer. Instead, the logarithm of the likelihood is used for
three reasons. First, the log(·) function is monotonic. Second, the values that the log-
likelihood takes do not cause the same numerical problems that likelihood does. Third,
it is easy to compute because the log of a product is simply the sum of the logs (e.g.,
log(xy) = log x+ log y), and the likelihood for a Bayesian network is a product of simple
terms.
Practically, however, there is a problem in learning the network structure by maxi-
mizing log-likelihood alone. Namely, for any arbitrary set of data, the most likely graph
is always the fully connected one (i.e. all edges are present), since adding an edge can
133
134 APPENDIX B. LEARNING BAYESIAN NETWORKS
only increase the likelihood of the data. To correct for this phenomenon, log-likelihood
is almost always supplemented with a regularization term that penalizes the complexity
of the model3. There are a plethora of regularization terms, some based on information
theory and others on Bayesian statistics (see [23] and references therein), which all serve
to promote sparsity in the learned graph structure, though different regularization terms
are better suited for particular applications.
Also in this case we choose to describe a particularly relevant and known score, the
Bayesian Information Criterion (BIC, [101]), which will be subsequently compared to
the performance of our approach.
The Bayesian Information Criterion. BIC uses a score that consists of a log-
likelihood term and a regularization term depending on a model G and data D
bic(G, D) = LL(G, D)− logm
2
dim(G). (B.1)
Here, D denotes the data, m denotes the number of samples and dim(G) denotes the
number of parameters in the model. Because, in general, dim(·) depends on the number
of parents each node has, it is a good metric for model complexity. Moreover, each edge
added to G increases model complexity. Thus, the regularization term based on dim(·)
favors graphs with fewer edges and, more specifically, fewer parents for each node. The
term logm/2 essentially weighs the regularization term. The effect is that the higher the
weight, the more sparsity will be favored over “explaining” the data through maximum
likelihood.
Note that the likelihood is implicitly weighted by the number of data points, since
each point contributes to the score. As the sample size increases, both the weight of the
regularization term and the “weight” of the likelihood increase. However, the weight of
the likelihood increases faster than that of the regularization term4. Thus, with more
data, likelihood will contribute more to the score, and we may trust our observations
more and have less need for regularization. Statistically speaking, BIC is a consistent
score [101]. In terms of structure learning, this observation implies that for sufficiently
large sample sizes, the network with the maximum BIC score is I-equivalent5 to the true
structure. Consequently, G contains the same independence relations as those implied
by the true structure. As the independence relations are encoded in the edges of the
graph, we are guaranteed to learn a Markov-equivalent network, with the same skeleton
and the same v-structures as the true graph, though not necessarily with the correct
orientations for each edge.
3Note that more edges in a graph require more parameters in the conditional probability distributions,
thus increasing model complexity. If it was known that the number of parameters for each node is fixed,
then regularization is not necessary.
4Specifically, the likelihood weight increases linearly, while the weight of the regularization term grows
only logarithmically.
5Two networks are I-equivalent if their structures encode the same independence statements.
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B.2.3 Learning logically constrained networks
In §B.1, we noted that an important class of BNs captures common binary logical op-
erators, such as ∧, ∨, and ⊕. Although the learning algorithms mentioned above can
be used to infer the structure of such networks, some algorithms employ knowledge of
these logical constraints in the learning process.
A widely used approach to learn a monotonic cancer progression network with a
directed acyclic graph (DAG) structure and conjunctive events are Conjunctive Bayesian
Networks (see CBNs, [10]). This model is a standard BN over Bernoulli random variables
with the constraint that the probability of a node X taking the value 1 is zero if at least
one of its parents has value 0. This defines a conjunctive relationship, in that all the
parents of X must be 1 for X to possibly be 1. Thus, this model alone cannot represent
noise, which is an essential part of any real data. In response to this shortcoming, hidden
CBNs [65] were developed by augmenting the set of variables: a correspondence to a
new variable Y that represents the observed state is assigned to each CBN variable
X, which captures the “true” state. Thus, each new variable Y takes the value of
the corresponding variable X with a high probability, and the opposite value with a
low probability. In this model, the variables X are latent, i.e., they are not present
in the observed data, and have to be inferred from the observed values for the new
variables. Learning is performed using a maximum likelihood approach and is separated
into multiple iterations of two steps. First, the parameters for the current hypothesized
structure are estimated using the Expectation-Maximization algorithm [132] and the
likelihood given those parameters is computed. Second, the structure is perturbed to
nudge the hill climbing scheme used to maximize expectation off local maximum. In their
work, the authors used the Simulated Annealing algorithm [97] for this step. These two
steps are repeated until the score converges. However, the Expectation-Maximization
algorithm only guarantees convergence to a likelihood local maximum and, thus, the
overall procedure is not guaranteed to converge to the optimal structure.
B.3 Bayesian interpretation of the proposed framework
The algorithms proposed in this thesis can be placed among the constrained approaches.
In particular, the aim is the one of reconstructing Bayesian graphical models whose
induced probability distributions are biased in terms of Suppes’ criteria as follows. For
any pair of nodes for which we have a directed edge from b to a,{
P(a | b) = θ
P(a | b) ≤ 
where θ,  ∈ [0, 1] and θ  . Specifically, θ represents the conditional probability of any
effect to follow its preceding cause and  models the probability of any noisy observation.
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CAPRESE - SUPPLEMENTARY MATERIALS
In this Chapter we will report the supplementary materials related to chapter §3.
C.1 Proofs
Here the proofs of all the propositions and theorems follow.
Proof of Proposition §3 (Statistical dependence).
Proof. For ⇒ write P(a ∧ b) = P(b)− P(a ∧ b), then write the pr as
P(a ∧ b)
P(a) >
P(b)− P(a ∧ b)
1− P(a)
and, since 0 < P(a) < 1, the proposition follows by simple algebraic arrangements of
P(a ∧ b) · [1−P(a)] > P(a)P(b)−P(a ∧ b) · P(a). The derivations are analogous but in
reverse order for the implication ⇐.
Proof of Proposition §4 (Mutuality).
Proof. The proof follows by Property §3 and the subsequent implication:
P(b | a) > P(b | a)⇔ P(a ∧ b) > P(a)P(b)⇔ P(a | b) > P(a | b) .
Proof of Proposition §5 (Natural ordering).
Proof. We first prove the forward direction ⇒. Let x = P(a ∧ b), y = P(a ∧ b) and
z = P(a ∧ b). We have two assumptions we will use later on:
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1. P(a) > P(b) which implies P(a ∧ b) < P(a ∧ b), i.e., x < z.
2. P(a | b) > P(a | b) which, when 0 < x + y < 1, implies by simple algebraic rear-
rangements the inequality
y[1− x− y − z] > xz . (C.1)
We proceed by rewriting P(b | a)/P(b | a) > P(a | b)/P(a | b) as
P(a ∧ b)P(a)
P(a ∧ b)P(a) >
P(a ∧ b)P(b)
P(a ∧ b)P(b)
which means that
P(b | a)
P(b | a) >
P(a | b)
P(a | b) ⇐⇒
P(a)
P(a ∧ b)P(a) >
P(b)
P(a ∧ b)P(b) (C.2)
We can rewrite the right-hand side of (§C.2) by using x, y, z where P(a) = P(a, b) +
P(a, b) = y + z and P(b) = P(a, b) + P(a, b) = x + y, and then do suitable algebraic
manipulations. We have
1− y − z
x(y + z)
>
1− x− y
z(x+ y)
⇐⇒ yz − y2z − xz2 − yz2 > xy − x2y − x2z − xy2 (C.3)
when x(y + z) 6= 0 and z(x + y) 6= 0. To check that the right side of (§C.3) holds we
show that
(xy − x2y − x2z − xy2)− (yz − y2z − xz2 − yz2) < 0 .
First, we rearrange it as (x− z)[y − y2 − xz − y(x+ z)] < 0 to show that
(x− z)[y(1− y − x− z)− zx] < 0 (C.4)
is always negative. By observing that, by assumption 1 we have z > x and thus (x−z) <
0, and, by equation (§C.1) we have y(1− y − x− z)− zx > 0, we derive
P(b | a)
P(b | a) >
P(a | b)
P(a | b)
which concludes the ⇒ direction.
The other direction⇐ follows immediately by contraposition: assume that P(a | b) >
P(a | b), P(b | a)/P(b | a) > P(a | b)/P(a | b) and P(b) ≤ P(a). We distinguish two
cases:
1. P(b) = P(a), then P(b | a)/P(b | a) = P(a | b)/P(a | b).
2. P(b) < P(a), then by symmetry P(b | a) > P(b | a), and by the⇒ direction of the
proposition it follows that P(b | a)/P(b | a) < P(a | b)/P(a | b).
In both cases we have a contradiction. This completes the proof.
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Proof of Proposition §6 (Monotonic normalization).
Proof. We prove the forward direction ⇒, the converse follows by a similar argument.
Let us assume
P(b | a)
P(b | a) >
P(a | b)
P(a | b) (C.5)
then P(b | a)P(a | b) > P(a | b)P(b | a). Now, to show the righthand side of the impli-
cation, we will show that[
P(b | a)− P(b | a)
][
P(a | b) + P(a | b)
]
>
[
P(b | a) + P(b | a)
][
P(a | b)− P(a | b)
]
which reduces to show
P(b | a)P(a | b)− P(b | a)P(a | b) > P(b | a)P(a | b)− P(b | a)P(a | b) .
By (§C.5), two equivalent inequalities hold
P(b | a)P(a | b)− P(b | a)P(a | b) > 0
P(b | a)P(a | b)− P(b | a)P(a | b) < 0
and hence the implication holds.
Proof of Proposition §7 (Coherence in dependency and temporal priority).
Proof. We make two assumptions:
1. P(b | a) > P(b | a) which implies αa→b > 0.
2. P(a, b) > P(a)P(b) which implies βa→b > 0.
The proof for dependency follows by Proposition §3 and its implication:
P(b | a) > P(b | a)⇔ P(a ∧ b) > P(a)P(b)⇔ αa→b > 0⇔ βa→b > 0.
Moreover, being β symmetric by definition, the proof for temporal priority follows di-
rectly by Proposition §4
Proof of Theorem §1 (Independent progressions).
Proof. For any ai ∈ G∗ it holds that
P(ai) > P(b) mai→b > 0
being prima facie, also a∗ → b is the edge selected by CAPRESE being the max{·} over
G∗. Thus, CAPRESE selects  → b instead of a∗ → b if, for any ai, it holds
1
1 + P(b) >
P(ai)
P(ai) + P(b)
P(ai ∧ b)
P(ai)P(b) .
With some algebraic manipulations we rewrite this as
P(ai)P(b) + P(b)2 > P(ai ∧ b)(1 + P(b)) ,
which gives the inequality in the theorem statement.
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Proof of Theorem §2 (Algorithm correctness).
Proof. It is clear that CAPRESE does not create disconnected components since, to
each node in G, a unique parent is attached (either from G or ). For the same reason,
no transitive connections can appear.
The absence of cycles results from Properties §5, §6 and §7. Indeed, suppose for
contradiction that there is a cycle (a1, a2), (a2, a3), . . . , (an, a1) in E, then by the three
propositions we have
P(a1) > P(a2) > . . . > P(an) > P(a1)
which is a contradiction.
Proof of Theorem §3 (Asymptotic convergence).
Proof. For any u ∈ G, when s → ∞ the observed probability P(u) (evaluated from D)
is equivalent to the product of the probabilities (in T ) obtained by traversing the forest
from the root  to u (Definition §3). Thus, P(u) ∈ (0, 1) since the traversal probabilities
are in (0, 1) too, hence all events are distinguishable and Algorithm 1 reconstructs a tree
with the same events set G of T .
We now observe that the distribution induced by T (Definition §3) respects a single-
cause prima facie topology where to each event is assigned at most a single cause. In
other words, Definition §8 holds for any edge (u, v) ∈ E:
• by the event-persistence property usually assumed in cancer (fixating mutations
are present in the progeny of a clone) the occurring times satisfy tu < tv which, in
a frequentist sense, implies P(u) > P(v);
• it holds by construction (Definition §3) that P(v ∧ u) = P(v), thus P(v | u) =
P(v)/P(u) which is strictly positive since P(v) and P(u) are, and that P(v ∧ u) =
0, thus P(v | u) = 0.
To correctly reconstruct T we rely on the fact that our score mu→v is consistent with
the prima facie probabilistic causation because of:
• Proposition §5, which states that pr (embedded as αu→v in m) subsumes a good
temporal priority model of occurring times, as stated above;
• Proposition §6 and §7 which ensure the monotonicity and sign coherency among
αu→v and βu→v in m.
Thus, m is consistent with a single-cause prima facie topology. We now show that
Algorithm 1 reconstructs correctly a generic edge in E, and hence also T .
Consider an event v ∈ G and edge (u, v) ∈ E. The set of its “candidate” parent
events is G \ {v}, we partition it in three disjoint sets G, S and N :
• G, genuine: all the backward-reachable events, in G \ {v}, from v;
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• S, spurious (or ambiguous): all the events (but v ) in the sub-forest which includes
the path from  to v, which are not in G;
• N , non prima facie: all other events, i.e., G \ ({v, } ∪ S ∪ G);
Notice that G = {v} ∪ G ∪ S ∪N , that u ∈ G and that all the effects of v are non prima
facie to v because of the temporal priority, as shown below.
v
u

T
genuine
transitivity
spurious
non prima
facie
non prima
facie
......
This way of partitioning events according to the structure of T subsumes a equivalent
partitioning based on the score α ∈ [0, 1], which we use to prove correctness of our
algorithm: for any x ∈ G it holds that αx→v = 1 if x ∈ G, 0 < αx→v < 1 if x ∈ S and
αx→v < 0 if x ∈ N .
We now show that CAPRESE correctly selects u ∈ G:
• a non prima facie event x ∈ N either satisfies (Proposition §3)
P(x ∧ v) ≤ P(x)P(v)
which means that αx→v < 0, βx→v < 0 (Proposition §7) and thus mx→v < 0, or it
is a descendant of v, which means that P(x) < P(v). By construction, CAPRESE
considers as candidate parents of v only not descendant events with positive score
(see step 3);
• a spurious event x ∈ S is prima facie to v but αx→v < 1 since:
– P(x)P(v) < P(v ∧ x) < P(v), otherwise x would be backward reachable from
x and thus in G;
– 0 < P(v ∧ x) = P(v)− P(v ∧ x) which means that P(v ∧ x) < P(x)P(v);
– by all of the above P(v | x) > 0 which implies that αx→v < 1.
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Recall now that λ→ 0, which means that mx→v ≈ αx→v < 1. CAPRESE will thus
not select any of these events as cause of v if there exist an event with mx→v = 1,
which is actually the case with genuine causes;
• genuine causes are the real cause of v, u, plus all the transitive backward-reachable
events. Any x of these has maximum score αx→v = 1 since:
– P(x)P(v) < P(v ∧ x) = P(v) and 0 = P(v ∧ x);
– by the above P(v | x) = 0 which implies αx→v = 1.
Thus, CAPRESE will pick an event from G, and not from S. We need to show
that u is the event with maximum score.
Enumerate the events in G as g1 (which is u), . . ., gk in a way that
P(g1) < . . . < P(gk)
and recall that this is a total ordering induced by the temporal priority, and that
this is consistent with coefficient β, which means that
βg1→v > . . . > βgk→v .
Thus, in the limit λ→ 0
max{mgi→v | gi ∈ G}
λ→0≈ 1 + max{βgi→v | gi ∈ G} ≈ 1 + βg1→v ≈ mu→v
is the event closer in time to v, with respect to β. This event, namely u, is chosen
by the algorithm as the real cause of v.
Finally, we show that the last step of the algorithm (the independent progression
filter, step 4), does not invalidate the edge (u, v). In fact, the algorithm would replace
such an edge with (, v) if, for all nodes x backward-reachable from v (i.e., those in G∪S)
it was
1
1 + P(v) >
P(x)
P(x) + P(v)
P(x ∧ v)
P(x)P(v) .
It suffices thus to show that the above inequality is violated just by one of the backward-
reachable nodes. We pick just u ∈ G and note that
P(u)
P(u) + P(v)
P(u ∧ v)
P(u)P(v) =
P(u | v)
P(u) + P(v) .
Also, we have that P(u) < 1, P(v) < 1 and, by construction, P(u | v) = 1 because all the
instances of v are co-occurring with those of u (but not the converse). Thus, inequality
1
1 + P(v) <
1
P(u) + P(v) ,
is always true and ensures that edge (u, v) is maintained, which concludes the proof.
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Proof of Corollary §1 (Uniform noise).
Proof. As shown in [173], the uniform rates + and − affect the observed probabilities
as follows
P(i)∗ = P(i)(1− −) + (1− P(i))+ (C.6)
P(i ∧ j)∗ = P(i ∧ j)(1− −)2 + [piij − P(i ∧ j)](1− −)+ + (1− piij)2+ , (C.7)
where piij = P(i) + P(j)− P(i ∧ j). It is important to note (Lemma 1, [173]) that
P(i) > P(j) =⇒ P(i)∗ > P(j)∗ ,
namely uniform noise is still implying temporal priority. Because of this, and since
the raw estimate α is monotonic relative to temporal priority, all the derivations for
Theorem §3 are still valid in this context, and the algorithm selects the correct genuine
cause for each effect.
To guarantee that no valid connection is broken by the independent progressions
filter, we again rely on Szabo’s result (Reconstruction Theorem 1, [173]). In particular,
for any correctly selected edge (u, v) in our algorithm, since we implement Desper’s filter
(or, analogously, Szabo’s) for independent progressions we do not mistake by deleting
(u, v) unless also their algorithms do. Since this is not the case when + <
√
pmin(1 −
+ − −) the proof is concluded.
C.2 Synthetic data generation
A set of random trees is generated to prepare synthetic tests. Let n be the number of
considered events and let pmin = 0.05 = 1 − pmax, a single tree with maximum depth
log(n) is generated as follows:
1: pick an event r ∈ G as the tree root;
2: assign to each event but r an integer value in [2, log(n)] representing its depth in the
tree, ensure that for each level there is at least one event (0 is reserved for , 1 for
r);
3: for all events e 6= r do
4: let l be the level assigned to e;
5: assign a father to e selecting an event among those at which level l−1 was assigned;
6: add the selected pair to the set of edges E;
7: end for
8: for all edges (i, j) ∈ E do
9: assign α((i, j)) a random value in [pmin, pmax];
10: end for
11: return the generated tree;
When a forest is to be generated, we repeat the above algorithm to create its constituent
trees. These trees (or forests), in turn, are used to sample the input matrix for the
reconstruction algorithms, with the parameters described in the main text.
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Figure C.1: Reconstruction with noisy synthetic data and λ→ 0. The settings of
the experiments are the same as those used in Figure §3.6, but in this case the estimator
is shrank by λ → 0, i.e., λ = 0.01. In the magnified image one can sees that the
performance of CAPRESE converges to Desper’s one already for ν ≈ 0.01, hence largely
faster than in the case of λ ≈ 1/2 (Fig. §3.6).
C.3 Further results
We show here the results of the experiments discussed but not presented in the main
text.
Reconstruction of noisy synthetic data with λ → 0. Although we know that
λ → 0 is not the optimal value of the shrinkage-like coefficient for noisy data, we show
in Figure §C.1 the analogue of Figure §3.6 when the estimator is shrank by λ → 0,
i.e., λ = 0.01. When compared to Figure §3.6 it is clear that a best performance of
CAPRESE is obtained with λ ≈ 1/2, as suggested by Figure §3.2.
Comparison with hidden Conjunctive Bayesian Networks, h-CBNs. We here
compare the performance of CAPRESE to hidden Conjunctive Bayesian Networks (h-
CBN) [65], as well as to oncotrees. The settings of the experiment are slightly different
from those of the previous analyses: we used 100 distinct random trees of 10 events
each. We ranged the number of samples available for reconstruction from 50 to 200,
with a step size of 50. The settings used for running h-CBNs are relatively standard
settings: we allowed for 50 annealing iterations with initial temperature equal to 1.
Since h-CBNs reconstruct DAGs, it is not possible to quantify its performance using
Tree Edit Distance, as we did in the comparison with oncotrees. Instead, we here adopt
Hamming Distance (computed on the connection adjacency matrix), as a closely related
and computationally feasible alternative for measuring performance [76].
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Figure C.2: Reconstruction with CAPRESE compared to oncotrees and h-
CBN with noisy synthetic data. Performance of CAPRESE compared to oncotrees
and h-CBNs as a function of the number of samples and noise ν. The λ parameter used
for CAPRESE is 1/2, and the reconstructed topologies contain 10 nodes each.
The results of the experiment can be found in Figure §C.2, and show that CAPRESE
clearly outperforms h-CBNs. In particular, it is possible to notice that, for all the
analyzed values of noise and sample sizes, both CAPRESE and oncotrees display a
(average) Hamming Distance between the reconstructed model and the original tree
topology that is significantly lower than h-CBNs, with the largest differences observed
in the noise-free case. This result would point at a much faster convergence of CAPRESE
with respect to the number of samples, also in presence of moderate levels of noise.
A few remarks are warranted about this experiment. First, in contrast to the com-
parison with oncotrees, we ran each experiment exactly once rather than averaging the
results over 10 repetitions, and on relatively smaller trees. These limitations are a conse-
quence of the extremely high time complexity of the simulated annealing step of h-CBNs.
However, the comparison between CAPRESE and h-CBNs shows a so large difference
in the performance that we do not expect this to be have significant impact. Second,
the results obtained by h-CBNs are perhaps worse than expected based on results in the
absence of noise presented in [72], which were however based on a unique tree topology.
Yet, this outcome may have been potentially influenced by either the estimation proce-
dure of the noise parameter in h-CBN, the adopted annealing procedure or by the used
number of iterations. In future work we plan to extend our algorithm to extract more
general topologies and to compare both methods in a greater detail.
Inference of models with multiple conjunctive parents. CAPRESE is specifi-
cally tailored to reconstruct models with independent progressions and a unique cause
for each event (i.e., trees or forests), while other approaches such as CBNs can recon-
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Figure C.3: Performance of CAPRESE to reconstruct models with conjunctive
parents and noisy data. Performance of CAPRESE measured in terms of the number
of false positives/negatives in the reconstructed model, when data are generated from
directed acyclic graphs with 10 nodes and where each event is caused by at most 3
conjunctive events (randomly assigned). The λ parameter is set to 1/2.
struct models where multiple conjunctive parents co-occur to cause an effect (i.e., a ∧ b
cause c). It is thus reasonable to use such conjunctive approaches to infer more complex
model, in spite of CAPRESE.
However, it is interesting to asses CAPRESE’s performance when (synthetic) data
are sampled from a model with multiple parents and noise. By sampling input data
from random directed acyclic graphs with 10 nodes and where each event is caused by at
most 3 conjunctive events (randomly assigned), we assess the number of false positives
and false negatives retrieved in the model reconstructed with CAPRESE. We show the
results in Figure §C.3. Our results indicate that for increasing sample size, the number
of false positives approaches 0. Thus, for sufficiently large number of samples, all the
causal claims returned by CAPRESE are true. In addition, the number of false negatives
is always higher and proportional to the connectivity of the target model. This is to be
expected since CAPRESE assigns at most one parent (the cause) to every node.
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CAPRI - SUPPLEMENTARY MATERIALS
In this Chapter we will report the supplementary materials related to chapter §4.
D.1 Theorems
The statements and proofs of the theorems mentioned in the main text follow.
D.1.1 Complexity
Let U denote the universe of all possible patterns over a set G of n events, as before.
Since |U| is exponential in |G|, then the following theorem holds.
Theorem 4 (Asymptotic complexity). Let |G| = n and D ∈ {0, 1}m×n where m  n,
and let N be the nodes in the DAG returned by CAPRI, the worst case time and space
complexity (ignoring the cost of bootstrap) of building a selectivity topology is:
• Θ(mn) time and Θ(n2) space, if Φ = ∅;
• Θ(|Φ|mn) time and Θ(|Φ|m) space, if Φ ⊂ U and |N |  m (i.e., there are suffi-
ciently many samples to characterize the input hypotheses);
• O(22n) time and space, if Φ = U .
Thus, the overall complexity of CAPRI is one of the above, as suitable in each case, plus
the complexity of likelihood fit with regularization.
Proof. Recall that k = |Φ|, n = |G| and D ∈ {0, 1}m×n, thus D(Φ) has K = (n + k)m
entries. We now analyze the complexity of CAPRI step-by-step.
• The cost of lifting depends on the input set Φ, if Φ = ∅ it is O(1) both in time
and space since D(∅) = D. For non-empty sets, it is necessary to evaluate k ·m
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entries, after each hypothesis ϕ e is evaluated. Given that every ϕ has at worst
n events included, its evaluation cost is at most O(n), even if lazy evaluation is
performed. Thus, the cost of lifting is Θ(k ·m · n), for a single bootstrap, which
amplifies the bootstrap cost, as discussed in the previous section, and does so in
a multiplicative fashion. In terms of space, if Φ 6= ∅ the overhead is Θ(K) if one
copies D in D(Φ), Θ(km) otherwise.
• The cost of computing the parent function for the DAG requires a pair-wise cal-
culation of the probabilistic scores, plus the cost of testing the v relation1. Let
w = |N |, where N is the set of nodes in the DAG returned by CAPRI. The score
matrices for temporal priority and probability raising are n×w, i.e., have columns
for both atomic events and the disjunctive patterns in the formulas of Φ, since
CAPRI disregards patterns of the form ϕi  ϕj and a  ϕ (differently, it would
have been w×w). With the simplest membership test algorithm, checking whether
an atomic event is present in a patterns is logarithmic in the size of the pattern,
if we lexicographically order its atomic events, thus bounded from above by log n.
Thus if we perform lazy evaluation for v the total number of comparison to select
the parent function is at most
n[(n− 1) + (w − n) log n],
yielding a Θ(n2) cost in time and space, if w−n is small (it is 0 if Φ = ∅), O(n(w−
n) log n) otherwise. In terms of space, the complexity is Θ(n[(n − 1) + (w − n)]),
for a general Φ.
• As explained in CAPRI’s definition, sometimes, albeit extremely rarely, a few
extra operations might have to be performed when degenerate scores and loops
are present. The procedure we suggested in CAPRI’s definition requires sorting
plus scan, thus its worst-case time complexity is O(n log n). Clearly, as this term
is omitted in the worst-case complexity analysis of the steps discussed above, this
unlikely scenario does not alter the complexity of the algorithm.
• Note that the cost of this analysis does not include the cost of BIC/likelihood
- or any regularization strategy one might adopt, as spelled out in the theorem
statement2.
The overall complexity follows, since:
• Φ = ∅ then the major cost is that of evaluating P(·) since usually m  n, thus
mn > n2. With regard to space, the only cost is that of book-keeping the scores.
1Relation v represents the usual syntactical ordering relation among atomic events, e.g., a, b, and
formulas, e.g., a v (a ∨ b) ∨ c ∨ d.
2Since in the current version of CAPRI, the likelihood fit is computed by a hill climbing heuristic
algorithm, the overall cost of CAPRI is still polynomial.
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• Let m  n and w − n > k, in this case since km  n and, under the mild
assumption that m > w and that k and log n are not relevant (in size) for m and
w, then km  (w − n) log n which is the cost of lifting; thus is Θ(kmn) in time.
Similarly, it follows that mk  n[(n− 1) + (w − n)].
• By computations similar to those carried out, it is indeed possible to see that U ,
which is clearly finite since G is, grows double-exponentially in size with |G| (i.e. the
number of n-ary boolean functions, defined over the atomic events in any pattern,
possibly with negated literals). Thus the bound follows.
D.1.2 Correctness and expressivity
Let W ⊆ U be the set of true patterns, which we seek to infer. Here, we investigate the
relation between W and the patterns retrieved by CAPRI, as a function of sample size
m and error present as false positives/negatives, which are assumed to occur at rates +
and −.
Hereafter, Σ denotes the set of patterns, implicit in the DAG returned by our algo-
rithm for an input set Φ and a matrix D; we write this fact as D(Φ)  Σ. We prove the
following theorems3.
Theorem 5 (Soundness and completeness). Let the sample size m → ∞ and the data
be uniformly randomly corrupted by false positives and negatives rates − = + ∈ [0, 1).
If the given input is a superset of the true patterns, then CAPRI reconstructs exactly the
true patterns in W, that is, W ⊂ Φ ⇒ D(Φ) W ∩ Φ.
Proof. We first prove the case with + = − = 0, that is, the case where data have no
noise. Some notations, used below: (i) we denote with ϕ e true patterns (i.e. in W),
and (ii) with ϕ∗  e false ones. We divide the proof into several steps:
• First, we show that a selectivity DAG contains all the true patterns, which is
∀ϕe∈W pi(e) = {ϕ} .
By the event-persistence property usually valid for cancer genomes (fixating mu-
tations are present in the progeny of a clone) the occurring times satisfy tϕ < te
which, in a frequentist sense, implies P(ϕ) > P(e). In addition, it holds by con-
struction that P(ϕ ∧ e) = P(e) when + = − = 0, thus P(e | ϕ) = P(e)/P(ϕ),
which is strictly positive since P(ϕ) and P(e) are, and that P(ϕ ∧ e) = 0 , thus
P(e | ϕ) = 0. Notice that e 6v ϕ by hypothesis.
• Now, we show that it might contain also spurious patterns, which is
∃ϕ∗e 6∈W pi(e) ⊆ clauses (ϕ∗) ∪ {ϕ∗} .
3These results assume a BIC regularisation but hold for any convergent regularization score.
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These ϕ∗  e are of two types: sub-formulas spurious or topologically spurious
(which include transitivities, as we may recall). For the former case note that
∀ϕe∈W ∀ϕˆ∗∈clauses(ϕ) ϕˆ∗  e 6∈ W,
but satisfies both temporal priority and probability raising. Also, consider any
other ϕˆ∗? v ϕˆ∗ and note that even this might satisfy both temporal priority and
probability raising. For the latter case, it might be that there exists some other ϕ∗
such that, it is positively statistically correlated to a real pattern, and that might
satisfy Suppe’s conditions as well.
Thus, for any e ∈ G such that ϕ e ∈ W
pi(e) = {ϕ} ∪ S,
where S is a set of spurious patterns. We now examine the relation holding between the
selectivity DAG and its modification performed via BIC. The derivations shown in the
following hold regardless of the type of regularization which enjoys convergency.
We denote these DAGs as Dpf and DBIC.
(i) First, we show that all true patterns in Dpf are in DBIC, i.e.
∀ϕe∈W piBIC(e) = {ϕ} .
Note that, although in general P(a ∧ b) ≤ min{P(a),P(b)}, for the true patterns
the following holds: P(ϕ ∧ e) = P(e), when + = − = 0; it is the maximum
value for this joint probability, thus ensuring the maximum-likelihood fit. Thus
the pattern is maintained in DBIC.
(ii) Second, we need to show that if ∀ϕ∗  e 6∈ W but present in Dpf, there exists a
pattern ϕ e ∈ W, which is present in Dpf and in DBIC and any ϕ∗  e is not in
DBIC.
Note that P(ϕ ∧ e) = P(e), as above. Instead, P(ϕ∗ ∧ e) < P(e) since it is spu-
rious, hence P(ϕ ∧ ϕ∗ ∧ e) < P(ϕ ∧ e), thus the likelihood fit of ϕ e is maximal
with respect to any of the patterns ϕ∗  e.
To extend the proof to + = − ∈ [0, 1) with uniform noise, it suffices to note that the
marginal and joint probabilities change monotonically as a consequence of the assump-
tion that the noise is uniform. Thus, all inequalities used in the preceding proof still
hold, which concludes the proof.
Notice that if it could be assumed that Φ characterizesW well, then all true patterns
would be in Φ, and the corollaries below follows immediately.
Corollary 2 (Exhaustivity). Assuming the same hypothesis as for the theorem above,
D(U) W.
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2
Corollary 3 (Least Fixed Point). W is the lfp of the monotonic transformation⊔
Φ
D(Φ) ≡ D
(⊔
Φ
Φ
)
W. 2.
Since a direct application of this theorem incurs a prohibitive computational cost,
it only serves to idealize the ultimate power of the framework we have proposed. That
is, the theorem only states that CAPRI is able to select only the true patterns asymp-
totically (in the sample size), regardless of how the putative hypotheses size U grows,
e.g., in the worst-case exponentially. It also clarifies that the algorithm is able to “filter
out” all the spurious patterns (true negatives), and produces the true positives more
and more reliably as a function of the computational and data resources.
Now we restrict our attention to co-occurrence types of patterns so as to enable a
fair comparison with [10]. We denote with C ⊂ U the set of all possible such patterns,
and we prove the following.
Theorem 6 (Inference of co-occurrence patterns). Suppose Φ = ∅; as before, let the
sample size m → ∞ and let the data be uniformly corrupted by false positives and
negatives rates − = + ∈ [0, 1). Then only co-occurrence patterns on atomic events
are inferred, which are either true or spurious for general CNF formulas. That is: if
D(∅)  Σ then Σ ⊆ C. Furthermore,
1. Σ ∩W are true patterns and
2. For any other pattern α  e ∈ (Σ \ Σ ∩W) there exist β  e ∈ W \ C such that β
screens off α from e.
Proof. Consider the proof of the previous theorem. In this case, we am dealing with
formulas such that clauses (ϕ) ⊆ G, i.e., formulas do not have any disjunctive component.
All the derivations for Theorem 2 can be carried out in this context, notice that: formulas
considered in step (i) of such a proof are those which are purely conjunctive and correctly
inferred. Similarly, formulas in (ii) are those that screen off the false patterns, but are
incorrectly present in DBIC.
This theorem states that, even if one is neither willing to pay the cost of augmenting
CAPRI’s input with patterns nor able to find any suitable one, the algorithm is still
capable of inferring singleton and conjunctive instances of  relation, whose members
are either true or part of a more complex types of patterns that fall outside CAPRI’s
scope. An immediate corollary of these two theorems is that CAPRI works as specified,
when it is fed with all possible co-occurrence patterns.
Corollary 4. Under the hypothesis of the above theorems, D(∅)  Σ ⇐⇒ D(C)  Σ.2
In practice, this algorithm, though still exponential, is certainly less computationally
intensive. For instance, when using C than with U , it can trade off computational
complexity against expressivity of the inferred patterns.
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D.2 Results: synthetic data
Setting for comparison. The performance of all the algorithms were evaluated em-
pirically with four different types of topologies: (i) trees, (ii) forests, (iii) DAGs without
disconnected components and (iv) DAGs with disconnected components. Irrespective of
the topology considered, we exclusively used atomic events, which implies that either
singleton or co-occurrence patterns were used in the experiments. Based on Corollary 3,
it sufficed to run CAPRI with Φ = ∅. This strategy is consistent with the fact that our
algorithm can infer more general formulas if an input “set of putative causes, Φ 6= ∅”
is given in addition – a fact which, without the care taken, could have unfairly and fa-
vorably biased our analysis in the more general situation. For the sake of completeness,
however, we also tested specific CNF formulas, as shown in the next sections.
Type (i − ii) topologies are DAGs constrained to have nodes with a unique parent;
condition (i) further restricts such DAGs to have no disconnected components, meaning
that all nodes are reachable from a starting root r. Practically, condition (i) satisfies
|pi(j)| = 1 for j 6= r, and pi(r) = ∅, while in (ii) we allow more roots to be present. This
kind of topologies can be reconstructed with either ad-hoc algorithms [117, 38, 173] or
general DAG-inference techniques [171, 179, 10, 167, 79]. Type (iii− iv) topologies are
DAGs which have either a unique starting node r, or a set of independent sub-DAGs.
Similarly, condition (iii) satisfies |pi(j)| ≥ 1 for j 6= r, and pi(r) = ∅, while in (iv) we allow
more roots to be present, as it was in (ii). This kind of topologies are not reconstructible
with tree-specific algorithms, and thus only algorithms in [171, 179, 10, 167, 79] could
be used for comparison. The algorithm for the synthetic data generation is described in
the following paragraph.
Generating synthetic data. Let n be the number of events we want to include in a
DAG and let pmin = 0.05, pmax = 0.95, pmin = 1 − pmax. A DAG without disconnected
components (i.e. an instance of type (iv) topology) with maximum depth log n and
where each node has at most w∗ parents (i.e. |pi(j)| ≤ w∗, for j 6= r) is generated as
follows:
1: pick an event r ∈ G as the root of the DAG;
2: assign to each j 6= r an integer in the interval [2, dlog ne] representing its depth in
the DAG (1 is reserved for r), ensure that each level has at least one event;
3: for all events j 6= r do
4: let l be the level assigned to e;
5: pick |pi(j)| uniformly over (0, w∗], and accordingly define pi(j) with events selected
among those at which level l − 1 was assigned;
6: end for
7: assign α(r) a random value in the interval [pmin, pmax];
8: for all events j 6= r do
9: let y be a random value in the interval [pmin, pmax], assign
α(j) = y
∏
x∈pi(j)
α(x) ;
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10: end for
11: return the generated DAG;
When an instance of type (iv) topology is to be generated, we repeat the above algo-
rithm to create its constituent DAGs. In this case, if multiple DAGs are generated, each
one with randomly sampled ni events we require that |G| =
∑
ni = n. When instances
of type (i) topology are required w∗ = 1, and by iterating multiple independent sampling
instances of type (ii) topology are generated. When required DAGs were sampled, these
are used to generate an instance of the input matrix D for the reconstruction algorithms.
D.2.1 Performance with different topologies and small datasets
Here we estimate the performance of CAPRI for datasets with sizes that are likely
to be found in currently available cancer databases, such as The Cancer Genome Atlas,
TCGA [136], i.e. m ≈ 250 samples, and 15 events. The results are shown in Figure §D.1,
for topologies (i) and (ii), and Figure §D.2, for topologies (iii) and (iv). There, we show
all the results obtained by running the algorithm with bootstrap resampling, although
results (data not shown) without this pre-processing leave the conclusions unaffected.
Results suggest a trend, as to be expected: namely, performance degrades as noise
increases and sample size diminishes. However, it is particularly interesting to notice
that, in various settings, CAPRI almost converges to a perfect score even with these small
datasets. This happens for instance with type (i − ii) topologies, where the Hamming
distance almost drops to 0 for m ≥ 150. In general, it is also clear that reconstructing
forests is easier than trees, when the same number of events n is considered. This is a
consequence of the fact that, once n is fixed, forests are likely to have less branches since
every tree in the forest has less nodes. When reconstructing type (iii − iv) topologies,
instead, the convergence-speed of CAPRI to lower Hamming distance is slower, as one
might reasonably expect. In fact, in those settings the distance never drops below
3, and more samples would be required to get a perfect score. We consider this to
be a remarkable result, when compared to the worst-case Hamming distance value of
15 · 14 = 210. Panels of Figure §D.2 also suggest that disconnected DAGs are easier to
reconstruct than connected ones, when a fixed number of events is considered. Similarly
to the above, this could be credited to the fact that the size of the conjunctive claims is
generally smaller, for fixed n. With respect to the precision and recall scores, one may
note that CAPRI seems to be quite robust to noise, since the loss in the score-values
appear nearly unaffected by any increase in the noise parameter.
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D.2.2 Comparison with other reconstruction techniques
We compare now with state-of-the-art approaches mentioned in the main text4, which
we divide into three categories: structural - Incremental Association Markov Blanket
(IAMB) and PC algorithm -, likelihood - Bayesian Information Criterion (BIC) and
Bayesian Dirichlet (BDE) and hybrid - Conjunctive Bayesian Networks (CBN) and Can-
cer Progression Inference with Single Edges (CAPRESE). For all the algorithms we
used their standard r implementations: for IAMB, BDE and BIC we used package
scutari2009learning [168], for the PC algorithm we used package pcalg, for CAP-
RESE we used TRONCO [4] (first release) and for CBN we used h-cbn [11].
Clearly, other algorithms exist in the literature, but we selected those which satisfied
at least one of the following criteria: earlier, they have proven to be more effective in
inferring “causal” claims, i.e., they are considered the best algorithms to infer “causal
networks” (i.e., IAMB and PC); they regularize the Bayesian over-fit (i.e., BDE and
BIC); they assume a prior (i.e. BDE) or they were developed specifically for cancer
progression inference (i.e., CBN and CAPRESE). Prominent among the ones absent in
this study are the following: Grow and Shrink [124], which preliminary analysis have
shown to be very similar to IAMB, and the DiProg algorithm [50], which unrealistically
requires advanced knowledge of input error rate to reconstruct a model; note that this
kind of information is not generally available a priori.
Notice that we selected all the algorithms capable of inferring generic DAGs but
CAPRESE [117], which can only be applied to infer trees or forests (i.e., type (i − ii)
topologies). In the literature there exist other approaches specifically tailored for such
topologies, e.g., [38, 173]; however, since in [117] it is shown that CAPRESE performs
better than other approaches, we assume no loss of information in restricting our study.
We place CAPRI in the Hybrid category, though we clearly compare its performance
with all the other approaches in order to quantify its suitability for reconstruction of all
classes of topologies, as defined earlier.
The general trend is summarized in Figure §D.3, where we rank all of these algorithms
according to their median performance, estimated as a function of noise and sample size,
and provide the parameters used for comparison. In Figure §D.4, we compare CAPRI
with the structural approaches (IAMB and PC). In Figure §D.5, we compare it with the
likelihood approaches (BIC and BDE) and, finally, in Figure §D.6, we compare it with the
hybrid algorithms. We remark that, because of the high computational cost of running
CBNs, which relies on a nested Expectation-Maximization algorithm with Simulated
Annealing, the number of ensembles performed is limited to 100 for CBNs, while it
is 1000 for all other algorithms. Though this strategy provides less robust statistics
for CBNs (i.e., less “smooth” performance surfaces), it is still sufficiently accurate to
indicate the general comparative trends and relative performance efficiency.
4Classic versions of the IAMB and PC algorithm were further subjected to log-likelihood optimization
to assign a direction to all of the computed non-oriented edges. This additional feature is necessary to
permit a fair comparison against various structural approaches, which, otherwise, would be penalized
with a worse Hamming distance, since these algorithms, in principle, can return non-oriented edges.
Note that progression models, by their very nature, consist only of oriented structures.
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D.2.3 Reconstruction without hypotheses: disjunctive patterns
Recall that our algorithm expects as input all the hypothesized patterns to infer more
expressive logical formulas, i.e., hypotheses with pure CNF formulas or even disjunctive
patterns over atomic events. Nonetheless, it is instructive to investigate its performance
under two specific conditions, especially to clarify the robustness with respect to imper-
fect regularities (the, e.g, “noisy and”): namely, (i) without hypotheses (Φ = ∅) and (ii)
for datasets sampled from topologies with disjunctive patterns.
To generate the input dataset, we have to modify the generative procedure used
for the other tests, thus reflecting the switch from co-occurrence to disjunctive patterns.
This task is actually rather simple, since we just change the labeling function α to account
for the probability of picking any subset of the clauses in the disjunctive pattern, while
omitting the others. We use DAGs with 10 events and disjunctive patterns with at
most 3 atomic events involved, which is a reasonable size, given the events considered.
Clearly, this setting is generally harder than the one shown in Figures §D.4– §D.6, thus
we expect performance to be somewhat inferior.
Here we compare CAPRI with all the algorithms used so far, and we show the re-
sult of this comparison in Figure §D.7, where Φ = ∅, as noted earlier. The plot clearly
confirms the trends suggested by previous analyses: namely, CAPRI infers the correct
patterns more often than the others. Note also that the performance is measured on the
reconstructed topology only, since, without input hypotheses, the algorithm evaluates
only co-occurrence types of patterns, and does not allow different types of relations (e.g.
disjunctions) to be inferred automatically. However, as anticipated, observed perfor-
mance improvement is now much lower, and the Hamming distance fails to rise above 4.
Furthermore, convergence to optimal performance was not observed for m ≤ 1000, and
it appears not to be reachable even for m  1000 (at least so, when no hypotheses are
used). It is also possible that, as n and the number of maximum disjunctive patterns
increase, the result could be an even less satisfactory speed of convergence.
D.2.4 Reconstruction with hypotheses: synthetic lethality
We wondered whether CAPRI would be able to infer synthetic lethality relations, when
these are directly hypothesized in the input set Φ. We started with a test of the simplest
form: e.g., [a ⊕ b  c], for a set of events G = {a, b, c}, where we force progression
from a to c to be preferential, i.e. it appears with 0.7 probability, whereas b to c
does so with only 0.3 probability, thus implying that samples involving (a ∧ b¯) will be
more abundant than those involving (a¯ ∧ b). Despite this being the smallest possible
synthetically lethal pattern, the goal was to estimate the probability of such a pattern
being robustly inferable, when Φ = {a⊕bc}, and its dependence on the sample size and
noise. We measured the performance of all the algorithms, with an input lifted according
to the pattern so that all algorithms start with the same initial pieces of information.
The performance metric estimates how likely an edge from a⊕ b to c could be found in
the reconstructed structures.
We show the results of this comparison in Figure §D.8. We note that CAPRI suc-
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Setting A (ν = 0) mean median standard deviation
CAPRESE 0.006 0.005 0.005
BIC 0.023 0.022 0.011
IAMB 0.028 0.027 0.005
CAPRI without bootstrap 0.029 0.029 0.003
BDE 0.041 0.032 0.063
PC 0.144 0.112 0.154
CAPRI with bootstrap 1.143 1.056 0.360
Setting B (ν = .10) mean median standard deviation
CAPRESE 0.005 0.005 0.001
BIC 0.022 0.022 0.003
IAMB 0.029 0.028 0.004
CAPRI without bootstrap 0.030 0.029 0.004
BDE 0.030 0.028 0.010
PC 0.103 0.094 0.034
CAPRI with bootstrap 0.719 0.689 0.138
Table D.1: Comparison in the execution time.
ceeds in inferring the synthetic lethality relation more frequently than 93% of the times,
irrespective of the noise and sample size used. More precisely, with m ≥ 60 the algorithm
infers the correct pattern under any execution, thus suggesting that CAPRI, with the
correct input hypotheses, is able to infer complicated structures, many of which could
have high biological significance. Naturally, it would be reasonably expected that the
performance of any of these algorithms would drop, were the target relations part of a
bigger model.
D.2.5 Execution time
We report in table §D.1 an evaluation of the execution time for all the algorithms we
tested, but CBN - which computation time is more than one order of magnitude higher
than the competing techniques. Two distinct settings of experiments were used: Setting
(A): n = 10 events, m = 100 samples, ν = 0 noise; Setting (B): n = 10, m = 100,
ν = .10. Results account for the average time of execution as of 100 randomly generated
topologies (one dataset sampled per topology). Time unit is second and the test was
performed on a MacBook with 2.3 GHz Intel i7 processor, 16 Gb of RAM and Yosemite
10.9 OS.
To allow a fair comparison of CAPRI against the other algorithms we both executed
the algorithm with and without bootstrap preprocessing, in order to asses the prima
facie condition (Mann-Withney U test being performed in the former case). Execution
timings are sorted according to mean time.
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D.3 Biological examples
In this Section two examples of analysis of genomic alterations will be presented.
D.3.1 Atypical Chronic Myeloid Leukemia
Input hypotheses for CAPRI (supervised mode)
By fetching the literature we selected the following patterns to input as CAPRI’s hy-
potheses:
(1) “exclusivity among asxl1 and sf3b1 mutations” [115]:
(asxl1 Nonsense point ⊕ asxl1 Ins/del ) ⊕ sf3b1 Missense point
(1) “exclusivity among tet2 and idh2 mutations” [53]:
(tet2 Nonsense point ⊕ tet2 Missense point ⊕ tet2 Ins/del ) ⊕ idh2 Missense
point
These patterns were used to build CAPRI’s hypotheses which were tested against all
events which do not appear in the above pattern itself, e.g., pattern (1) was tested
against all input events but those involving asxl1 and sf3b1 genes.
As shown in the main text, among all, the following hypothesis gets selected by
CAPRI
(asxl1 Nonsense point ⊕ asxl1 Ins/del ) ⊕ sf3b1 Missense point  cbl Missense
point
aCML progression model with different techniques
In Figure §D.9 one can find the progression models reconstructed on the the aCML
dataset [154], with 3 different algorithms: (i) CAPRESE, (ii) BIC and (iii) IAMB.
These three techniques were chosen for this comparative study because of the overall
better performance on synthetic tests (see Section 3.2-3.4 of the SI). The reconstruction
obtained with CAPRI can be found in Figure 5 in the main text. For a biological
interpretation of the results please refer to Section 4.2 in the main text.
Note that all the progression model share some specific selective advantage relations,
yet being substantially different. Relations involving setbp1 and asxl1 and those in-
volving tet2 and ezh2 are, in fact, inferred by all the four algorithms, yet with different
confidences and, sometimes, edge direction. In addition, IAMB does not include cbl in
the path involving setbp1 and asxl1, and none of the algorithms but CAPRI can infer
the complex pattern involving asxl1 mutations of both types and sf3b1 (Figure 5 in
the main text). Finally, note that IAMB and BIC are often not able to disambiguate
the edge direction and this represent a major limit of these techniques with respect to
CAPRI and CAPRESE.
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D.3.2 Ovarian cancer
Ovarian cancer progression model with different techniques
We analyzed an ovarian cancer dataset reporting chromosome-level amplifications and
deletions detected via Comparative Genome Hybridization in [100]. Similar to the case
of aCML, we used 4 different techniques to infer a progression models for events included
in the dataset: CAPRI (unsupervised), CAPRESE, BIC and IAMB. Models and input
dataset are shown in Figure §D.10. Like with aCML extraction, the progression models
share only some of the inferred relations. Among the most relevant differences is the
conjunctive pattern inferred by CAPRI between the loss on chromosome 5q (5q−) and
the gain on chromosome 8q (8q+) which is predicted to select for a loss on 8p; note
also the aforementioned limitation of BIC and IAMB in disambiguating the direction
of some of the inferred relations. Note that CAPRI infers a co-occurrence pattern of
selective advantage which is not input a priori as hypothesis - unsupervised execution.
In summary, CAPRI displays a better overall confidence on the reconstructed model.
157
Figure D.1: Reconstruction of trees and forests with small datasets. Hamming distance, precision and
recall of CAPRI for synthetic data generated by trees (i.e., models with a singleton pattern per event and a
unique progression), in top panels, and by forests (i.e., models with a singleton pattern per event but multiple
independent progressions), in bottom panels. In both cases n = 15 events are considered, m ranges from 50 to
250 and the noise rate ranges from 0% to 20%. To have a reliable statistics, for each type of topology, we generate
100 distinct progression models and, for each value of sample size and noise rate, we sample 10 datasets from
each topology. Thus, every performance entry is the average of 1000 reconstruction results. Notice that Hamming
distance almost drops to 0 for m ≥ 150 and that precision and recall decrease very little as noise increases.
Figure D.2: Reconstruction of DAGs with small datasets. Hamming distance, precision and recall of CAPRI
for synthetic data generated by connected DAGs (i.e., models with either a singleton or co-occurrence pattern per
event and a unique progression), in top panels, and by disconnected DAGs (i.e., models with either a singleton or
co-occurrence pattern per event and multiple progressions), in bottom panels. In both cases the same parameters
as in Figure §D.1 are used (n = 15, 50 ≤ m ≤ 250, 0% ≤ ν ≤ 20% and every performance entry is the average
of 1000 reconstructions). In this setting, which is harder than the one shown in Figure §D.1, Hamming distance
does not reach values below 3 – a reasonably small number for our purposes – while precision and recall still suffer
very little as noise increases.
Parameter values
n number of events 10
m number of samples [50, 1000]
ν rate of false positives + and negatives − [0, 0.2] (0%-20% noise rate)
− ensemble size 1000 (100 for CBN)
Figure D.3: Co-occurrence patterns: performance ranking. We rank the algorithms we compared in
Figure §D.4, §D.5 and §D.6 according to their performance for the parameters in the table. Rankings are divided
according to the topology type and sorted according to the median performance.
Figure D.4: Comparison with related works: structural algorithms. We compare CAPRI, IAMB and the
PC algorithm to infer trees, forests, connected DAGs and disconnected DAGs with the parameters described in
Table §D.3. Average Hamming distance, precision and recall are shown.
Figure D.5: Comparison with related works: likelihood-based algorithms. We compare CAPRI against
likelihood-based methods optimizing BIC and BDE scores to infer trees, forests, connected DAGs and disconnected
DAGs with the parameters described in Table §D.3. Average Hamming distance, precision and recall are shown.
Figure D.6: Comparison with related works: hybrid algorithms. We compare CAPRI, CBNs and CAP-
RESE to infer trees, forests, connected and disconnected DAGs with the parameters of Table §D.3 but, because of
the computational cost of running CBNs with 100 annealing steps, we reduced the number of ensembles performed
as: 100 for CBNs, 1000 for CAPRESE and, for CAPRI, 100 for DAGs and 1000 otherwise. Average Hamming
distance, precision and recall are shown.
Figure D.7: Reconstruction of disjunctive patterns with no hypotheses. We compare CAPRI against all
the algorithms to infer progressions with disjunctive patterns. In top panel we show IAMB as the best structural
algorithm, and the BIC score as the best among likelihood-based methods, according to Table §D.3. In bottom
panel we compare the other algorithms. No hypotheses (Φ = ∅) are given as input to CAPRI. Input data is
generated by DAGs with 10 atomic events and disjunctive patterns with at most 3 atomic events involved. Sample
size ranges from 50 to 1000, noise rate from 0% to 20% and 1000 ensembles are generated for each configuration
of noise and sample size. This setting is generally harder than the one shown in Figures §D.4– §D.6. Hamming
distance, precision and recall are shown and confirm that this type or pattern is harder than the co-occurent one
to be inferred, hinting at the difficulty of modeling unbalanced confluent progressions.
Figure D.8: Reconstruction with hypotheses: synthetic lethality. We show the average probability of
inferring a claim a ⊕ b  c (synthetic lethality), when this is provided in the input set Φ. We show such a
probability for CAPRI, the likelihood-based algorithms with BIC and BDE scores, and the structural IAMB and
PC Algorithm. Data is generated from the model in the upper left panel (unbalanced “exclusive or” with a
preferential progression), samples size ranges from 30 to 120, noise rate from 0% to 20% and 1000 ensembles are
generated for each configuration of noise and sample size. Results suggest that a threshold level on the number
of samples exists such that CAPRI infers the correct claim when Φ = {a⊕ b c}. We executed all the algorithms
with an input matrix lifted to contain the target claim.
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Figure D.9: CAPRESE, IAMB and BIC progression models of aCML. Progression models reconstructed
from the aCML dataset described in the main text - taken from [154] - obtained with the following algorithms:
CAPRESE, IAMB and BIC. The model inferred by CAPRI is shown in the Main Text. Confidence shown is
assessed as for the CAPRI algorithm. Nodes are scaled differently to better layout the graphs reconstructed by
every algorithm.
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Figure D.10: CAPRI, CAPRESE, IAMB and BIC inferred progression models of ovarian cancer.
Progression models reconstructed from the ovarian cancer Comparative Genome Hybridization dataset shown in
top [100]. Algorithms used to infer the models are CAPRI, CAPRESE, IAMB and BIC. Confidence is shown as
non-parametric bootstrap and hypergeometric test (p-values). Nodes are scaled differently to better layout the
graphs reconstructed by every algorithm.
APPENDIX E
CRC STUDY - SUPPLEMENTARY MATERIALS
Here we detail all the steps implemented to perform the pipeline widely discussed in
Chapter §6. The source code to replicate this study is available for download along with
the documentation detailing all the implementation at:
http://bimib.disco.unimib.it/index.php/Tronco
E.1 TCGA COADREAD project data
COADREAD provides genome-scale analysis of samples with exome sequence, DNA
copy number, promoter methylation, messenger RNA and microRNA expression data
which we used to define “training” and “control” datasets. In both validation and control
datasets, only samples with both mutations and CNAs profiles were used. Table §E.1
details each of the four datasets.
Training dataset. Samples published in [137] were used as training; for these samples,
TCGA provides somatic mutation profiles and high-resolution focal CNAs via GISTIC.
These are obtained from TCGA data freeze as of 2 February 2012, downloaded on 12
March 2015, from the repository:
https://tcga-data.nci.nih.gov/docs/publications/coadread 2012/
The following files were processed to produce the training data:
• TCGA CRC Suppl Table2 Mutations 20120719.xlsx. Somatic mutations profiles
obtained via whole-exome sequencing of 224 colorectal tumors1. All annotated
mutations were considered for analysis;
115995 mutations in 228 samples are annotated in a Manual Annotation Format (MAF). Samples were
selected to univocally match the 224 patients as of the TCGA guidelines for aliquote disambiguation,
see https://wiki.nci.nih.gov/display/TCGA/TCGA+barcode.
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• crc gistic.txt.zip. Focal Copy Number Alterations (CNAs) for 564 patients de-
rived from whole-genome sequencing using the Illumina HiSeq platform. High-level
gains and homozygous deletions were considered for analysis by selecting entries
with GISTIC scores ±2;
• crc clinical sheet.txt. Clinical data summary with patient stage and Micro
Satellite Stabe/Instable (MSS/MSI) status being any of: MSS, MSI-high and MSI-
low.
The list of patients used was first reduced to those having both CNAs and somatic
mutation data, and then was split in two groups: MSI-HIGH and MSS. The training
cohort has 152 MSS and 27 MSI-HIGH samples; samples flagged as low MSI were ex-
cluded from the study as they have not been shown to differ in their clinicopathologic
features or in most molecular features from MSS tumors [149].
Validation dataset. For samples collected afterwards the consortium provides raw
sequencing data, and CNAs (also in the file crc clinical sheet.txt). Thus, reads
were processed to produce mutation profiles.
Bowtie 2.0 software was used to align sequences over the human reference genome
HG19 [105]. To refine the data, reads unmapped, reads with unmapped mate, not
primary alignments, and reads that were PCR or optical duplicates were discarded from
the study (http://picard.sourceforge.net/). We also executed a local realignment around
indels defined in SnpDB [169] and 1000G [29]. Variant calling was executed with GATK
software and low quality variants (mapping quality below 30 or read depth below 10),
were discarded [37]. Germline variants were also removed, i.e., variants that were present
in non-tumoral samples, and variants reported in the 1000G project. Finally, variants
were annotated using the SeattleSeq Variant Annotation web tool [140].
The input cohort of patients was partitioned according to the number of mutations
per sample r, see Figure §E.2; a curated cutoff of 500 mutations per sample was used to
determine 203 samples with MSS status (r < 500) and 36 MSI-HIGH samples (r ≥ 500).
The former group had mutations in 14580 genes, and the latter in 15071.
E.1.1 Driver events selection
We have selected 33 genes annotated to 5 pathways as drivers of colorectal tumorigenesis
[137]. These are well-known cancer genes, frequently reported as relevant to colorectal
progression and to the major pathways involved in CRC. Driver events are alterations
in:
• wnt genes (14): apc, dkk-4, tcf7l2, ctnnb1, lrp5, fbxw7, dkk-1, fzd10,
arid1a, dkk-2, fam123b, sox9, dkk-3 and axin2;
• rtk/ras genes (5): erbb2, erbb3, nras, kras and braf;
• tgf-β genes (5): tgfbr1, smad3, tgfbr2, smad4, acvr1b, acvr2a and smad2;
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• igf2/pi3k genes (5): igf2, irs2, pik3ca, pik3r1 and pten;
• p53 genes (2): tp53 and atm.
In Chapter §6,rtk/ras and igf2/pi3k pathways are shortly denoted as ras and pi3k.
E.1.2 Mutual exclusivity groups of alterations
Groups of alterations showing a trend of mutual exclusivity were scanned with MUTEX
and mutations and CNA hitting any of the 33 selected genes as input. MUTEX was
run independently on MSS and MSI-HIGH groups (Supplementary Table §E.2, running
times: approximately 6 and 3.5 hours, respectively, on a standard Desktop machine).
We selected only groups with score < 0.2, where the score is derived from p-values
corrected for false discovery rate. 3 groups are found for MSI-HIGH tumors and 6 for
MSS. For MSI-HIGH tumors, the three predicted groups consists of genes acvr1b,
acvr2a, tp53 and erbb2, of genes braf, nras and tgfbr2, and of genes kras and
braf.
Further groups of exclusive alterations were considered consistent with results re-
ported in [137]. These include groups derived by consolidated knowledge of colorectal
progression: the well-known Wnt alterations in apc/ctnnb1 [64], as well as RAS alter-
ations in kras, nras and braf genes [194]. Similarly, we used also a group collected by
scanning non-hypermutated tumors with the MEMO tool in [137] - this group includes
pik3ca, pten, erbb2 and igf2 genes. These groups were restricted to account only
for genes actually altered in a certain subtype, e.g., MSI-HIGH tumors lack ctnnb1
mutation, making the Wnt group irrelevant. Groups for MSS tumors are shown as
Supplementary Figure §E.3.
E.1.3 CAPRI’s execution
CAPRI was run, on each group of tumors, by selecting alterations from the pool of 33
pathway genes; every alteration on a gene x is included if any of these apply:
• the alteration frequency of x - sum of mutation and CNA frequency - is greater
than 5%;
• x it is part of an exclusivity group.
The set of selected events for MSI-HIGH training tumors is shown in Chapter §6, the
analogous for MSS tumors is shown in Figure §E.4.
CAPRI was executed in its supervised mode by writing formula over groups and
genes with multiple alterations associated, as explained in Chapter §6. For instance,
for MSI-HIGH tumors with alterations in ras pathway we grouped hard exclusivity
of nras mutations and deletions, with soft exclusivity of kras and braf mutations.
Our aim was to account for a small subset of samples with concurrent kras and nras
alterations (see Chapter §6). The list of all Boolean formulas written over groups is
in Tables §E.3 and §E.4; this approach was adopted also when a gene harbors multiple
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alterations in a subtype, e.g., erbb2 in MSS training samples which shows a trend of soft
exclusivity between mutations and amplifications. We used both AIC and BIC scores
to regularize inference after 100 non-parametric bootstrap iterations for estimation of
the preliminary selective advantage relations. Statistical significance was determined in
terms of p-values using the Mann-Whitney U test for CAPRI’s inequalities. In most
cases these are orders of magnitude below significance threshold - exact values reported
as Additional File CRC-pvalues.xslx. CAPRI’s models with such p-values and non-
parametric bootstrap confidence are shown in Figures §E.5 and §E.6.
E.2 Single-cell synthetic data
We sampled single-cell data from the clonal phylogeny tree (see Chapter §6). Such a
tree reports the presence of the following clones in patient RMH004:
clone signature
c1 vhl frame-shift
c2 vhl frame-shift, smarca4 SNV
c3 vhl frame-shift, arid1a SNV
c4 vhl, pten frame-shift
c5 vhl, pten frame-shift, atm SNV
c6 vhl, pten frame-shift, atm SNV, 6q deletion
c7 vhl, pten frame-shift, atm SNV, msh6 stop codon
c8 vhl, pten frame-shift, atm SNV, 2q amplification
where when there are multiple undistinguishable alterations we report the first ap-
pearing in the plot, from left to right. Single-cell sampling consists in sampling any
of these clones, where a clone-sampling probability is a function of the probability to
sample each of its constituting alterations. The probabilities of sampling any of the con-
sidered alterations is given by the shown in Chapter §6, where marginal and conditional
probabilities are estimated by the observed frequencies in the input data.
So, for instance, the probability of sampling clone c4 is
p(c4) =p(vhl:fs) sample the trunk event
× p(pten:fs) and its downstream event,
×
(
1− p(arid1a:SNV)
)
do not sample private events of c2,
×
(
1− p(smarca4:SNV)
)
do not sample private events of c3,
×
(
1− p(atm:SNV)
)
do not sample private events of c5. (E.1)
where ‘fs’ is a short-hand for frame-shift. In this way, we can easily transform a clone
sample in a binary signature which can be inputed to CAPRESE’s reconstruction, being
a 0/1 Bernoulli model. So, for instance a sample of clone c4 will be the binary vector:
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vhl smarca4 arid1a pten atm 6q msh6 2q
1 0 0 1 0 0 0 0
To make the problem more realistic, we included a noise parameter which is the
probability to assign a random value to any entry of such vector, regardless its actual
value. This aims at mimicing the problem of missing coverage for variant calling or
other artefacts such as error in measurements. In Chapter §6, we sampled datasets with
number of cells n spanning from 5 to 200 (with discretization at different densities),
with noise ranging from 0 to 20% (i.e., probability .2, discretization .05). For each of
these settings we generate 100 independent datasets, and average the performance. In
Figure §E.7, we show further results with n ≤ 1000 - to report method’s convergency
for increased sample size. The performance of CAPRESE was measure as precision
and recall, computed as standard, and Hamming distance, which provides a standard
approach to measure similarity between the phylogeny tree reconstructed by running the
algorithm on a single dataset, and the tree shown in Chapter §6.
E.3 Supplementary tables and figures
Training dataset
statistics alteration type
cancer† n m |G| mutations amplifications deletions
MSI-HIGH 27 16100 13798 11556 2888 1656
MSS 152 21317 16371 12417 6925 1975
† Samples were classified as MSI-HIGH/LOW and MSS by TCGA; see
flag MSI status in clinical data available for the COADREAD project.
Validation dataset
statistics alteration type
cancer† n m |G| mutations amplifications deletions
MSI-HIGH 36 16891 15779 15071 199 1621
MSS 202 24957 18158 14567 5846 4544
† Samples were classified as MSI-HIGH if they had more than 500
mutations, as MSS otherwise; see Figure §E.2.
Table E.1: COADREAD Datasets. Data used in this study, derived from the TCGA
COADREAD project [137].
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MUTEX parameters
Parameter Value Description
signalling-network - MUTEX network†
max-group-size 5 maximum size of a result group
first-level-random-iteration 10000 number of randomisation to estimate null distri-
bution of member p-values in groups
second-level-random-iteration 100 number of runs to estimate the null distribution
of final scores
fdr-cutoff - false-discovery-rate cutoff maximising the ex-
pected value of true positives - false positives is
estimated from data
search-on-signaling-network TRUE reduce the search space using the signalling net-
work
† Manually curated from Pathway Commons, SPIKE and SignaLink databases. Provided with the tool;
available for download at https://code.google.com/p/mutex/.
MUTEX groups with score < .2
MSI-HIGH Groups score q-value
1 kras, braf, 0.095 0.48
2 nras, braf, tgfbr1 0.1677 0.45
3 erbb2, tp53, acvr1b, acvr2a 0.1703 0.355
MSS Groups score q-value
1 tp53, atm, 0.051 0.34
2 arid1a, tp53 0.075 0.193
3 kras, nras, braf, 0.0864 0.1975
4 ctnnb1, apc, dkk2, 0.098 0.144
5 dkk1, tp53, atm, dkk2 0.1387 0.176
6 pik3ca, tp53, atm 0.164 0.207
Table E.2: MUTEX: parameters and results. Top: Parameters used to run MUTEX
on the training MSS/MSI-HIGH datasets with input CNA and somatic mutations in
the pathway genes described in Text. Bottom: MUTEX identified 3 and 6 groups of
alterations showing a trend of mutual exclusivity in these groups with score below the
suggested cutoff of 0.2.
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Figure E.1: CRC pipeline processing MSI/MSS tumors. we process Microsatellite
Stable and highly Instable tumors collected from the The Cancer Genome Atlas project
“Human Colon and Rectal Cancer”. We implement a test/training study on selected
somatic mutations and focal CNAs in 33 driver genes manually annotated to 5 pathways
in the project. We scan groups of exclusive alterations with computational tools and
from the project results, and we select which alterations we input to CAPRI. Then,
inference is performed with various settings of regularization and confidence.
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Figure E.2: MSI/MSS samples in the test dataset. Mutation rate per sample, r,
in data collected for testing (which do not have clinical annotation from TCGA COAD-
READ project). To distinguish between tumors with MSS/MSI-HIGH status we set an
empirical cutoff of 500 mutations to define two groups of 203 (r ≤ 500) and 36 (r > 500)
samples respectively.
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Exclusivity groups for MSS tumors
event
59% TP537% ARID1A1% TP53
stage
47% KRAS9% NRAS4% BRAF1% NRAS1% BRAF1% KRAS
stage
78% APC7% CTNNB11% DKK21% APC
stage
59% TP5310% ATM1% DKK21% DKK11% ATM1% TP53
stage
59% TP5315% PIK3CA10% ATM1% ATM1% TP53
stage
stage
Stage I
Stage IIA
Stage IIIA
Stage IIIB
Stage IIIC
Stage IV
NA
pathway
none
Deletion
Amplification
Mutation
Knowledge-based priors: WNT exclusivity
78%APC
7%CTNNB1
1%APC
stage
47%KRAS
9%NRAS
4%BRAF
1%NRAS
1%BRAF
1%KRAS
stage
Knowledge-based priors: RAF exclusivity
15% PIK3CA
5% ERBB2
5% ERBB2
3% PTEN
3% PTEN
3% IGF2
stage
Computational priors: MEMO group
59% TP5310% ATM1% ATM1% TP53
stage
Computational priors: Mutex groups with score < 0.2
RAS
Wnt
TGFb
P53
PI3K
Figure E.3: Groups of exclusive alterations for MSS tumors. Knowledge-based
groups of exclusive alterations consist of: kras, nras and braf genes (raf pathway)
and apc and ctnnb1 genes (wnt pathway). The MEMO[28] group identified in [137]
in this cohort consists of genes pik3ca, erbb2, igf2 and pten. Finally, 6 groups are
predicted by MUTEX [8] with score below .2, one of these is equivalent to the known
exclusive alterations in raf pathway.
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Figure E.4: Selected data for MSS tumors. Colorectal tumors with Microsatellite
Stable clinical status in the TCGA COADREAD project, restricted to 152 samples
with both somatic mutations and CNA data available. 33 driver genes annotated to 5
pathways are selected as of the list published in [137] to automatically detect groups
of mutually exclusive alterations. Events selected for reconstruction are those involving
genes altered in at least 5% of the cases, or part of group of alterations showing an
exclusivity trend (see Figure §E.3). This dataset is used to infer the set of selective
advantage relations which constitute the MSS progression model presented in Chapter
§6.
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Figure E.7: Single-cell synthetic data: performance. Reconstruction performance
with CAPRESE and n ≤ 1000 as sample size. Precision and recall are reported as well as
Hamming Distance between the phylogeny tree which generated the data (see Chapter
§6) and the inferred by the algorithm.
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APPENDIX F
THE CAUSAL STRUCTURE OF DISCRIMINATION
Discrimination discovery from data is an important task aiming at identifying pat-
terns of illegal and unethical discriminatory activities against protected-by-law groups,
e.g., ethnic minorities. While any legally-valid proof of discrimination requires evidence
of causality, the state-of-the-art methods are essentially correlation-based, albeit, as it
is well known, correlation does not imply causation.
In this Chapter we present how the framework proposed in this thesis can be also
adopted to tackle the data mining problem of discrimination detection in databases.
Following Suppes’ probabilistic causation theory, we define a method to extract, from a
dataset of historical decision records, the causal structures existing among the attributes
in the data. The result is a type of constrained Bayesian network, which we dub Suppes-
Bayes Causal Network (SBCN). Next, we develop a toolkit of methods based on random
walks on top of the SBCN, addressing different anti-discrimination legal concepts, such as
direct and indirect discrimination, group and individual discrimination, genuine require-
ment, and favoritism. Finally experiments on real-world datasets confirm the inferential
power of this approach in all these different tasks. As a reference for this work, see [17].
F.1 Introduction
The importance of discrimination discovery. At the beginning of 2014, as an
answer to the growing concerns about the role played by data mining algorithms in
decision-making, USA President Obama called for a 90-day review of big data collecting
and analysing practices. The resulting report1 concluded that “big data technologies can
cause societal harms beyond damages to privacy”. In particular, it expressed concerns
about the possibility that decisions informed by big data could have discriminatory
1http://www.whitehouse.gov/sites/default/files/docs/big_data_privacy_report_may_1_
2014.pdf
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effects, even in the absence of discriminatory intent, further imposing less favorable
treatment to already disadvantaged groups.
Discrimination refers to an unjustified distinction of individuals based on their mem-
bership, or perceived membership, in a certain group or category. Human rights laws
prohibit discrimination on several grounds, such as gender, age, marital status, sexual
orientation, race, religion or belief, membership in a national minority, disability or ill-
ness. Anti-discrimination authorities (such as equality enforcement bodies, regulation
boards, consumer advisory councils) monitor, provide advice, and report on discrimi-
nation compliances based on investigations and inquiries. A fundamental role in this
context is played by discrimination discovery in databases, i.e., the data mining problem
of unveiling discriminatory practices by analyzing a dataset of historical decision records.
Discrimination is causal. According to current legislation, discrimination occurs
when a group is treated “less favorably” [107] than others, or when “a higher propor-
tion of people not in the group is able to comply” with a qualifying criterion [109].
Although these definitions do not directly imply causation, as stated in [56] all dis-
crimination claims require plaintiffs to demonstrate a causal connection between the
challenged outcome and a protected status characteristic. In other words, in order to
prove discrimination, authorities must answer the counterfactual question: what would
have happened to a member of a specific group (e.g., nonwhite), if he or she had been
part of another group (e.g., white)?
“The Sneetches”, the popular satiric tale2 against discrimination published in 1961
by Dr. Seuss, describes a society of yellow creatures divided in two races: the ones with
a green star on their bellies, and the ones without. The Star-Belly Sneetches have some
privileges that are instead denied to Plain-Belly Sneetches. There are, however, Star-On
and Star-Off machines that can make a Plain-Belly into a Star-Belly, and viceversa.
Thanks to these machines, the causal relationship between race and privileges can be
clearly measured, because stars can be placed on or removed from any belly, and multiple
outcomes can be observed for an individual. Therefore, one could readily answer the
counterfactual question, saying with certainty what would have happened to a Plain-
Belly Sneetch had he or she been a Star-Belly Sneetch.
In the real world however, proving discrimination episodes is much harder, as one
cannot manipulate race, gender, or sexual orientation of an individual. This highlights
the need to assess discrimination as a causal inference problem [32] from a database of
past decisions, where causality can be inferred probabilistically. Unfortunately, the state
of the art of data mining methods for discrimination discovery in databases does not
properly address the causal question, as it is mainly based on correlation-based methods
(surveyed in Section §F.2).
Correlation is not causation. It is well known that correlation between two variables
does not necessarily imply that one causes the other. Consider a unique cause X of two
effects, Y and Z: if we do not take in account X, we might derive wrong conclusions
because of the observable correlation between Y and Z. In this situation, X is said to
2http://en.wikipedia.org/wiki/The_Sneetches_and_Other_Stories
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act as a confounding factor for the relationship between Y and Z.
Variants of the complex relation just discussed can arise even if, in the example, X
is not the actual cause of either Y or Z, but it is only correlated to them, for instance,
because of how the data were collected. Consider for instance a credit dataset where
there exists high correlation between a variable representing low income and an other
variable representing loan denial and let us assume that this is due to an actual legitimate
causal relationship in the sense that, legitimately, a loan is denied if the applicant has low
income. Let us now assume that high correlation between low income and being female
is also observed, which, for instance, can be due to the fact that the women represented
in the specific dataset in analysis, tend to be underpaid. Given these settings, in the
data we would also observe high correlation between the variable gender being female
and the variable representing loan denial, due to the fact that we do not account for the
presence of the variable low income. Following common terminologies, we will say that
such situations are due to spurious correlations.
However, the picture is even more complicated: it could be the case, in fact, that
being female is the actual cause of the low income and, hence, be the indirect cause of
loan denial through low income. This would represent a causal relationship between the
gender and the loan denial, that we would like to detect as discrimination.
Disentangling these two different cases, i.e., female is only correlated to low income
in a spurious way, or being female is the actual cause of low income, is at the same time
important and challenging. This highlights the need for a principled causal approach to
discrimination detection.
Another typical pitfall of correlation-based reasoning is expressed by what is known as
Simpson’s paradox3 according to which, correlations observed in different groups might
disappear when these heterogeneous groups are aggregated, leading to false positives
cases of discrimination discovery. One of the most famous false-positive examples due to
Simpson’s paradox occurred when in 1973 the University of California, Berkeley was sued
for discrimination against women who had applied for admission to graduate schools.
In fact, by looking at the admissions of 1973, it first appeared that men applying were
significantly more likely to be admitted than women. But later, by examining the
individual departments carefully, it was discovered that none of them was significantly
discriminating against women. On the contrary, most departments had exercised a small
bias in favor of women. The apparent discrimination was due to the fact that women
tended to apply to departments with lower rates of admission, while men tended to apply
to departments with higher rates [16]. Later in Section §F.5.5 we will use the dataset
from this episode to highlight the differences between correlation-based and causation-
based methods.
Spurious correlations can also lead to false negatives (i.e., discrimination existing but
not being detected) as is commonly seen in “reverse-discrimination”. The typical case
is when authorities take affirmative actions, e.g., with compensatory quota systems, in
order to protect a minority group from a potential discrimination. Such actions, while
trying to erase the supposed discrimination (i.e., the spurious correlation), fail to address
3http://en.wikipedia.org/wiki/Simpson’s_paradox
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the real underlying causes for discrimination, potentially ending up denying individual
members of a privileged group from access to their rightful shares of social goods. In
the early 70’s, a case involving the University of California at Davis Medical School
highlighted one such incident as the school’s admissions program reserved 16 of the 100
places in its entering class for “disadvantaged” applicants, thus unintentionally reducing
the chances of admission for a qualified applicant.4
These are just few typical examples of the pitfalls of correlation-based reasoning in
the discovery of discrimination. Later in Section §F.5.5 we show concrete examples from
real-world datasets where correlation-based methods to discrimination discovery are not
satisfactory.
The proposal and contributions. In this Chapter we take a principled causal ap-
proach to the data mining problem of discrimination detection in databases. Following
Suppes’ probabilistic causation theory [80, 172] we define a method to extract, from a
dataset of historical decision records, the causal structures existing among the attributes
in the data.
In particular, we define the Suppes-Bayes Causal Network (SBCN), i.e., a directed
acyclic graph (dag) where we have a node representing a Bernulli variable of the type
〈attribute = value〉 for each pair attribute-value present in the database. In this dag an
arc (A,B) represents the existence of a causal relation between A and B (i.e., A causes
B). Moreover, each arc is labeled with a score, representing the strength of the causal
relation.
The SBCN is a constrained Bayesian network reconstructed by means of maximum
likelihood estimation (MLE) from the given database, where we force the conditional
probability distributions induced by the reconstructed graph to obey Suppes’ constraints:
i.e., temporal priority and probability rising. Imposing Suppes’ temporal priority and
probability raising we obtain what we call the prima facie causes graph [172], which
might still contain spurious causes (false positives). In order to remove these spurious
case we add a bias term to the likelihood score, favoring sparser causal networks: in
practice we sparsify the prima facie causes graph by extracting a minimal set of edges
which best explain the data. This regularization is done by means of the Bayesian
Information Criterion (BIC) [167].
The obtained SBCN provides a clear summary, amenable to visualization, of the
probabilistic causal structures found in the data. Such structures can be used to reason
about different types of discrimination. In particular, we show how using several random-
walk-based methods, where the next step in the walk is chosen proportionally to the edge
weights, we can address different anti-discrimination legal concepts. The experiments
show that the measures of discrimination produced by the methods are very strong,
almost binary, signals: the measures are very clearly separating the discrimination and
the non-discrimination cases.
To the best of our knowledge this is the first proposal of discrimination detection in
databases grounded in probabilistic causal theory.
4http://en.wikipedia.org/wiki/Regents_of_the_University_of_California_v._Bakke
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Roadmap. The rest of the Chapter is organized as follows. Section §F.2 discusses the
state of the art in discrimination detection in databases. In Section §F.3 we formally
introduce the SBCN and we present the method for extracting such causal network
from the input dataset. Once extracted the SBCN, in Section §F.4 we show how to
exploit it for different concepts of discrimination detection, by means of random-walk
methods. Finally Section §F.5 presents the experimental assessment and comparison
with correlation-based methods on two real-world datasets.
F.2 Related work
Discrimination analysis is a multi-disciplinary problem, involving sociological causes,
legal reasoning, economic models, statistical techniques [31, 162]. Some authors [73, 94]
study how to prevent data mining from becoming itself a source of discrimination. In
this Chapter instead we focus on the data mining problem of detecting discrimination
in a dataset of historical decision records, and in the rest of this section we present the
most related literature.
Pedreschi et al. [153, 180, 165] propose a technique based on extracting classification
rules (inductive part) and ranking the rules according to some legally grounded measures
of discrimination (deductive part). The result is a (possibly large) set of classification
rules, providing local and overlapping niches of possible discrimination. This model only
deals with group discrimination.
Luong et al. [120] exploit the idea of situation-testing [163] to detect individual dis-
crimination. For each member of the protected group with a negative decision outcome,
testers with similar characteristics (k-nearest neighbors) are considered. If there are sig-
nificantly different decision outcomes between the testers of the protected group and the
testers of the unprotected group, the negative decision can be ascribed to discrimination.
Zliobaite et al. [200] focus on the concept of genuine requirement to detect that part
of discrimination which may be explained by other, legally grounded, attributes. In [41]
Dwork et al. address the problem of fair classification that achieves both group fairness,
i.e., the proportion of members in a protected group receiving positive classification is
identical to the proportion in the population as a whole, and individual fairness, i.e.,
similar individuals should be treated similarly.
The above approaches assume that the dataset under analysis contains attributes
that denote protected groups (i.e., direct discrimination). This may not be the case
when such attributes are not available, or not even collectable at a micro-data level as in
the case of the loan applicant’s race. In these cases we talk about indirect discrimination
discovery. Ruggieri et al. [152] adopt a form of rule inference to cope with the indirect
discovery of discrimination. The correlation information is called background knowledge,
and is itself coded as an association rule.
Mancuhan and Clifton [123] propose Bayesian networks as a tool for discrimina-
tion discovery. Bayesian networks consider the dependence between all the attributes
and use these dependencies in estimating the joint probability distribution without any
strong assumption, since a Bayesian network graphically represents a factorization of the
187
188 APPENDIX F. THE CAUSAL STRUCTURE OF DISCRIMINATION
joint distribution in terms of conditional probabilities encoded in the edges. Although
Bayesian networks are often used to represent causal relationships, this needs not be the
case, in fact a directed edge from two nodes of the network does not imply any causal
relation between them. As an example, let us observe that the two graphs A→ B → C
and C → B → A impose exactly the same conditional independence requirements and,
hence, any Bayesian network would not be able to disentangle the direction of any causal
relationship among these events.
The work departs from this literature as (i) it is grounded in probabilistic causal the-
ory instead of being based on correlation, (ii) it proposes a holistic approach able to deal
with different types of discrimination in a single unifying framework, while the methods
in the state of the art usually deal with one and only one specific type of discrimination.
This is also the first work to adopt graph theory and social network analysis concepts,
such as random-walk-based centrality measures and community detection, for discrimi-
nation detection. The proposed methods also have low computational cost compared to
the existing approaches in the literature.
F.3 Suppes-Bayes Causal Network
In order to study discrimination as a causal inference problem, we exploit the criteria
defined in the theories of probabilistic causation [80]. In particular, we follow [172], where
Suppes proposed the notion of prima facie causation that is at the core of probabilistic
causation. Suppes’ definition is based on two pillars: (i) any cause must happen before
its effect (temporal priority) and (ii) it must raise the probability of observing the effect
(probability raising).
In the rest of this Section we introduce the method to construct, from a given rela-
tional table D, a type of causal Bayesian network constrained to satisfy the conditions
dictated by Suppes’ theory, which we dub Suppes-Bayes Causal Network (SBCN).
In the literature many algorithms exist to carry out structural learning of general
Bayesian networks and they usually fall into two families [101]. The first family, con-
straint based learning, explicitly tests for pairwise independence of variables conditioned
on the power set of the rest of the variables in the network. These algorithms exploit
structural conditions defined in various approaches to causality [80, 127, 192]. The sec-
ond family, score based learning, constructs a network which maximizes the likelihood
of the observed data with some regularization constraints to avoid overfitting. Several
hybrid approaches have also been recently proposed [19].
The framework can be considered a hybrid approach exploiting constrained maximum
likelihood estimation (MLE) as follows: (i) we first define all the possible causal relation-
ship among the variables in D by considering only the oriented edges between events that
are consistent with Suppes’ notion of probabilistic causation and, subsequently, (ii) we
perform the reconstruction of the SBCN by a score-based approach (using BIC), which
considers only the valid edges.
The idea of adopting Suppes’ theory to reconstruct the causal structure subsumed
by a progression model is the main contribution of this thesis and, as already deeply
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discussed, it was introduced for the first time in [117, 158], albeit in a completely different
context, i.e., modelling somatic evolution in cancer.
We next present in details the whole learning process.
F.3.1 Suppes’ constraints
We start with an input relational table D defined over a set A of h categorical attributes
and s samples. In case continuous numerical attributes exists in D, we assume they have
been discretized to become categorical. From D, we derive D′, an m× s binary matrix
representing m Bernoulli variables of the type 〈attribute = value〉, where an entry is 1
if we have an observation for the specific variable and 0 otherwise.
Temporal priority. The first constraint, temporal priority, cannot be simply checked
in the data as we have no timing information for the events. In particular, in this context
the events for which we want to reason about temporal priority are the Bernoulli variables
〈attribute = value〉.
The idea here is that, e.g., income = low cannot be a cause of gender = female,
because the time when the gender of an individual is determined is antecedent to that
of when the income is determined. This intuition is implemented by simply letting the
data analyst provide as input to the framework a partial temporal order r : A → N
for the h attributes, which is then inherited from the m Bernoulli variables. Note that
the learning technique requires the input order r to be correct and complete in order
to guarantee its convergence. Nevertheless, if this is not the case, it is still capable
of providing valuable insights about the underlying causal model, although with the
possibility of false positive or false negative causal claims.
Based on the input dataset D and the partial order r we produce the first graph
G = (V,E) where we have a node for each of the Bernoulli variables, so |V | = m, and
we have an arc (u, v) ∈ E whenever r(u) ≤ r(v). This way we will immediately rule out
causal relations that do not satisfy the temporal priority constraint.
Probability raising. Given the graph G = (V,E) built as described above the next
step requires to prune the arcs which do not satisfy the second constraint, probability
raising, thus building G′ = (V,E′), where E′ ⊆ E. In particular we remove from E each
arc (u, v) such that P(v | u) ≤ P(v | ¬u). The graph G′ so obtained is called prima facie
graph.
As previously proved in [117], we recall that the probability raising condition is
equivalent to constraining for positive statistical dependence: in the prima facie graph
we model all and only the positive correlated relations among the nodes already partially
ordered by temporal priority, consistently with Suppes’ characterization of causality in
terms of relevance.
F.3.2 Network simplification
As proved in [158], Suppes’ conditions are necessary but not sufficient to evaluate cau-
sation: especially when the sample size is small, the model may have false positives
(spurious causes), even after constraining for Suppes’ temporal priority and probability
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Figure F.1: One portion of the SBCN extracted from the Adult dataset. This subgraph
corresponds to the C2 community reported later in Table §F.3 (Section §F.5) extracted
by a community detection algorithm.
raising criteria (which aim at removing false negatives). Consequently, although we ex-
pect all the statistically relevant causal relations to be modelled in G′, we also expect
some spurious ones in it.
In this proposal, in place of other structural conditions used in various approaches to
causality, (see e.g., [80, 127, 192]), we perform a network simplification (i.e., we sparsify
the network by removing arcs) with a score based approach, specifically by relying on
the Bayesian Information Criterion (BIC) as the regularized likelihood score [167].
We consider as inputs for this score the graph G′ and the dataset D′. Given these,
we select the set of arcs E∗ ⊆ E′ that maximizes the score:
scoreBIC(D′, G′) = LL(D′|G′)− log s
2
dim(G′).
In the equation, G′ denotes the graph, D′ denotes the data, s denotes the number of
samples, and dim(G′) denotes the number of parameters in G′. Thus, the regulariza-
tion term −dim(G′) favors graphs with fewer arcs. The coefficient log s/2 weighs the
regularization term, such that the higher the weight, the more sparsity will be favored
over “explaining” the data through maximum likelihood. Note that the likelihood is
implicitly weighted by the number of data points, since each point contributes to the
score.
Assume that there is one true (but unknown) probability distribution that generates
the observed data, which is, eventually, uniformly randomly corrupted by false positives
and negatives rates (in [0, 1)). Let us call correct model, the statistical model which
best approximate this distribution. The use of BIC on G′ results in removing the false
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positives and, asymptotically (as the sample size increases), converges to the correct
model. In particular, BIC is attempting to select the candidate model corresponding to
the highest Bayesian Posterior probability, which can be proved to be equivalent to the
presented score and its log(s) penalization factor.
We denote with G∗ = (V,E∗) the graph that we obtain after this step. We note that,
as for general Bayesian network, G∗ is a dag by construction.
F.3.3 Confidence score
Using the reconstructed SBCN, we can represent the probabilistic relationships between
any set of events (nodes). As an example, suppose to consider the nodes representing
respectively income = low and gender = female being the only two direct causes
(i.e., with arcs toward) of loan = denial. Given SBCN, we can estimate the conditional
probabilities for each node in the graph, i.e., probability of loan = denial given income =
low AND gender = female in the example, by computing the conditional probability
of only the pair of nodes directly connected by an arc. For an overview of state-of-
the-art methods for doing this, see [101]. However, we expect to be mostly dealing
with full data, i.e., for every directly connected node in the SBCN, we expect to have
several observations of any possible combination attribute = value. For this reason, we
can simply estimate the node probabilities by counting the observations in the data.
Moreover, we will exploit such conditional probabilities to define the confidence score of
each arc in terms of their causal relationship.
In particular, for each arc (v, u) ∈ E∗ involving the causal relationship between two
nodes u, v ∈ V , we define a confidence score W (v, u) = P(u | v) − P(u | ¬v), which,
intuitively, aims at estimating the observations where the cause v is followed by its effect
u, that is P(u | v), and the ones where this is not observed, i.e., P(u | ¬v), because of
imperfect causal regularities. We also note that, by the constraints discussed above, we
require P(u | v)  P(u | ¬v) and, for this reason, each weight is positive and no larger
than 1, i.e., W : E∗ → (0, 1].
Combining all of the concepts discussed above, we conclude with the following defi-
nition.
Definition 9 (Suppes-Bayes Causal Network). Given an input dataset D′ of m Bernoulli
variables and s samples, and given a partial order r of the variables, the Suppes-Bayes
Causal Network SBCN = (V,E∗,W ) subsumed by D′ is a weighted dag such that the
following requirements hold:
• [Suppes’ constraints] for each arc (v, u) ∈ E∗ involving the causal relationship
between nodes u, v ∈ V , under the mild assumptions that 0 < P(u),P(v) < 1:
r(v) ≤ r(u) and P(u | v) > P(u | ¬v) .
• [Simplification] let E′ be the set of arcs satisfying the Suppes’ constraints as
before; among all the subsets of E′, the set of arcs E∗ is the one whose corresponding
graph maximizes BIC:
E∗ = arg max
E⊆E′,G=(V,E)
(LL(D′, |G)− log s
2
dim(G)) .
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• [Score] W (v, u) = P(u | v)− P(u | ¬v), ∀(v, u) ∈ E∗
An example of a portion of a SBCN extracted from a real-world dataset is reported in
Figure §F.1. Algorithm §7 summarized the learning approach adopted for the inference
of the SBCN .
Algorithm 7: Learning the Suppes-Bayes Causal Network
1: Inputs: D′ an input dataset of m Bernoulli variables and s samples,
and r a partial order of the variables
2: Output: SBCN(V,E∗,W ) as in Definition 2
3: [Suppes’ constraints]
4: for all the arcs (v, u) between each pair of the m Bernoulli variables do
5: if r(v) ≤ r(u) and P(u | v) > P(u | ¬v) then
6: Set to the arc (v, u) its weight, being W (v, u) = P(u | v)− P(u | ¬v).
7: Add the arc (v, u) to SBCN .
8: end if
9: end for
10: [Simplification]
11: Consider G(V,E∗,W )fit = ∅.
12: while !StoppingCriterion() do
13: Let G(V,E∗,W )neighbors be the neighbor solutions of G(V,E∗,W )fit.
14: Remove from G(V,E∗,W )neighbors any solution whose arcs are
not included in SBCN .
15: Consider a random solution Gcurrent in G(V,E
∗,W )neighbors.
16: if scoreBIC(D′, Gcurrent) > scoreBIC(D′, Gfit) then
17: Gfit = Gcurrent.
18: Assign to the arcs of Gfit the related weights of SBCN .
19: end if
20: end while
21: SBCN = Gfit.
22: return SBCN .
Given D′ an input dataset over m Bernoulli variables and s samples, and r a partial
order of the variables, Suppes’ constraints are verified (Lines 4-9) to construct a dag
as described in Section §F.3.1. The likelihood fit is performed by hill climbing (Lines
12-21), an iterative optimization technique that starts with an arbitrary solution to
a problem (in this case an empty graph) and then attempts to find a better solution
by incrementally visiting the neighbourhood of the current one. If the new candidate
solution is better than the previous one it is considered in place of it. The procedure is
repeated until the stopping criterion is matched. The !StoppingCriterion occurs (Line
12) in two situations: (i) the procedure stops when we have performed a large enough
number of iterations or, (ii) it stops when none of the solutions in Gneighbors is better
than the current Gfit. Note that Gneighbors denotes all the solutions that are derivable
from Gfit by removing or adding at most one edge.
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Time and space complexity. The computation of the valid dag according to Suppes’
constraints (Lines 4-10) requires a pairwise calculation of the probabilistic scores leading
to a polynomial cost. After that, the likelihood fit by hill climbing (Lines 11-21) is
performed5. Hence, let m denotes the number of the Bernoulli variables and s the
number of records in D′, and l the maximum number of iterations required for the hill
climbing, the total computational complexity of Algorithm §7 is O(s ·m) in time and
m2 in space.
F.3.4 Expressivity of a SBCN
We conclude this Section with a discussion on the causal relations that we model by a
SBCN .
Let us assume that there is one true (but unknown) probability distribution that
generates the observed data whose structure can be modelled by a dag. Furthermore,
let us consider the causal structure of such a dag and let us also assume each node
with more then one cause to have conjunctive parents: any observation of the child node
is preceded by the occurrence of all its parents. As before we call correct model, the
statistical model which best approximate the distribution. On these settings, we can
prove the following theorem.
Theorem 1. Let the sample size s → ∞, the provided partial temporal order r be
correct and complete and the data be uniformly randomly corrupted by false positives
and negatives rates (in [0, 1)), then the SBCN inferred from the data is the correct
model.
Proof. [Sketch] Let us first consider the case where the observed data have no noise.
On such an input, we observe that the prima facie graph has no false negatives: in
fact ∀[c→ e] modelling a genuine causal relation, P(e ∧ c) = P(e), thus the probability
raising constraint is satisfied, so it is the temporal priority given that we assumed r to
be correct and complete.
Furthermore, it is know that the likelihood fit performed by BIC converges to a class
of structures equivalent in terms of likelihood among which there is the correct model:
all these topologies are the same unless the directionality of some edges. But, being the
prima facie graph already ordered by temporal priority, we can conclude that in this
case the SBCN coincides with the correct model.
To extend the proof to the case of data uniformly randomly corrupted by false pos-
itives and negatives rates (in [0, 1)), we note that the marginal and joint probabili-
ties change monotonically as a consequence of the assumption that the noise is uni-
form. Thus, all inequalities used in the preceding proof still hold, which concludes the
proof.
5Note that being an heuristic, the computational cost of hill climbing depends on the sopping criterion.
However, constraining by Suppes’ criteria tends to regularize the problem leading on average to a quick
convergence to a good solution.
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In the more general case of causal topologies where any cause of a common effect is
independent from any other cause (i.e., we relax the assumption of conjunctive parents),
the SBCN is not guaranteed to converge to the correct model but it coincides with
a subset of it modeling all the edges representing statistically relevant causal relations
(i.e., where the probability raising condition is verified).
F.4 Discrimination discovery by random walks
In this Section we propose several random-walk-based methods over the reconstructed
SBCN, to deal with different discrimination-detection tasks.
F.4.1 Group discrimination and favoritism
The basic problem in the analysis of direct discrimination is precisely to quantify the
degree of discrimination suffered by a given protected group (e.g., an ethnic group) with
respect to a decision (e.g., loan denial). In contrast to discrimination, favoritism refers to
the case of an individual treated better than others for reasons not related to individual
merit or business necessity: for instance, favoritism in the workplace might result in a
person being promoted faster than others unfairly. In the following we denote favoritism
as positive discrimination in contrast with negative discrimination.
Given an SBCN we define a measure of group discrimination (either negative or
positive) for each node v ∈ V . Recall that each node represents a pair 〈attribute =
value〉, so it is essentially what we refer to as a group, e.g., 〈gender = female〉. The
task is to assign a score of discrimination ds− : V → [0, 1] to each node, so that the
closer ds−(v) is to 1 the more discriminated is the group represented by v.
We compute this score by means of a number n of random walks that start from v
and reaches either the node representing the positive decision or the one representing
the negative decision. In these random walks the next step is chosen proportionally to
the weights of the out-going arcs. Suppose a random walk has reached a node u, and
let degout(u) denote the set of outgoing arcs from u. Then the arc (u, z) is chosen with
probability
p(u, z) =
W (u, z)∑
e∈degout(u)W (e)
.
When a random walk ends in a node with no outgoing arc before reaching either the
negative or the positive decision, it is restarted from the source node v.
Definition 10 (Group discrimination score). Given a SBCN = (V,E∗,W ), let δ− ∈ V
and δ+ ∈ V denote the nodes indicating the negative and positive decision, respectively.
Given a node v ∈ V , and a number n ∈ N of random walks to be performed, we denote
as rwv→δ− the number of random walks started at node v that reach δ− earlier than δ+.
The discrimination score for the group corresponding to node v is then defined as
ds−(v) =
rwv→δ−
n
.
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This implicitly also defines a score of positive discrimination (or favoritism): ds+(v) =
1− ds−(v).
Taking advantage of the SBCN we also propose two additional measures capturing
how far a node representing a group is from the positive and negative decision respec-
tively. This is done by computing the average number of steps that the random walks
take to reach the two decisions: we denote these scores as as−(v) and as+(v).
F.4.2 Indirect discrimination
The European Union Legislation [109] provides a broad definition of indirect discrimi-
nation as occurring “where an apparently neutral provision, criterion or practice would
put persons of a racial or ethnic origin at a particular disadvantage compared with other
persons”. In other words, the actual result of the apparently neutral provision is the
same as an explicitly discriminatory one. A typical legal case study of indirect discrim-
ination is concerned with redlining : e.g., denying a loan because of ZIP code, which in
some areas is an attribute highly correlated to race. Therefore, even if the attribute race
cannot be required at loan-application time (thus would not be present in the data), still
race discrimination is perpetrated. Indirect discrimination discovery refers to the data
mining task of discovering the attributes values that can act as a proxy to the protected
groups and lead to discriminatory decisions indirectly [153, 180, 73].
In the considered setting, indirect discrimination can be detected by applying the
same method described in Section §F.4.1.
F.4.3 Genuine requirement
The legal concept of genuine requirement refers to detecting that part of the discrim-
ination which may be explained by other, legally-grounded, attributes; e.g., denying
credit to women may be explainable by the fact that most of them have low salary or
delay in returning previous credits. A typical example in the literature is the one of the
“genuine occupational requirement”, also called “business necessity” in [108, 49]. In the
state of the art of data mining methods for discrimination discovery, it is also known as
explainable discrimination [74] and conditional discrimination [200].
The task here is to evaluate to which extent the discrimination apparent for a group
is “explainable” on a legal ground. Let v ∈ V be the node representing the group which
is suspected of being discriminated, and ul ∈ V be a node whose causal relation with
a negative or positive decision is legally grounded. As before, δ− and δ+ denote the
negative and positive decision, respectively. Following the same random-walk process
described in Section §F.4.1, we define the fraction of explainable discrimination for the
group v:
fed−(v) =
rwv→ul→δ−
rwv→δ−
,
i.e., the fraction of random walks passing trough ul among the ones started in v and
reaching δ− earlier than δ+. Similarly we define fed+(v), i.e., the fraction of explainable
positive discrimination.
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F.4.4 Individual and subgroup discrimination
Individual discrimination requires to measure the amount of discrimination for a spe-
cific individual, i.e., an entire record in the database. Similarly, subgroup discrimination
refers to discrimination against a subgroup described by a combination of multiple pro-
tected and non-protected attributes: personal data, demographics, social, economic and
cultural indicators, etc. For example, consider the case of gender discrimination in credit
approval: although an analyst may observe that no discrimination occurs in general, it
may turn out that older women obtain car loans only rarely.
Both problems can be handled by generalizing the technique introduced in Sec-
tion §F.4.1 to deal with a set of starting nodes, instead of only one. Given an SBCN =
(V,E∗,W ) let v1, . . . , vn be the nodes of interest. In order to define a discrimination
score for v1, . . . , vn, we perform a personalized PageRank [90] computation with respect
to v1, . . . , vn. In personalized PageRank, the probability of jumping to a node when
abandoning the random walk is not uniform, but it is given by a vector of probabili-
ties for each node. In this case the vector will have the value 1n for each of the nodes
v1, ..., vn ∈ V and zero for all the others. The output of personalized PageRank is a score
ppr(u|v1, ..., vn) of proximity/relevance to {v1, ..., vn} for each other node u in the net-
work. In particular, we are interested in the score of the nodes representing the negative
and positive decision: i.e., ppr(δ−|v1, ..., vn) and ppr(δ+|v1, ..., vn) respectively.
Definition 11 (Generalized discrimination score). Given an SBCN = (V,E∗,W ), let
δ− ∈ V and δ+ ∈ V denote the nodes indicating the negative and positive decision,
respectively. Given a set of nodes v1, ..., vn ∈ V , we define the generalized (negative)
discrimination score for the subgroup or the individual represented by {v1, ..., vn} as
gds−(v1, ..., vn) =
ppr(δ−|v1, ..., vn)
ppr(δ−|v1, ..., vn) + ppr(δ+|v1, ..., vn) .
This implicitly also defines a generalized score of positive discrimination: gds+(v1, ..., vn) =
1− gds−(v1, ..., vn).
F.5 Experimental Evaluation
This section reports the experimental evaluation of this approach on four datasets,
Adult, German credit and census-income from the UCI Repository of Machine Learning
Databases6, and Berkeley Admissions Data from [57]. These are well-known real-life
datasets typically used in discrimination-detection literature.
Adult: consists of 48,842 tuples and 10 attributes, where each tuple correspond to an
individual and it is described by personal attributes such as age, race, sex, relationship,
education, employment, etc. Following the literature, in order to define the decision
attribute we use the income levels, ≤50K (negative decision) or >50K (positive decision).
We use four levels in the partial order for temporal priority: age, race, sex, and native
6http://archive.ics.uci.edu/ml
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country are defined in the first level; education, marital status, and relationship are
defined in the second level; occupation and work class are defined in the third class, and
the decision attribute (derived from income) is the last level.
German credit: consists of 1000 tuples with 21 attributes on bank account holders
applying for credit. The decision attribute is based on repayment history, i.e., whether
the customer is labeled with good or bad credit risk. Also for this dataset the partial
order for temporal priority has four orders. Personal attributes such as gender, age,
foreign worker are defined in the first level. Personal attributes such as employment
status and job status are defined in the second level. Personal properties such as savings
status and credit history are defined in the third level, and finally the decision attribute
is the last level.
Census-income: consists of 299,285 tuples and 40 attributes, where each tuple corre-
spond to an individual and it is described by demographic and employment attributes
such as age, sex, relationship, education, employment, ext. Similar to Adult dataset, the
decision attribute is the income levels and we define four levels in the partial order for
temporal priority.
The main characteristics of the extracted SBCN are reported in Table §F.1, while
the distribution of the edges scores W (e) is plotted in Figure §F.2.
Dataset |V | |A| avgDeg maxInDeg maxOutDeg
Adult 92 230 2.5 7 19
German credit 73 102 1.39 3 7
Census-income 386 1426 3.69 8 54
Table F.1: SBCN main characteristics.
As discussed in the Introduction we also use the dataset from the famous 1973 episode
at University of California at Berkeley, in order to highlight the differences between
correlation-based and causation-based methods.
Berkeley Admissions Data: consists of 4,486 tuples and three attributes, where each
tuple correspond to an individual and it is described by the gender of applicants and the
department that they apply for it. For this dataset the partial order for temporal priority
has three orders. Gender is defined in the first level, department in the second level,
and finally the decision attribute is the last level. Table §F.2 is a three-way table that
presents admissions data at the University of California, Berkeley in 1973 according to
the variables department (A, B, C, D, E), gender (male, female), and outcome (admitted,
denied). The table is adapted from data in the text by Freedman, et al. [57].
F.5.1 Community detection on the SBCN
Given that the SBCN is a directed graph with edge weight, as a first characterization we
try to partition it using a random-walks-based community detection algorithm, called
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Figure F.2: Distribution of the edge scores.
Male Female
Admitted Denied Admitted Denied Department
512 313 89 19 A
313 207 17 8 B
120 205 202 391 C
138 279 131 244 D
53 138 94 299 E
22 351 24 317 F
Table F.2: Berkeley Admission Data
Walktrap and proposed in [155], whose unique parameter is the maximum number of
steps in a random walk (we set it to 8), and which automatically identifies the right
number of communities. The idea is that short random walks tend to stay in the same
community (densely connected area of the graph). Using this algorithm over the recon-
structed SBCN from Adult dataset, we obtain 5 communities: two larger ones and three
smaller ones (reported in Table §F.3). Interestingly, the two larger communities seem
built around the negative (C1) and the positive (C2) decisions.
Figure §F.1 in Section §F.3 shows the subgraph of the SBCN corresponding to C2
(that we can call, the favoritism cluster): we note that such cluster also contains nodes
such as sex Male, age old, relationship Husband. The other large community C1, can
be considered the discrimination cluster: beside the negative decision it contains other
nodes representing disadvantaged groups such as sex Female, age young, race Black, mar-
ital status Never married. This good separability of the SBCN in the two main clusters of
discrimination and favoritism, highlights the goodness of the causal structure captured
198
F.5. EXPERIMENTAL EVALUATION 199
by the SBCN.
C1
negative dec, wc:Private, ed:Some college, ed:Assoc acdm,
ms:Never married, ms:Divorced, ms:Widowed,
ms:Married AF spouse, oc:Sales, oc:Other service,
oc:Priv house serv, re:Own child, re:Not in family, re:Wife,
re:Unmarried, re:Other relative, ra:Black, oc:Armed Forces,
oc:Handlers cleaners, oc:Tech support, oc:Transport moving,
ed:7th 8th, ed:10th, ed:12th, ms:Separated,
ed:HS grad,ed:11th, nc:Outlying US Guam USVI etc,
nc:Haiti, ag:young, sx:Female, ra:Amer Indian Eskimo,
nc:Trinadad Tobago, nc:Jamaica, oc:Machine op inspct,
ms:Married spouse absent, oc:Adm clerical,
C2
positive dec, oc:Prof specialty, wc:Self emp not inc,
ms:Married civ spouse, oc:Craft repair,oc:Protective serv,
re:Husband, ed:Prof school, wc:Self emp inc,
ag:old , wc:Local gov, oc:Exec managerial,
ed:Bachelors, ed:Assoc voc, ed:Masters, wc:Never worked,
wc:State gov, ed:Doctorate, sx:Male, nc:India, nc:Cuba
C3
oc:Farming fishing, wc:Without pay, nc:Mexico, nc:Canada,
nc:Italy, nc:Guatemala, nc:El Salvador, ra:White,
nc:Poland, ed:1st 4th, ed:9th,ed:Preschool, ed:5th 6th
C4
nc:Iran, nc:Puerto Rico, nc:Dominican Republic,
nc:Columbia, nc:Peru, nc:Nicaragua, ra:Other
C5
nc:Philippines, nc:Cambodia, nc:China, nc:South,
nc:Japan, nc:Taiwan, nc:Hong, nc:Laos, nc:Thailand,
nc:Vietnam, ra:Asian Pac Islander
Table F.3: Communities found in the SBCN extracted from the Adult dataset by Walk-
trap[155]. In the table the attributes are shortened as in parenthesis: age (ag), education
(ed), marital status (ms), native country (nc), occupation (oc), race(ra), relationship
(re), sex (sx), workclass (wc).
F.5.2 Group discrimination and favoritism
We next focus on assessing the discrimination score ds− we defined in Section §F.4.1, as
well as the average number of steps that the random walks take to reach the negative
and positive decisions, denote as−(v) and as+(v) respectively.
Tables §F.4, §F.5 and §F.6 report the top-5 and bottom-5 nodes w.r.t. the discrimi-
nation score ds−, for datasets Adult, German and Census-income, respectively. The first
and most important observation is that this discrimination score provides a very clear
signal, with some disadvantaged groups having very high discrimination score (equal to
1 or very close), and similarly clear signals of favoritism, with groups having ds−(v) = 0,
or equivalently ds+(v) = 1. This is more clear in the Adult dataset, where the positive
and negative decisions are artificially derived from the income attribute. In the German
credit dataset, which is more realistic as the decision attribute is truly about credit,
both discrimination and favoritism are less palpable. This is also due to the fact that
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German credit contains less proper causal relations, as reflected in the higher sparsity
of the SBCN. A consequence of this sparsity is also that the random walks generally
need more steps to reach one of the two decisions. In Census-income dataset, we observe
favoritism with respect to married and asian pacific individuals.
F.5.3 Genuine requirement
We next focus on genuine requirement (or explainable discrimination). Table §F.7 re-
ports some examples of fraction of explainable discrimination (both positive and neg-
ative) on the Adult dataset. We can see how some fractions of discrimination against
protected groups, can be “explained” by intermediate nodes such as having a low educa-
tion profile, or a simple job. In the case these intermediate nodes are considered legally
grounded, then one cannot easily file a discrimination claim.
Similarly, one can observe that the favoritism towards groups such as married man,
is not just simple favoritism but it is explainable, to a large extent, by higher education
and good working position, such as managerial or executive roles.
F.5.4 Subgroup and Individual Discrimination
We next turn the attention to subgroup and individual discrimination discovery. Here
the problem is to assign a score of discrimination not to a single node (a group), but to
multiple nodes (representing the attributes of an individual or a subgroup of citizens). In
Section §F.4.4 we have introduced based on the PageRank of the positive and negative
decision, ppr(δ+) and ppr(δ−) respectively, personalized on the nodes of interest. Figure
§F.3 presents a scatter plot of ppr(δ+) versus ppr(δ−) for each individual in the German
credit dataset. One can observe the perfect separation between individuals correspond-
ing to a high personalized PageRank with respect to the positive decision, and those
associated with a high personalized PageRank relative to the negative decision.
Such good separation is also reflected in the generalized discrimination score (Defi-
nition 4) that we obtain by combining ppr(δ+) versus ppr(δ−).
In Figure §F.4 we report the distribution of the generalized discrimination score
gds− for the population of the German credit dataset: one can make a note of the clear
separation between the two subgroups of the population.
In the Adult dataset (Figure §F.5) we do not observe the same neat separation in
two subgroups as in the German credit dataset, also due to the much larger number of
points. Nevertheless, as expected, ppr(δ+) and ppr(δ−) still exhibit anticorrelation. In
Figure §F.5 we also use colors to show two different groups: red dots are for age Young
and blue dots are for age Old individuals. As expected we can see that the red dots are
distributed more in the area of higher ppr(δ−).
The plots in Figure §F.6 have a threshold t ∈ [0, 1] on the X-axis, and the fraction of
tuples having gds−() ≥ t on the Y-axis, and they show this for different subgroups. The
first plot, from the Adult dataset, shows the group female, young, and young female. As
we can see the individuals that are both young and female have a higher generalized
discrimination score. Similarly, the second plot shows the groups old, single male, and
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Figure F.3: Scatter plot of ppr(δ+) versus ppr(δ−) for each individual in the German
credit dataset.
old single male from the German credit dataset. Here one can observe much lower rates
of discrimination with only 1/5 of the corresponding populations having gds−() ≥ 0.5,
while in the previous plot it was more than 85%.
F.5.5 Comparison with prior art
We next discuss examples in which the causation-based method draws different conclu-
sions from the correlation-based methods presented in [153, 180, 165] using the same
datasets and the same protected groups.7
The first example involves the foreign worker group from German Credit dataset, whose
contingency table is reported in Figure §F.8. Following the approachs of [153, 180, 165]
the foreign worker group results strongly discriminated. In fact Figure §F.8 shows an
RD value (risk difference) of 0.244 which is considered a strong signal: in fact RD > 0
is already considered discrimination [165].
However, we can observe that the foreign worker group is per se not very significant,
as it contains 963 tuples out of 1000 total. In fact the causal approach does not detect
any discrimination with respect to foreign worker which appears as a disconnected node
in the SBCN.
The second example is in the opposite direction. Consider the race black group
from Adult dataset whose contingency table is shown in Figure §F.9. The causality-
based approach detects a very strong signal of discrimination (ds−() = 0.994), while the
7We could not compare with [123] due to repeatability issues: we contacted the authors asking their
help, but we didn’t get a reply.
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Figure F.4: Individual discrimination: histogram representing the distribution of the
values of the generalized discrimination score gds− for the population of the German
credit dataset.
approachs of [153, 180, 165] fail to discover discrimination against black minority when
the value of minimum support threshold used for extracting classification rules is more
than 10%. On the other hand, when such minimum support threshold is kept lower, the
number of extracted rules might be overwhelming. Moreover, the value of RD is not
very strong, while in this method the discrimination reported is strong, regardless of the
small size of the black population contained in the dataset.
Figure §F.7 presents the SBCN extracted by this approach from Berkeley Admission
Data. Interestingly, we observe that there is no direct edge between node sex Female
and Admission No. And sex Female is connected to node Admission No through nodes of
Dep C, Dep D, Dep E, and Dep F, which are exactly the departments that have lower
admission rate. By running the random walk-based methods over SBCN we obtain the
value of 1 for the score of explainable discrimination confirming that apparent discrimi-
nation in this dataset is due the fact that women tended to apply to departments with
lower rates of admission.
Similarly, we observe that is no direct edge between node sex Male and Admission Yes.
And sex Male is connected to node Admission Yes through nodes of Dep A, and Dep B,
which are exactly the departments that have higher admission rate. By running the
random walk-based methods over SBCN we obtain the value of 1 for the score of ex-
plainable discrimination confirming that apparent favoritism towards men is due to the
fact that men tended to apply to departments with higher rates of admission.
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Figure F.5: Individual discrimination: scatter plot of ppr(δ+) versus ppr(δ−) for each
individual in the Adult dataset. Red dots are for age Young and blue dots are for age Old.
However, following the approaches of [153, 180, 165], the contingency table shown in
Figure §F.10 can be extracted from Berkeley Admission Data. As shown in Figure §F.10,
the value of RD suggests a very strong signal of discrimination versus women. This high-
lights once more the pitfalls of correlation-based approaches to discrimination detection
and the need for a principled causal approach.
F.6 Conclusions
Discrimination discovery from databases is a fundamental task in understanding past
and current trends of discrimination, in judicial dispute resolution in legal trials, in
the validation of micro-data before they are publicly released. While discrimination is a
causal phenomenon, and any discrimination claim requires to prove a causal relationship,
the bulk of the literature on data mining methods for discrimination detection is based
on correlation reasoning.
In this Chapter we propose the first discrimination detection method grounded in
probabilistic causal theory. We first define a method to extract a graph representing
the causal structures found in the database, and then we propose several random-walk-
based methods over the causal structures, addressing a range of different discrimination
problems.
The experimental assessment confirmed the great flexibility of the proposal in tack-
ling different aspects of the discrimination detection task, and doing so with very clean
signals, clearly separating discrimination cases.
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Figure F.6: Subgroup discrimination: plots reporting a threshold t ∈ [0, 1] on the X-axis,
and the fraction of tuples having gds−() ≥ t on the Y-axis. The top plot is from Adult,
while the bottom is from German credit.
decision
- +
foreign worker=yes 298 667 968
foreign worker=no 2 30 32
300 700 1000
p1 = 298/968 = 0.307
p2 = 2/32 = 0.0625
RD = p1 − p2 = 0.244
Table F.8: Contingency table for foreign worker in the German credit dataset.
decision
- +
race=black 4119 566 4685
race 6=black 33036 11121 44157
37155 11687 48842
p1 = 4119/4685 = 0.879
p2 = 33036/44157 = 0.748
RD = p1 − p2 = 0.13
Table F.9: Contingency table for race black in the Adult dataset.
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ds−(v) as−(v) as+(v)
relationship Unmarried 1 1.164 -
marital status Never married 0.996 1.21 2.14
age Young 0.995 2.407 3.857
race Black 0.994 2.46 4.4
sex Female 0.98 2.60 3.76
ds−(v) as−(v) as+(v)
relationship Husband 0 - 2
marital status Married civ spouse 0 - 2.06
sex Male 0 - 3.002
native country India 0.002 4.0 3.25
age Old 0.018 2.062 2.14
Table F.4: Top-5 and bottom-5 groups by discrimination score ds−(v) in Adult dataset.
ds−(v) as−(v) as+(v)
residence since le 1d6 1 6.0 -
residence since gt 2d8 1 2.23 -
residence since from 1d6 le 2d2 1 6.0 -
age gt 52d6 0.86 3.68 4.0
personal status male single 0.791 5.15 5.0
ds−(v) as−(v) as+(v)
job unskilled resident 0 - 2.39
personal status male mar or wid 0.12 8.0 4.4
age le 30d2 0.186 7.0 3.34
personal status female 0.294 6.48 4.4
div or sep or mar
Table F.5: Top-5 and bottom-4 groups by discrimination score ds−(v) in German credit.
We report only the bottom-4, because there are only 4 nodes in which ds+(v) > ds−(v).
ds−(v) as−(v) as+(v)
MIGSAME Not in universe under 1 year old 0.71 4.09 8.82
WKSWORK 94 5 inf 0.625 3.0 6.76
AWKSTAT Not in labor force 0.59 2.0 6.16
VETYN 0 5 20 5 0.58 1.01 5.17
MARSUPWT 3188 455 4277 98 0.55 5.0 9.25
ds−(v) as−(v) as+(v)
AHGA Doctorate degreePhD EdD 0 - 3.07
AMARITL Married A F spouse present 0 - 4.49
AMJOCC Sales 0 - 2.0
ARACE Asian or Pacific Islander 0 - 6.47
VETYN 20 5 32 5 0 - 5.89
Table F.6: Top-5 and bottom-5 groups by discrimination score ds−(v) in Census-income
dataset.
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Source node Intermediate fed−(v)
race Amer Indian Eskimo education HS grad 0.481
sex Female occupation Other service 0.310
age Young occupation Other service 0.193
relationship Unmarried education HS grad 0.107
race Black education 11th 0.083
Source node Intermediate fed+(v)
relationship Husband occupation Exec managerial 0.806
sex Male occupation Exec managerial 0.587
native country Iran education Bachelors 0.480
native country India education Prof school 0.415
age Old occupation Exec managerial 0.39
Table F.7: Fraction of explainable discrimination for some exemplar pair of nodes in the
Adult dataset.
Male
Dep_A
0.252
Dep_B
0.183
Admission_Yes
0.33 0.254
Female
Dep_C
0.201
Dep_D
0.047
Dep_E
0.142
Dep_F
0.045
Admission_No
0.039 0.052 0.15 0.378
Figure F.7: The SBCN constructed from Berkeley Admission Data dataset.
decision
- +
gender=female 1278 557 1835
gender=male 1493 1158 2651
2771 1715 4486
p1 = 1278/1835 = 0.696
p2 = 1493/2651 = 0.563
RD = p1 − p2 = 0.133
Table F.10: Contingency table for female in the Berkeley Admission Data dataset.
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